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The first chapter of this dissertation describes the use of an intramolecular 
Staudinger/aza-Wittig reaction in the synthesis of 1,2,5,6-tetrahydro-1,2,4-triazines, a structural 
motif of the natural product noelaquinone. The DEF ring system of noelaquinone was prepared 
in 13 steps and 2% overall yield with key steps featuring a Cu(I)-catalyzed C-arylation and the 
controlled acidic hydrolysis of the PMB protective group. 
The second chapter describes the investigation of reactions between methyl 3-oxo-2-
oxabicyclo[2.2.0]hexane-6-carboxylate and an indolo-indoline dimer in the presence of 
BF3·OEt2. Two tricyclic-fused heterocyclic products and a diene carboxylic acid have been 
obtained through a ring opening process, a retro-[2+2] cycloaddition, and a conjugate addition 
from the indole fragment. 
The third chapter describes progress toward the total synthesis of haouamine A. Several 
routes to the marine alkaloid have been attempted. The challenges associated with the late stage 
lactam reduction, epoxidation, and aromatization strategy to prepare the necessary 
tetrahydropyridine and aza-cyclophane moieties are discussed. 
Synthetic Studies Toward Complex Polycyclic Natural Products  
 Liming Cao, PhD 
University of Pittsburgh, 2018
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1 
1.0  1, 2, 4-TRIAZINE SYNTHESIS USING THE STAUDINGER/AZA-WITTIG 
REACTION AND ITS APPLICATION TOWARD THE SYNTHESIS OF THE DEF 
RING SYSTEM OF NOELAQUINONE 
1.1 INTRODUCTION 
1.1.1 Applications of the Staudinger/aza-Wittig (SAW) Reaction 
The organic azide is a functional group with versatile applications in organic synthesis.
1,2
 In this work, the 
Staudinger/aza-Wittig (SAW) reaction
3
 is the relevant transformation involving the organic azide, as 
shown in Scheme 1-1. In this transformation, the organic azide is treated with trialkyl/triaryl phosphines 
and phosphites to form iminophosphorane intermediates 1-1, which can then undergo hydrolysis to the 
substituted amines 1-2 by subsequent reaction with water (Staudinger reaction), or can be converted to the 
corresponding imines 1-3 by reaction with carbonyl compounds consisting of aldehydes, ketones, acid 
halides, or heterocumulenes (Staudinger/aza-Wittig reaction). There are several polymer-supported 
phosphine reagents developed to simplify the removal of phosphine oxide by-products from the desired 
imine products
4
 since phosphine oxide is generally difficult to remove by ordinary purification methods.  
2 
 
Scheme 1-1 Staudinger/aza-Wittig reaction 
Less reactive carbonyl functionalities of imides, esters, and amides have also been shown to 
participate in the intramolecular SAW reactions, as shown in Scheme 1-2. 
5
 
 
Scheme 1-2 Intramolecular Staudinger/aza-Wittig reaction 
The SAW reaction has been successfully applied toward the construction of complex natural 
products.  
A key step in Forsyth and Chen’s total synthesis of the anticancer agent aprotaxin A 1-10 
involves a SAW reaction on a thioamide to generate the thiazoline-containing intermediate 1-9 (Scheme 
1-3).
6
 
3 
 
Scheme 1-3 Thiazoline formation in Forsyth and Chen’s preparation of apratoxin A 1-10 
The Williams’ approach to the stemona alkaloid (-)-stemonine 1-14 involves an azepane 
formation via a SAW reaction, followed by a NaBH4 reduction of the resulting imine (Scheme 1-4).
7
  
 
Scheme 1-4 Williams preparation of stemonine 1-14 
Eguchi et al. have described a versatile strategy that prepares iminolactam derivatives 1-16 
through SAW reaction by treatment of azides 1-15 with PPh3 in refluxing toluene.
8
 This interesting 
transformation serves as a precedent for the aza-Wittig reaction using phthalimides, which extends the 
scope of the methodology to the preparation of structurally unique 1,2,4-triazine derivatives such as 1-17 
(Scheme 1-5). 
4 
 
Scheme 1-5 Eguchi’s Staudinger/aza-Wittig reaction to form iminolactam derivatives 1-17 
1.1.2 Wipf Group Methodology: 1,2,4-Triazine Synthesis 
Previous work in the Wipf group has shown that 1,2,4-triazines such as 1-19 can be prepared from alkyl 
azides such as 1-18 by treatment with trialkyl/aryl phosphines (Scheme 1-6).
9
 With this methodology, a 
series of substituted triazines of this class has been successfully synthesized.  
 
Scheme 1-6 Staudinger/aza-Wittig reaction to prepare 1,2,4-triazines 
Amantini et al. have shown that hydrazide derivatives such as 1-22 can be prepared by reductive 
amination of aryl hydrazides 1-20. Subsequent N-alkylation and TBS group deprotection afforded 1-23.  
Conversion to azides 1-24 using standard conditions followed by treatment with trialkylphosphines under 
microwave irradiation provided the corresponding cyclic azides 1-25 (54-86%). Representative triazines 
are depicted in Scheme 1-7.
9
 
5 
 
Scheme 1-7 Preparation of substituted 1,2,4-triazines 1-25 
Alternatively, the azide-containing hydrazides can be initially installed through reductive 
amination followed by N-alkylation to the requisite cyclization precursor 1-24 (Scheme 1-8).
9
 
 
 
Scheme 1-8 Alternative method for preparing hydrazide 1-24 
1.1.3 Xestospongia Metabolites: Noelaquinone and Related Structures  
The triazine-containing moiety of the natural product noelaquinone 1-28 can be constructed through the 
use of an intramolecular SAW reaction. Noelaquinone 1-28 was first isolated in 1996 from an 
unidentified Xestospongia sp. at Derawan Island, Indonesia, by Paul Scheuer and co-workers (Scheme 1-
9).
10
 At present, the potential biological activities of noelaquinone 1-28 are unclear, but structurally 
6 
related compounds such as halenaquinone
11
 1-34, have antibiotic
11
, cytotoxic, and antifungal effects.
12
 In 
addition, halenaquinone 1-34 and xestoquinone
13
 1-31 are potent Pfnek-1 kinase inhibitors.
14
 Other 
natural products isolated from Xestospongia sp. include Kitagawa’s quinol 1-29 and monosulfate15 1-30, 
methoxyhalenaquinone 1-32, and hydroxyhalenaquinone 1-33. 
 
 
Scheme 1-9 Noelaquinone and related natural products 
1.1.4 Halenaquinone and Wortmannin Analogs Prepared in the Wipf group 
Wortmannin 1-35 and viridin 1-36 are two members of the viridin family that contain a tricyclic furan 
moiety,
15
 which is also present in the structure of halenaquinone 1-34 (Scheme 1-9). As a result of their 
unselective kinase activities, wortmannin 1-35 and viridin 1-36 are unsuitable therapeutic candidates.
16
  
However, a research project in the Wipf group involves the design and discovery of protein tyrosine and 
phosphatidylinositol 3-kinase (PI-3 kinase) inhibitors. 
17-19
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Scheme 1-10 Natural products containing the reactive tricyclic furan group 
 
The proposed biological mechanism of action of these molecules involves a Michael addition of 
the Lys-802 (P110 PI-3-kinase) residue to the tetrahydrofuran group to form covalent adducts such as 1-
38 that inactivate protein function.
20,21
 This strategy is supported by the diallylamine adduct of 
wortmannin (PX-866 1-39) developed in the Wipf group that is a potent inhibitor of phosphoinositide 
(PtdIns)-3-kinase (IC50 = 0.1 nmol/L)
22
, as depicted in Scheme 1-11.                                                                             
 
Scheme 1-11 Proposed mechanism of action for kinase inhibition and the design of inhibitor PX-866 1-39 
The Wipf group has also studied halenaquinone 1-34 and derivatives that target Pfnek-1 protein 
kinase which is essential to the malaria parasite Plasmodium falciparum.
23
 Malaria is a disease with three 
to five hundred million clinical cases and more than two million deaths yearly.
24,25
 Its prevention has been 
the focus of the U.S. Army since the infection of the disease causes a potential health hazard to its 
worldwide personnel. The Walter Reed Army Institute of Research (WRAIR) supports new treatments for 
8 
drug-resistant strains of malaria.
26
 A more selective Pfnek-1 protein kinase inhibitor was reported by Wipf 
et al.
27,28
 that replaces the furan ring with a thiophene. This new analog was designed to attenuate the 
electrophilic reactivity which was supported by computational calculations indicating a 2.6 kcal/mol 
lower strain energy for the new thiophene analog (Scheme 1-12).  
 
Scheme 1-12 Proposed analog of halenoquinone 1-34-thiohalenaquinone 1-40 
In collaboration with the Dow group at WRAIR, several thiohalenoquinone analogs were 
screened for Pfnek-1 activity and the results are summarized in Table 1-1.
28
 
Table 1-1 IC50 values of thiohalenoquinone analogs 
 
entry Thiohalenaquinone 
analog 
IC50 (μM)* 
1 1-41 2.8-3.9 
2 1-42 >2500 
3 1-43 >2500 
4 1-40 4.6-6.7 
* Several thiohalenoquinone analogs were screened for Pfnek-1 activity. 
9 
Thiohalenaquinone 1-40 could be obtained by Diels-Alder cycloaddition of diene precursor 1-46 
with 1-45 (prepared in 12 linear steps from 2,3-dibromothiophene 1-44 ). Intramolecular Heck-cyclization 
provided 1-48 with 10% overall yield over 4 steps. Deprotection and conversion to aldehyde 1-49 
followed by allylation furnished alcohol 1-50 as a mixture of diastereomers. Treatment of 1-50 with 
Hoveyda-Grubbs 2
nd
 generation ruthenium catalyst proceeded to give the multi-functionalized pentacyclic 
intermediate 1-51 that was further manipulated into thiohalenaquione 1-40 in a few steps (Scheme 1-13).   
 
Scheme 1-13 Preparation of thiohalenaquinone 1-40 
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1.1.5 Model Studies toward the DEF Ring System of Noelaquinone 
Our initial attempts to construct 1,2,4- triazine-containing scaffolds were unsuccessful using the SAW 
conditions outlined in Scheme 1-14.
9
  
 
Scheme 1-14 SAW reaction attempts on lactams 
A second generation approach to the DEF ring system of noelaquinone 1-28 was developed 
(Scheme 1-15). The pivotal homophthalimide 1-55 can be prepared from acylation of hydrazine 1-60 and 
subsequent arylation-cyclization. For this model system, an intramolecular SAW reaction on 
homophthalimide 1-57 was envisioned to construct the tricyclic ring system.
9,29
 
 
Scheme 1-15 Retrosynthesis of the model system 1-55 
1.1.5.1 Synthesis of Homophthalimide 1-57 
After screening numerous hydrazine protecting groups, it was found that the ethyl pyruvate derived 
hydrazone was suitable for the proposed transformations.
30
  
11 
Thus, condensation of 2-hydroxyethylhydrazine 1-62 with ethyl pyruvate 1-61 gave hydrazone 1-
63, which was readily converted to azide 1-64 via mesylate displacement. The stability of the hydrazone 
moiety was very important
31
 since the undesired hydrolysis could generate the low molecular weight 
azide 1-66, which has been shown to be explosive (Scheme 1-16).
1,9,29
 
 
Scheme 1-16 Synthesis of hydrazine 1-60 
The potentially explosive N-benzylhydrazine 1-60, produced by cleavage of  hydrazone 1-65, was 
used directly in the next step to provide acyl hydrazide 1-67.
32
 Treatment of 1-67 with CuI, picolinic acid, 
diethylmalonate 1-59, and Cs2CO3 in dioxane provided an α-arylmalonate intermediate
33,34
 (not shown) 
that was used in the next step following workup (Scheme 1-17). A cyclization/decarboxylation of the α-
arylmalonate intermediate was promoted with cat. p-TSA to furnish homophthalimide 1-57.
9,29
 
 
Scheme 1-17 Preparation of homophthalimide 1-57 
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1.1.5.2 Oxidation and Staudinger/aza -Wittig Reaction  
The initial approach toward the DEF ring model system 1-52 started with the SAW reaction followed by 
benzylic oxidation of the corresponding intermediate (Scheme 1-18). It was previously shown that 
treatment of azide substrate 1-57 with either PBu3 or DPPB using microwave irradiation conditions gave 
triazine 1-68. It was also determined that tautomer 1-69 was preferred as indicated by the vinyl-proton 
peak at 5.55 ppm in the 
1
H NMR spectrum.
29
 
 
Scheme 1-18 Staudinger/aza-Wittig reaction followed by oxidation 
 
Interestingly, enamine 1-69 undergoes a facile oxidation when stored at room temperature for 
several days (Scheme 1-19). The proposed mechanism involves the formation of a hydroperoxy 
intermediate 1-70
35
, followed by an opening of the cyclic peroxide and proton transfer to form 1-71. The 
desired DEF ring system 1-55 was obtained after dehydration (Scheme 1-20).
29
 
 
Scheme 1-19 Model system obtained by auto-oxidation 
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Scheme 1-20 Proposed mechanism for auto-oxidation of enamine 1-69 
However, efforts to identify a controlled conversion of 1-69 to the desired model system 1-55 
were not successful, as the conditions mostly resulted in a decomposed material (Table 1-2). The strategy 
was then redirected toward the oxidation of the benzylic position before performing the SAW reaction.
29
 
Table 1-2 Oxidation of enamine 1-69 
 
entry reagent solvent temperature time result 
1
36
 
Fremy’s salt EtOH(aq.) rt 12 h 
SM* 
2
37
 CAN THF (aq.) rt 24 h decomposition 
3 CAN on alumina THF (aq.) rt 12 h decomposition 
4 K3Fe(CN)6, Cs2CO3 THF (aq.) rt 12 h decomposition 
5 5% CAN, NaBrO3 THF (aq.) rt 2.5 h decomposition 
*Starting material was identified by TLC. 
 
14 
Successful benzylic oxidations using CAN in aqueous THF or HNO3/AcOH gave ketone 1-72 
albeit in modest yields. However, subsequent SAW cyclization attempts did not provide the dione 1-55 
(Scheme 1-21). At this point, a ketone protecting group strategy was investigated.
29
 
 
Scheme 1-21 Preparation of model system 1-55 using an oxidation/SAW sequence 
 
A cyclic thioketal was introduced for the incorporation of the necessary benzylic oxidation state 
(Scheme 1-22) and was anticipated to provide a more compatible substrate for the SAW reaction.
38
 The 
cyclic thioketal 1-73 was obtained in 3 steps from acyl hydrazide 1-57 in 59% yield.
9,29
  
 
Scheme 1-22 Preparation of cyclic thioketal 1-73 
When subjected to the microwave irradiation SAW conditions, thioketal azide 1-73 was 
converted to a mixture of inseparable regioisomers 1-74 and 1-75 in low to moderate yields, as shown in 
Scheme 1-23. Through the use of high-temperature 
1
H NMR analysis, it was not possible to conclusively 
determine the composition of the apparent mixture. All attempts to remove the thioketal resulted in either 
no reaction or decomposition (Table 1-3).
29
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Scheme 1-23 Putative regioisomers from the Staudinger/aza-Wittig reaction 
 
Table 1-3 Removal of cyclic thioketal from SAW product 1-74 and 1-75 
 
entry reagent solvent temperature time result 
1
39
 PIFA CH3CN/H2O rt 40 min decomposition 
2
40
 NBS acetone/H2O 0 °C 5 min decomposition 
3
41
 CuCl2, CuO acetone/H2O rt 6 h SM* 
4
42
 I2 DMSO rt; 100 °C 1.5 h; 1 h decomposition 
5
43
 PIFA MeOH/H2O rt 30 min decomposition 
6 CAN CH3CN/H2O rt 1 h decomposition 
7 PIFA, AcOH THF/H2O rt 1.5 h decomposition 
8 30% H2O2 MeOH rt 40 min decomposition 
9
44
 Hg(OAc)2 CH3CN/H2O rt 12 h decomposition 
10 AgNO3, NCS CH3CN/H2O 0 °C 3 h decomposition 
16 
11
45
 Chloramine T EtOH/H2O rt 9.5 h SM* 
12
46
 NaNO2, TFA H2O rt 20 h decomposition 
*Starting material was identified by TLC. 
As a result of the difficulties in the removal of the thioketal functionality, an alternative 
conversion to the dimethoxylketal 1-76 was accomplished using PIFA in dry MeOH in 60% yield.
39
 This 
dethionylation-protecting group exchange proved to be pivotal for the success of the intramolecular SAW 
reaction to cleanly afford triazine 1-77 in 61% yield (Scheme 1-24).
9,29
 
 
 
Scheme 1-24 Desulfurization/SAW sequence to arrive at dimethyketal 1-77 
1.2 RESULTS AND DISCUSSION 
1.2.1 Hydrolysis of Dimethoxyketal to Ketone 
A series of mild ketal hydrolysis conditions were attempted (Table 1-4) and led to either decomposition 
products or recovery of starting material. 
Table 1-4 Mild hydrolysis conditions 
 
17 
 entry reagent solvent temperature time result 
1 HCl acetone 50 °C 12 h decomposition 
2
47
 I2 acetone rt 12 h SM* 
3
48
 p-TSA acetone rt 24 h SM* 
4 HCl AcOH rt 24 h decomposition 
5
49
 Bi(NO3)3·5H2O CH2Cl2 40 °C 12h no reaction 
6 BiBr3 H2O rt; reflux 24h; 2 h unknown product 
*Starting material was identified by TLC. 
After substantial reaction optimizations, it was determined that treatment of 1-77 with a mixture 
of conc. H2SO4 in H2O/CH2Cl2 (1/1/2- volume ratio) at 40 °C for 12 h could provide the desired triazine-
dione 1-55 along with an unexpected regioisomer 1-78 in 32% and 13% yields, respectively (Scheme 1-
25).
9
  
The structures of both of the triazine regioisomers were unequivocally determined by X-ray 
crystallographic analysis (Figure 1).
9
 
 
Scheme 1-25 Hydrolysis of dimethyl ketal 1-77 
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Figure 1 X-ray crystallographic analysis of two regioisomers 1-55 and 1-78 
 
A plausible mechanism for the conversion of 1-55 into 1-78 under acidic conditions is depicted in 
Scheme 1-26.
50
 An acid-mediated ring opening process presumably gives an initial oxonium ion 
intermediate 1-79. Nucleophilic attack of the resulting secondary amine to the oxonium species followed 
by deprotonation afforded the observed regioisomer 1-78.  Furthermore, it was found that the 
isomerization products could be formed preferentially through the use of weak acids, such as formic acid.  
While this strategy was successful in assembling the DEF rings of a model system, we were 
unable to identify conditions that avoided the accompanying isomerization. 
 
Scheme 1-26 Proposed mechanism for isomerization of 1-55 
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1.2.2 Removal of Benzyl Protecting Group 
With the key tricycle 1-55 in hand we turned our attention to the removal of the N-benzyl group. A series 
of conditions were screened including both reductive and oxidative methods depicted in Table 1-5. 
Unfortunately, all of these attempts were not productive and either gave decomposition products 
or recovery of unreacted starting materials (Table 1-5). 
The efforts to convert the benzyl group into other functional groups to facilitate removal were 
also not successful (Table 1-6, entries 1-2). In addition, a complete isomerization of 1-55 into 1-78 was 
observed under catalytic hydrogenation conditions (Table 1-5, entry 8). 
 
 
Table 1-5 Conditions to remove benzyl group 
 
entry reagent solvent temperature time result 
1
51
 BBr3 CH2Cl2 rt 12 h decomposition 
2
52
 5% Pd/C, H2 1,1-dichloroethane/MeOH rt 12 h unknown product 
3
53,54
 Pd(OH)2, H2 MeOH rt 12 h decomposition 
20 
4
52
 5% Pd/C, H2 1,1,2-trichloroethane rt 5 h decomposition 
5
55
 5% Pd/C, H2 MeOH rt 12 h decomposition 
6
56,57
 
5% Pd/C, 
HCOOH 
MeOH rt 12 h unknown product 
7
58
 
5% Pd/C, 1,4-
cyclohexadiene 
MeOH rt 12 h decomposition & SM* 
8
56,57
 
0.2 eq 5% 
Pd/C, HCOOH 
MeOH rt 12 h 1-78 (56%) 
9
56,57
 
2 eq 5% Pd/C, 
HCOOH 
MeOH rt 12 h decomposition 
10
59
 
Zn, ammonium 
formate 
MeOH rt 12 h decomposition 
11
60
 FeCl3 CH3CN rt 12 h decomposition 
12
61
 CAN CH3CN/H2O rt 12 h unknown product 
13
62
 NIS CH2Cl2 rt 12 h SM* 
14 NaNO2, TFA CH2Cl2/H2O rt 12 h decomposition & SM* 
*Starting material was identified by TLC and 
1
H NMR. 
 
 
Table 1-6 Conditions to convert benzyl group to other protecting groups 
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entry reagents solvent temperature time results 
1
63,64
 TrocCl, NaHCO3 CH3CN rt 12 h SM* 
2
65
 
Pd(OH)2, PMHS, 
Boc2O 
EtOH rt 12 h decomposition 
*Starting material was identified by TLC and 
1
H NMR. 
 
Unfortunately, the removal of the N-benzyl group proved problematic. An alternative strategy 
was devised using the p-methoxybenzyl (PMB) protecting group from the start of the reaction sequence.  
1.2.3 Model Studies for the DEF Ring System of Noelaquinone Using the PMB Protecting 
Group 
The first few steps of this modified approach proceeded according to those previously described. 
Hydrazone 1-64 was treated with freshly-prepared p-methoxybenzyl bromide at room temperature to 
afford the N-PMB-hydrazone 1-84 in 82% yield. This hydrazone was then cleaved with excess hydrazine 
dihydrochloride in aqueous THF to yield hydrazine 1-85, which was used immediately following 
chromatographic purification (Scheme 1-27).
9
 
 
Scheme 1-27 Preparation of hydrazine 1-85 
 
22 
A similar acylation-arylation-cyclization approach was used to assemble the PMB-containing 
homophthalimide 1-87 (Scheme 1-28, see Scheme 1-17). Once again, the resulting α-arylmalonate 
intermediate (not shown) was subjected to cat. p-TSA to complete the cyclization/decarboxylation 
cascade.
9
  
 
 
Scheme 1-28 Preparation of homophthalimide 1-87 
The cyclic thioketal 1-88 was formed using trimethylene dithiotosylate. Transformation of cyclic 
thioketal 1-88 to dimethyl ketal 1-89 was accomplished with iodobenzenebistrifluoroacetate (PIFA) in 
methanol in the presence of trifluoroacetic acid.  The subsequent SAW reaction proceeded smoothly 
under microwave irradiation to afford the desired triazine 1-90 in 88% yield (Scheme 1-29).
9
  
 
Scheme 1-29 Preparation of triazine 1-90 
1.2.4 Removal of the PMB Protecting Group and Hydrolysis of the Dimethoxyacetal 
The remaining steps toward the preparation of the DEF rings of noelaquinone 1-82 involved the 
hydrolysis of the dimethyl acetal and PMB removal. The application of our previously successful acetal 
23 
exchange conditions to 1-90 did not provide dione 1-91. We speculated that the strongly acidic conditions 
might be incompatible with the PMB group, which may have contributed to the decomposition. 
Therefore, several milder conditions were attempted with similarly unproductive results (Table 1-7).
9
  
Table 1-7 Conditions to remove dimethyl acetal 
 
entry reagent solvent temperature time result 
1 conc. H2SO4 CH2Cl2/H2O 40 °C 12 h decomposition 
2
66-68
 LiBF4 CH3CN/H2O rt; 55 °C 8 h; 1 h SM* 
3
69
 amberlyst-15 acetone/H2O rt 40 h SM* 
4
70
 PPTS acetone/H2O reflux 18 h SM* 
*Starting material was identified by TLC and 1H NMR. 
In order to decrease the presumed acid lability of 1-90, this compound was treated with a H2SO4-
H2O/CH2Cl2 mixture at -20 °C for 12 h, which instead provided the dimethyl acetal-containing triazine 
derivative 1-92 in 72% yield (Scheme 1-30).
9
 
 
 
Scheme 1-30 Removal of the PMB group 
Based on this interesting result, our deprotection strategy was reversed. Following extensive 
reaction optimization conditions (Table 1-8), the final hydrolysis to 1-82 without concomitant 
isomerization was accomplished by subjecting ketal 1-92 to conc. H2SO4 in an H2O/CH2Cl2 mixture at 
24 
room temperature for 6.25 h. Interestingly, the different triazine substituents control the isomerization 
rates (1-77 and 1-92). It was rationalized that the oxocarbenium ion formed in the hydrolysis of 1-92 was 
stabilized to a greater extent due to the smaller lipophilicity of the whole molecule, which largely helps 
the solvation of 1-92 in the aqueous solution. Therefore, dimethyl ketal 1-92 was found to react at a 
slightly lower temperature and with no apparent isomerization. The structural assignment of 1-82 was 
confirmed by X-ray crystallographic analysis (Figure 2).
9
  
Table 1-8 Dimethoxyacetal hydrolysis to afford model system 1-82 
 
entry reagent solvent temperature time result 
1
71
 TFA CH2Cl2/H2O rt 12 h SM* 
2 HCl MeOH/H2O rt 12 h 
undetermined 
product 
3 H2SO4 MeOH/H2O rt 12 h SM* 
4
72
 DDQ CH3CN/H2O rt 18 h SM* 
5 conc. H2SO4 THF/H2O 4 °C 12 h SM* 
6 conc. H2SO4 THF/H2O rt 12 h SM* 
7 conc. H2SO4 CH2Cl2/ H2O 4 °C 12 h SM* 
8 conc. H2SO4 CH2Cl2/H2O 35 °C 12 h decomposition 
9 conc. H2SO4 CH2Cl2/H2O rt 6.25 h 62% 
*Starting material was identified by TLC and 
1
H NMR. 
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Figure 2 X-ray crystallographic analysis of model system 1-82 
1.3 CONCLUSION 
In summary, we have demonstrated a first generation approach toward the preparation of the DEF model 
system of noelaquinone, in which a Staudinger/aza-Wittig (SAW) reaction was utilized to construct the 
tetrahydro-1,2,4-triazine moiety.  In this sequence, homophthalimides 1-57 and 1-85 were accessed via a 
Cu(I)- catalyzed C-arylation of diethyl malonate followed by cyclization-decarboxylation. Isomerization 
of 1-55 to 1-78 was observed under acidic hydrolysis conditions when the N-benzyl protecting group was 
used, whereas the use of the PMB protecting group with milder acidic deprotection conditions avoided the 
isomerization.  The DEF ring system of noelaquinone was synthesized in 13 steps and 2% overall yield, 
and its structure was confirmed by X-ray analysis.
9
  
1.4 EXPERIMENTAL PART 
General: All reactions were performed under an N2 atmosphere and all glassware was dried in an oven at 
140 °C for 2 h prior to use. Reactions carried out at -78 °C employed a CO2/acetone bath. THF and Et2O 
were distilled over sodium/benzophenone ketyl, Et3N was distilled from CaH2, and CH2Cl2 and toluene 
26 
were purified using an alumina column filtration system. All other reagents and solvents were used as 
received unless otherwise noted. Reactions were monitored by TLC analysis (pre-coated silica gel 60 F254 
plates, 250 μm layer thickness) and visualization was accomplished with a 254 nm UV light and by 
staining with a PMA solution (5 g of phosphomolybdic acid in 100 mL of 95% EtOH), p-anisaldehyde 
solution (2.5 mL of p-anisaldehyde, 2 mL of AcOH, and 3.5 mL of conc. H2SO4 in 100 mL of 95% 
EtOH), Vaughn’s reagent (4.8 g of (NH4)6Mo7O24•4H2O and 0.2 g of Ce(SO4)2 in 100 mL of a 3.5 N 
H2SO4 solution) or a KMnO4 solution (1.5 g of KMnO4 and 1.5 g of K2CO3 in 100 mL of a 0.1% NaOH 
solution). Flash chromatography on SiO2 was used to purify the crude reaction mixtures. 
NMR spectra were recorded using XWIN-NMR software. 
 1
H NMR spectra were obtained at 300, 
400, 500, 600 or 700 MHz in CDCl3. Chemical shifts were reported in parts per million with the residual 
solvent peak used as an internal standard. 
1
H NMR spectra were obtained and are tabulated as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), number of 
protons, and coupling constant(s). 
13
C NMR spectra were obtained using a proton-decoupled pulse 
sequence with a d1 of 3 sec, and are tabulated by observed peak unless otherwise noted. Melting points 
were determined on a Mel-Temp II and are uncorrected. High-resolution mass spectrometry (HRMS) data 
(ESI/APCI technique) were recorded using a Waters Q-Tof Ultima API-US instrument. HRMS data (EI 
technique) were recorded using a Micromass Autospec instrument. Mass spectrometry data were also 
recorded using an Applied Biosystems MDS SCIEX API 2000 LC/MS/MS system. 
All organic azides and azide waste products should be considered toxic as well as potentially 
explosive and must be handled and stored with care. Avoid using halogenated solvents when performing 
reactions involving sodium azide, in addition to using halogenated solvents in reaction workup. Avoid 
quenching/manipulating/treating sodium azide reactions with acid, as the generation of trace amounts of 
hydrazoic acid (HN3) may result in an explosion. In general, a safety shield must be used when 
conducting reactions involving either sodium azide or organic azide derivatives. 
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2-Benzyl-3,4-dihydro-2H-[1,2,4]triazino[4,3-b]isoquinoline-6,11-dione (1-78); 4-benzyl-3,4-dihydro-
2H-[1,2,4]triazino[2,3-b]isoquinoline-6,11-dione (1-55). After concentrated H2SO4 (3.0 mL) was added 
dropwise into H2O (3.0 mL), the mixture was stirred for 5 min, cooled to room temperature and treated 
with a solution of 1-77 (29.8 mg, 0.0848 mmol) in CH2Cl2 (6.0 mL). The reaction mixture was stirred at 
40 °C for 12 h under argon, cooled to 25 °C, and solid Na2CO3 was added until pH>7. The mixture was 
extracted with CH2Cl2 (3×30 mL), dried (Na2SO4), concentrated, and purified by chromatography on SiO2 
(hexanes:EtOAc, 1:1 with 1% Et3N) to afford 1-78 (3.5 mg, 0.011 mmol, 13%) as golden needles and 1-
52 (8.4 mg, 0.028 mmol, 32%) as yellow crystals. 1-78: Mp 171.1-174.5 °C; IR (neat) 2923, 2852, 1659, 
1597, 1527, 1453, 1361, 1342, 1314, 1281, 1246, 1079, 1064, 1008 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
8.33 (td, J = 7.0, 2.0 Hz, 1 H), 8.32 (t, J = 6.5 Hz, 1 H), 7.80 (dtd, J = 18, 7.5, 1.5 Hz, 2 H), 7.35-7.33 (m, 
5 H), 4.73 (s, 2 H), 4.15 (t, J = 5.2 Hz, 2 H), 3.25 (t, J = 5.2 Hz, 2 H); 
13
C NMR (125 MHz, CDCl3; some 
rearrangement and decomposition occurred during the spectral data collection) δ 173.8, 157.7, 135.6, 
134.4, 133.3, 130.3, 129.0, 128.8, 128.4, 127.2, 63.1, 43.8, 38.1; HRMS (ESI) m/z calcd for C8H16N3O2 
([M+H]
+
) 306.1243, found 306.1250. 1-55: Mp 121.1-124.3 °C; IR (neat) 3068, 2917, 2974, 2924, 2865, 
1698, 1597, 1489, 1376, 1355, 1226, 1084, 1070, 984, 690 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.37 (dd, 
J = 7.5, 1.0 Hz, 1 H), 8.28 (dd, J = 7.5, 1.0 Hz, 1 H), 7.87 (td, J = 7.5, 1.0 Hz, 1 H), 7.79 (td, J = 7.5, 1.0 
Hz, 1 H), 7.54 (d, J = 7.0 Hz, 2 H), 7.4-7.3 (m, 3 H), 4.10 (s, 2 H), 3.97 (t, J = 6.5 Hz, 2 H), 3.12 (t, J = 
6.5 Hz, 2 H); 
13
C NMR (125 MHz, CDCl3; some rearrangement and decomposition occurred during the 
spectral data collection) δ 176.0, 157.5, 144.4, 135.6, 135.2, 133.8, 131.4, 130.1, 129.7, 129.5, 128.7, 
128.3, 127.7, 58.7, 43.3, 40.6; HRMS (ESI) m/z calcd for C18H16N3O2 ([M+H]
+
) 306.1237, found 
306.1243. 
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(E)-Ethyl 2-(2-(2-azidoethyl)-2-(4-methoxybenzyl)hydrazono)propanoate (1-84). To a solution of 1-
64 (3.93 g, 45.4 mmol) in DMF (50 mL) was added of K2CO3 (8.18 g, 59.2 mmol), KI (9.82 g, 59.2 
mmol), and 4-methoxybenzyl bromide (9.13 g, 45.4 mmol). The mixture was stirred at room temperature 
for 84 h, quenched with water (10 mL) and extracted with EtOAc (3×15 ml). The combined organic 
layers were washed with water (20 mL), brine(20 mL), dried (Na2SO4), concentrated in vacuo and 
purified by chromatography on SiO2 (100% hexanes to hexanes:EtOAc, 1:1 gradient with 1% Et3N) to 
afford 1-84 as a yellow oil(5.15 g, 16.1 mmol, 82%): IR(neat) 2954, 2097, 1707, 1610, 1510, 1299, 1245, 
1126, 831 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.27 (d, J = 8.0 Hz, 2 H), 6.88 (d, J = 8.0 Hz, 2 H), 4.31 (q, 
J = 7.2 Hz, 2 H), 3.98 (s, 2H), 3.80 (s, 3 H), 3.30 (t, J = 6.0 Hz, 2 H), 3.20 (t, J = 6.0 Hz, 2 H), 2.21 (s, 3 
H), 1.35 (t, J = 7.2 Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 164.9, 159.2, 153.2, 129.6, 128.6, 114.1, 
61.8, 60.3, 55.8, 55.3, 49.7, 16.0, 14.3; HRMS (ESI) m/z calcd for C15H22N5O3 ( [M+H]
+
) 320.1723, 
found 320.1732.  
  
1-(2-Azidoethyl)-1-(4-methoxybenzyl)hydrazine (1-85). To a solution of 1-84 (477 mg, 1.49 mmol) in 
THF (20 mL) and H2O (0.5 mL) at 25 ℃ was added hydrazine dihydrochloride (470 mg, 4.48 mmol). 
This mixture was stirred at 25 ℃ for 3 h, quenched with solid Na2CO3, and concentrated in vacuo. The 
resulting oil was immediately purified by chromatography on SiO2 (hexanes:EtOAc, 1:1 with 1% Et3N) to 
1-85 as an unstable, colorless oil (227 mg, 1.03 mmol, 69%): IR (neat) 3338, 3344, 2934, 2831, 2097, 
1610, 1510, 1461, 1243, 1172, 1031, 755 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.23(dt, J = 9.0, 2.5 Hz, 2 
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H), 6.86(dt, J = 9.0, 2.5 Hz, 2 H), 3.77 (s, 3 H), 3.64 (s, 2H), 3.44 (t, J =5.6 Hz, 2H), 2.70 (t, J = 2.8 Hz, 
2H), 2.69(br s, 2H) ; 
13
C NMR (125 MHz, CDCl3) δ159.0, 130.2, 129.0, 113.8, 66.7, 58.3, 55.1, 48.5; 
HRMS (ESI) m/z calcd for C10H16N5O ( [M+H]
+
) 222.1355, found 222.1350. 
 
N'-(2-Azidoethyl)-2-iodo-N'-(4-methoxybenzyl)benzohydrazide (1-86). To a solution of 1-55 (259 mg, 
0.972 mmol) in CH2Cl2 (20 mL) cooled to 0 °C was added a solution of 1-85 (226 mg, 1.02 mmol) in 
CH2Cl2 (5 mL) via syringe, followed by Et3N (0.20 mL, 1.5 mmol). After addition, the vessel was 
removed from the ice bath and the solution was allowed to warm to 25 °C overnight. After 12 h, the 
reaction mixture was quenched with satd. NaHCO3 (15 mL) and extracted with CH2Cl2 (3 ×10 mL). The 
combined organic phases were dried (Na2SO4), concentrated in vacuo, and purified by chromatography on 
SiO2 (hexanes:EtOAc, 4:1 with 1% Et3N) to afford 1-86 (304 mg, 0.675 mmol, 69%) as colorless flake-
like crystals: IR (neat) 3215.2, 3047.4, 2907.6, 2093.1, 1653.2, 1610.4, 1509.7, 1459.4, 1297.2, 1245.1, 
1172.4, 1030.7, 820.1 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.69 (dd, J = 8.0, 1.0 Hz, 1 H), 7.40 (s, 1 H), 
7.28 (dt, J = 8.5, 2.0 Hz, 2 H), 7.18 (td, J = 7.5, 1.0 Hz, 1 H), 6.97 (td, J = 7.5, 1.0 Hz, 1 H), 6.86 (dd, J = 
7.5, 1.5 Hz, 1 H), 6.82 (dt, J = 9.0, 2.0 Hz, 2 H), 4.10 (s, 2 H), 3.73 (s, 3 H), 3.44 (t, J = 6.0 Hz, 2 H), 3.18 
(t, J = 6.0 Hz, 2 H); 
13
C NMR (125 MHz, CDCl3) δ 168.5, 158.9, 140.3, 139.4, 131.0, 130.4, 128.6, 127.8, 
113.6, 92.6, 59.8, 55.1, 54.4, 48.6; HRMS (ESI) m/z calcd for C17H19IN5O2 ([M+H]
+
) 452.0584, found 
452.0564. 
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2-((2-Azidoethyl)(4-methoxybenzyl)amino)isoquinoline-1,3(2H,4H)-dione (1-87). To a flame-dried 
flask was added 1-86 (215 mg, 0.476 mmol), CuI (9.1 mg, 0.048 mmol), 2-picolinic acid (11.7 mg, 
0.0951 mmol) and Cs2CO3 (465 mg, 1.43 mmol). The reaction mixture was purged 3x with N2, and 
diluted with anhydrous dioxane (19 mL). After addition of 1-56 (94 mg, 0.59 mmol), the reaction flask 
was placed in a pre-heated oil bath at 70 °C under a N2 atmosphere. TLC analysis (hexanes:EtOAc, 6:1) 
after 3 h showed that the starting material was consumed. The mixture was cooled to 25 °C, quenched 
with satd. NH4Cl (10 mL), extracted with EtOAc (3×10 mL), washed with brine (20 mL), and 
concentrated in vacuo. The residue was dissolved in toluene (13 mL) and H2O (3 mL), and p-TSA (45.2 
mg, 0.238 mmol) was added. The pink colored mixture was heated at reflux for 20 h, cooled to 25 °C, and 
quenched with satd. NaHCO3 (20 mL). The biphasic mixture was partitioned and then the aqueous phase 
was extracted with EtOAc (3x10 mL). The crude mixture showed one spot by TLC (hexanes: EtOAc, 
5:1). The combined organic phases were washed with brine (10 mL), dried (Na2SO4), concentrated in 
vacuo, and purified by chromatography on SiO2 (hexanes:EtOAc, 10:1 to 5:1) to afford 1-87 (109 mg, 
0.297 mmol, 63%) as a bright yellow oil: IR (neat) 3068, 2947, 2097, 1726, 1681, 1609, 1510, 1459, 
1342, 1245, 1171, 1033, 757 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.13 (d, J = 8.0 Hz, 1 H), 7.52 (t, J = 
7.5 Hz, 1 H), 7.39 (t, J = 7.5 Hz, 1 H), 7.34 (dt, J = 8.5, 2.0 Hz, 2 H), 7.16 (d, J = 7.5 Hz, 1 H), 6.76 (dt, J 
= 8.5, 2.0 Hz, 2 H), 4.35, 4.30 (AB, J = 12.0 Hz, 2 H), 3.96, 3.80 (AB, J = 22.0 Hz, 2 H), 3.71 (s, 3 H), 
3.43-3.31 (m, 4 H); 
13
C NMR (125 MHz, CDCl3) δ 169.7, 165.0, 159.1, 133.7, 130.6, 129.2, 128.8, 127.7, 
127.0, 125.7, 113.6, 59.2, 55.2, 52.7, 50.1, 37.6; HRMS (ESI) m/z calcd for C17H20N5O3 ([M+H]
+
) 
366.1566, found 366.1589.  
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2'-((2-Azidoethyl)(4-methoxybenzyl)amino)-1'H-spiro[[1,3]dithiane-2,4'-isoquinoline]-1',3'(2'H)-
dione (1-88). To a solution of 1-87 (109 mg, 0.297 mmol) in CH2Cl2 (30 mL) at 25 °C was added Et3N 
(91.9 µL, 0.654 mmol) followed by trimethylene di(thiotosylate) (156 mg, 0.357 mmol). The green-
yellow solution was stirred at 25 °C under N2 for 21 h, quenched with satd. NH4Cl (10 mL), extracted 
with CH2Cl2 (2×10 mL), dried (Na2SO4), concentrated, and purified by chromatography on SiO2 
(hexanes:EtOAc, 4:1) to afford 1-88 (92.1 mg, 0.196 mmol, 66%) as a colorless oil: IR (neat) 3009, 2927, 
2871, 2097, 1723, 1681, 1611, 1512, 1335, 1243, 1171,751, 699 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.16 
(dd, J = 8.0, 1.0 Hz, 1 H), 8.10 (dd, J = 8.0, 1.0 Hz, 1 H), 7.63 (td, J = 8.0, 1.0 Hz, 1 H), 7.48 (td, J = 8.0, 
1.0 Hz, 1 H), 7.42 (dt, J = 8.0, 2.0 Hz, 2 H),  6.81 (dt, J = 8.0, 2.0 Hz, 2 H), 4.38, 4.34 (AB, J = 7.0 Hz, 2 
H), 3.80 (td, J = 13.5, 2.0 Hz, 1 H), 3.75 (td, J =13.5, 2.0 Hz, 1 H), 3.74 (s, 3 H), 3.45-3.30 (m, 4 H), 2.73 
(dt, J = 13.5, 3.5 Hz, 1 H), 2.66 (dt, J = 13.5, 3.5 Hz, 1 H), 2.32-2.29 (m, 1 H), 2.05-1.97 (m, 1 H); 
13
C 
NMR (125 MHz, CDCl3) δ 169.8, 163.1, 159.2, 136.9, 134.2, 130.7, 129.7, 129.5, 129.0, 125.0, 113.7, 
59.6, 55.3, 52.2, 49.8, 49.4, 29.0, 28.9, 23.5; HRMS (ESI) m/z calcd for C22H23N5O3S2Na ([M+Na]
+
) 
492.1140, found 492.1170.  
 
2-((2-Azidoethyl)(4-methoxybenzyl)amino)-4,4-dimethoxyisoquinoline-1,3(2H,4H)-dione (1-89). To 
a solution 1-88 (92.1 mg, 0.196 mmol) in dry MeOH (8.0 mL) was added TFA (43.7 µL, 0.588 mmol) 
and PIFA (288 mg, 0.670 mmol) at 23 °C. The mixture was stirred for 15 min when TLC analysis 
(hexanes:EtOAc, 4:1) of an aliquot neutralized with Na2CO3 showed that the starting material was 
converted to a slightly more polar spot. After 20 min, the reaction was quenched with solid Na2CO3 until 
pH>7, causing the yellow solution to change to colorless as the pH increased. The mixture was extracted 
with CH2Cl2 (4×10 mL), dried (MgSO4), concentrated, and purified by chromatography on SiO2 
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(hexanes:EtOAc, 5:1 to 3:1 with 1% Et3N) to afford 1-89 (56.6 mg, 0.133 mmol, 68%) as a pale yellow 
oil: IR (neat) 2992, 2936, 2863, 2097, 1739, 1691, 1739, 1512, 1458, 1333, 1282, 1243, 1172, 1083, 764 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.13 (d, J = 12.0 Hz, 1 H), 7.65 (d, J = 4.0 Hz, 2 H), 7.56-7.53 (m, 1 
H), 7.33 (d, J = 8.5 Hz, 2 H), 6.75 (d, J = 8.5 Hz, 2 H), 4.38, 4.29 (AB, J = 12.5 Hz, 2 H), 3,71 (s, 3 H), 
3.50-3.45 (m, 1 H), 3.37-3.33 (m, 3 H), 3.30 (s, 3 H), 3.11 (s, 3 H); 
13
C NMR (125 MHz, CDCl3) δ 168.5, 
163.8, 159.3, 135.7, 133.6, 130.9, 130.3, 129.2, 128.6, 126.6, 126.5, 113.7, 95.9, 59.5, 55.3, 52.7, 52.2, 
52.1, 49.7; HRMS (ESI) m/z calcd for C21H23N5O5Na ([M+Na]
+
) 448.1597, found 448.1629.  
 
11,11-Dimethoxy-4-(4-methoxybenzyl)-3,4-dihydro-2H-[1,2,4]triazino[2,3-b]isoquinolin-6(11H)-one 
(1-90). To a flame-dried microwave vial was added a solution of 1-89 (56.6 mg, 0.133 mmol) in distilled 
PhCl (2.5 mL), followed by a solution of PBu3 (46.0 mg, 0.228 mmol) in distilled PhCl (580 µL). The 
green-brown mixture was stirred at room temperature for 10 min then heated at 180 °C in the microwave 
reactor for 20 min. TLC analysis (EtOAc:hexanes, 4:1) showed that the starting material was converted to 
a much more polar spot. The dark purple solution was concentrated under a stream of N2 and the residue 
was purified by chromatography on SiO2 (EtOAc:hexanes, 4:1 with 1% Et3N) to produce 1-90 (44.5 mg, 
0.117 mmol, 88%) as a dark brown oil: IR (neat) 3096, 3046, 2990, 2936, 2872, 1735, 1692, 1646, 1586, 
1512, 1443, 1363, 1351, 1297, 1277, 1234, 1172, 1073, 1033, 938 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 
8.14 (dd, J = 8.0, 1.0 Hz, 1 H), 7.69 (dd, J = 7.5, 1.0 Hz, 1 H), 7.61 (td, J = 7.5, 1.5 Hz, 1 H), 7.50 (td, J = 
7.5, 1.5 Hz, 1 H), 7.42 (dt, J = 9.5, 2.5 Hz, 2 H), 6.85 (dt, J = 9.5, 2.5 Hz, 2 H), 3.97 (brs, 2 H), 3.76 (s, 3 
H), 3.77-3.72 (m, 2 H), 3.35 (brs, 6 H), 3.14 (t, J = 6.0 Hz, 2 H); 
13
C NMR (125 MHz, CDCl3) δ 159.6, 
159.4, 148.1, 135.6, 132.7, 131.0. 129.8, 129.0, 127.8, 127.3, 126.1, 113.9, 96.2, 57.6, 55.2, 52.4, 45.4, 
38.9; HRMS (ESI) m/z calcd for C21H23N3O4 (M
+
) 381.1689, found 381.1718. 
33 
 
11,11-Dimethoxy-3,4-dihydro-2H-[1,2,4]triazino[2,3-b]isoquinolin-6(11H)-one (1-92).  Concentrated 
H2SO4 (3 mL) was added dropwise into H2O (3 mL), and the acid mixture was stirred for 5 min and 
cooled to 4 °C. A solution of 1-90 (15.5 mg, 0.0406 mmol) in CH2Cl2 (10 mL) was added into the acid 
solution at 4 °C. The reaction mixture was immediately cooled to -20 °C, stirred at -20 °C for 12 h, and 
quenched with solid Na2CO3 at -20 - 4 °C until pH>7. The mixture was diluted with H2O (20 mL), 
extracted with CH2Cl2 (3×30 mL), dried (Na2SO4), concentrated, and purified by chromatography on SiO2 
(EtOAc:hexanes, 4:1 with 1% Et3N) to afford 1-92 (7.6 mg, 0.0291 mmol, 72%) as a light yellow solid: 
IR (neat) 3276.7, 3271.1, 3066.0, 2926.3, 2849.8, 2875.9, 2831.2, 1675.6, 1638.3, 1584.3, 1552.6, 1364.3, 
1284.2, 1237.6, 1036.3 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.16 (dd, J = 8.0, 1.0 Hz, 1 H), 7.73 (dd, J = 
7.5, 1.0 Hz, 1 H), 7.66 ( td, J = 7.5, 1.0 Hz, 1 H), 7.55 (td, J = 7.5, 1.0 Hz, 1 H), 6.52 (br s, 1 H), 3.89 (t, J 
= 5.0 Hz, 2 H), 3.34 (s, 6 H), 3.28 (t, J = 5.0 Hz, 2 H); 
13
C NMR (75 MHz, CDCl3) δ157.7, 145.5, 136.1, 
133.2, 130.0, 128.4, 126.4, 126.1, 96.0, 52.3, 46.5, 43.9; HRMS (ESI) m/z calcd for C13H16N3O3([M+H]
+
) 
262.1192, found 262.1200.  
 
3,4-Dihydro-2H-[1,2,4]triazino[2,3-b]isoquinoline-6,11-dione (1-82). Concentrated H2SO4 (3 mL) was 
added dropwise into H2O (3 mL), and the acid mixture was stirred for 5 min and cooled to room 
temperature. A solution of 1-92 (18.0 mg, 0.0689 mmol) in CH2Cl2 (10 mL) was added into the acid 
solution. The reaction mixture was stirred for 6 h 15 min at room temperature, and quenched with solid 
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Na2CO3 to pH>7. The mixture was diluted with H2O (20 mL), extracted with CH2Cl2 (3×20 mL), dried 
(Na2SO4), and concentrated in vacuo. The crude 
1
HNMR showed that the reaction was complete. The 
product was purified by chromatography on SiO2 (EtOAc:hexanes, 4:1 with 1% Et3N) to afford 1-82 (9.2 
mg, 0.0427 mmol, 62%) as yellow powder: IR (neat) 3282, 2924, 2867, 2850, 1694, 1661, 1609, 1596, 
1581, 1458, 1437, 1379, 1297, 1241, 1215, 1102, 1010 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.28 (dd, J = 
7.5, 1.0 Hz, 1 H), 8.25 (dd, J = 7.5, 1.0 Hz, 1 H), 7.85 (td, J = 7.5, 1.0 Hz, 1 H), 7.76 (td, J = 7.5, 1.0 Hz, 
1 H), 6.64 ( br s, 1 H), 4.05 (td, J = 5.0, 1.0 Hz, 2 H), 3.35-3.33 (m, 2 H);
 13
C NMR (125 MHz, CDCl3) δ 
175.4, 156.0, 141.8, 135.7, 133.8, 131.1, 129.2, 128.8, 128.0, 48.1, 42.6; HRMS (ESI) m/z calcd for 
C11H10N3O2([M+H]
+
) 216.0773, found 216.0759.  
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2.0  REACTIONS INVOLVING METHYL 3-OXO-2-OXABICYCLO[2.2.0]HEXANE-
6-CARBOXYLATE 
2.1 INTRODUCTION 
Methyl 3-oxo-2-oxabicyclo[2.2.0]hexane-6-carboxylate 2-2 is a strained bicycle that contains a fused 
cyclobutene and a β-propiolactone moiety. This compound has been synthesized through a photochemical 
4π-electrocyclization reaction from methyl coumalate 2-173,74 (Scheme 2-1), which adopts a syn geometry 
as predicted by orbital symmetry analysis
75
 (Figure 3).  
 
Scheme 2-1 Electrocyclization of methyl coumalate 2-1 to methyl 3-oxo-2-oxabicyclo[2.2.0]hexane-6-carboxylate 
2-2 
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Figure 3 Orbital symmetry analysis of the photochemical 4π-electrocyclization76 
Photochemical mediated electrocyclizations of this type were first reported by Corey et al. in 
1964.
77
  In these cases, the 2-pyrone 2-3 and N-methyl-2-pyridone 2-5 were subjected to UV irradiation to 
quantitatively afford the corresponding β-propiolactone 2-4 and β-lactam 2-6 (Scheme 2-2).  
 
Scheme 2-2 Corey’s synthesis of β-propiolactone 2-4 and β-lactam 2-6 
Neckers et al.
73
 further elaborated this transformation using methyl coumalate 2-1 and irradiation 
at 300 nm to provide methyl 3-oxo-2-oxabicyclo[2.2.0]hexane-6-carboxylate 2-2 in quantitative yield. 
This compound underwent a thermal decarboxylation to presumably give a cyclobutadiene intermediate 
which readily polymerized. Trapping experiments using methyl propiolate 2-8 were used to support the 
existence of cyclobutene intermediate 2-7.  
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Scheme 2-3 Neckers’ transformation of lactone 2-2 
Zwitterion 2-11 or cyclobutenyl cation 2-12 have been postulated as possible reaction 
intermediates using the photolytic alcoholysis transformation of 2-pyrone 2-4 into 5-alkoxy-2-cis-4-trans-
pentadienoic acids 2-15 (Scheme 2-4).
78
 This pathway was supported by treating 2-pyrone 2-4 with 
anhydrous hydrogen chloride to generate a 1/2.2 mixture of trans- and cis-chlorocyclobut-2-ene 
carboxylic acids 2-16 and 2-17, which were converted to  5-chloro-2-trans-4-trans-pentadienoic acid 2-19 
and 5-chloro-2-cis-4-trans-pentadienoic acid 2-18 upon heating in CCl4 (Scheme 2-5).
78
 
 
Scheme 2-4 Conversion of 2-pyrone 2-4 to 5-alkoxy-2-cis-4-trans-pentadienoic acids 2-15 
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Scheme 2-5 Reaction between lactone 2-2 and anhydrous hydrogen chloride gas 
Maulide et al. have converted lactone 2-4 into the cis-cyclobutene carboxylic acid derivatives 2-
21 using a Tsuji-Trost reaction catalyzed by Pd(PPh3)4 and substituted malonate  2-20. High 
diastereoselectivities were observed using numerous nucleophiles (Scheme 2-6).
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Scheme 2-6 Synthesis of cis-cyclobutene carboxylic acid derivatives 2-21 
In the total synthesis of piperarborenine B 2-25 and the reported structure of piperarborenine D 2-
26, Baran
74
 et al. demonstrated a C-H functionalization strategy to construct these unsymmetrical 
cyclobutane-containing natural products starting from methyl coumalate. Pyrone 2-2 was prepared from 
methyl coumalate 2-1 by a photochemical electrocyclization. Subsequent treatment of pyrone 2-2 with 
Pt/C generated the cis-cyclobutane carboxylate 2-22. The 2-aminothioanisole 2-23 was installed to direct 
the requisite C-H arylation reaction. This substrate was then converted to piperarborenine B 2-25 and 
piperarborenine D (reported structure) 2-26 by selective C-H cross-coupling arylation reactions (Scheme 
2-7). 
39 
 
Scheme 2-7 Baran’s total synthesis of piperarborenine B 2-25 and the reported structure of piperarborenine D 2-26 
The creative work of Maulide and Baran demonstrated the utility of cyclobutane-containing 
compounds originating from photocyclization of lactone 2-2.
74,79
 In addition, this approach serves as an 
inspiration to construct several additional cyclobutane-containing natural products
80-83
 (dictazole B, 
piplartine dimer, piperarboresine, piperarborenine A-E; Scheme 2-8). It was envisioned that lactone 2-2 
could undergo a ring opening via treatment with a suitable Lewis acid to give acid 2-32 (Scheme 2-9). 
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Scheme 2-8 Examples of cyclobutane-containing natural products 
 
Scheme 2-9 Synthesis of cyclobutane-containing compounds 2-32 
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2.2 RESULTS AND DISCUSSION 
2.2.1 Synthesis of Lactone 2-2  
Following a well-precedented literature protocol,
73,74
 the commercially available coumalic acid 2-33 was 
first converted to methyl coumalate 2-1 in 64% yield. Lactone 2-2 was obtained quantitatively by 
irradiation using a 450 W Hanovia lamp for 38 h. A solution of lactone 2-2 (1 mg/mL) could be stored at -
20 °C for 1 month without noticeable loss of integrity. 
 
Scheme 2-10 Preparation of lactone 2-2 
2.2.2 Reaction between Lactone 2-2 and Nucleophiles with Lewis Acids 
The reaction of lactone 2-2 with several indole-based nucleophiles and a series of Lewis acids was 
examined with the ultimate goal to prepare dictazole-related natural products.  The initial results of these 
conditions to promote the two-step reaction to substituted cyclobutanes are summarized in Table 2-1.  
Table 2-1 Conditions with indole-based nucleophiles 
 
42 
entry nucleophile Lewis acid temperature additive time result 
1 3 eq. indole 1.3 eq. 
BF3·OEt2 
-78 °C to -40 °C; 
rt 
5 eq. TMSCHN2 5h; 12 h indolo-indoline 
dimer (23%) 
2
84,85
 3 eq. indole 1.3 eq. MAD -78 °C to -40 °C; 
0 °C 
NA 4h; 36 h undetermined 
product 
3
84,85
 3 eq. indole 
carbamate 
1.3 eq. MAD 0 °C to rt NA 36 h SM* 
4 3 eq. indole 
carbamate 
0.3 eq. 
BF3·OEt2 
0 °C to rt 1 eq. 2,6-di-tert-
butyl-4-
methylpyridine 
40 h methyl 
coumalate* + 
undetermined 
product 
5
86
 3 eq. indole 2 eq. 
BH3·THF, 2 
eq. CH3COOH 
0 °C 2 eq. 1,1'-bi-2-
naphthol 
30 h methyl 
coumalate* + 
undetermined 
product 
6
86
 3 eq. indole 2 eq. 
BH3·THF, 2 
eq. CH3COOH 
-20 °C to rt 2 eq. 1,1'-bi-2-
naphthol 
48 h decomposition 
7 3 eq. indole 
carbamate 
0.3 eq. 
BF3·OEt2 
0 °C to rt 1 eq. 2,6-di-tert-
butyl-4-
methylpyridine 
48 h undetermined 
product 
8 3 eq. indole 0.3 eq. 
BF3·OEt2 
-20 °C to rt NA 5 h decomposition 
9
87
 3 eq. indole 1 eq. SnCl4 -20 °C to rt 2 eq. 1,1'-bi-2-
naphthol, 200 
wt% molecular 
sieves 
5 h decomposition 
10
88-90
 3 eq. indole 0.05 eq. 
AgOAc 
-20 °C 0.1 eq. binaphyl 
phosphoric acid 
48 h methyl 
coumalate* 
*Starting material and methyl coumalate were identified by TLC. 
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Several rhodium-catalyzed conjugated additions of phenylboronic acids to lactone 2-2 were also 
attempted (Table 2-2). Unfortunately, the strong Lewis acids BF3•OEt2 and binaphthol-SnCl4 caused only 
decomposition, with no desired product 2-35 obtained. Rhodium-catalyzed conjugated additions were 
also not observed. 
Table 2-2 Rhodium-catalyzed conjugated additions 
 
entry catalyst time result 
1
91
 0.03 eq. [Rh(cod)Cl]2 24 h 
methyl 
coumalate* 
2 0.03 eq. Rh(acac)(C2H4)2 48 h SM* 
*Starting material and methyl coumalate were identified by TLC. 
2.2.3 Reaction between Lactone 2-2 and Indole with BF3•OEt2 
The incorporation of an indole nucleophile using the BF3·OEt2 catalyzed conditions provided encouraging 
results as indicated by crude LCMS analysis. Several compounds which were difficult to isolate and fully 
characterize showed mass correlation to double indole adducts of lactone 2-2. After considerable effort, 
one of these products was purified in 2% yield and its unexpected fused ring system 2-36 structure was 
determined by X-ray crystallographic analysis (Figure 4).  
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Scheme 2-11 Fused rings 2-36 from lactone 2-2 
 
Figure 4 X-ray crystallographic analysis of 2-36 
2.2.4 Reaction between Lactone 2-2 and Indole Dimer 2-38 with BF3•OEt2 
It was proposed that indolo-indoline dimer 2-38 is formed under the Lewis acid conditions and can then 
undergo addition and cyclization with lactone 2-2.  
 
Scheme 2-12 Hypothesis for the generation of indole dimer 2-38 
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In order to test this hypothesis, indolo-indoline dimer 2-38 was prepared in 68% yield using 
BF3·OEt2.  Subsequent treatment of indolo-indoline dimer 2-38 with lactone 2-2 and BF3·OEt2 at -23 °C 
for 5 h resulted in three distinct products with identical mass traces corresponding to the adduct according 
to LCMS. Purification and isolation using Florisil
TM
 provided a clean sample of this mixture containing 
the three products. Since all of these products contain a carboxylic acid functionality, the mixture was 
converted to the TIPS-ester by treatment with TIPSCl and triethylamine (Scheme 2-13).  
Despite the low yields, we were able to isolate and separate these compounds. One of these 
adducts 2-39 was found to have an identical 
1
H NMR spectrum to that of the TIPS-ester formed in low 
yield from the X-ray sample of 2-36 (Scheme 2-14).  
The remaining products were crystallized and their structures were elucidated by X-ray 
crystallographic analysis.  A diastereomer of 2-40 (Figure 5) was obtained along with a conjugated diene 
product 2-41 (Figure 6).  
 
Scheme 2-13 Reaction between lactone 2-2 and indolo-indoline dimer 2-38 in the presence of BF3•OEt2 
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Scheme 2-14 Preparation of 2-39 
 
Figure 5 X-ray crystallographic analysis of 2-40 
 
 
 
Figure 6 X-ray crystallographic analysis of 2-41 
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2.2.5 Reaction between Lactone 2-2 and Indole Dimer 2-38 
These preliminary investigations using lactone 2-2 and the indolo-indoline dimer 2-38 suggest an initial 
reaction through a distinct color change to bright yellow even before the addition of BF3·OEt2. Therefore, 
a series of similar reactions were conducted in the absence of Lewis acid. In addition, 2,4,6-
trichlorophenol and 2,6-di-tert-butyl pyridine were introduced into the reaction as it was believed that 
proton transfer may be playing an important role in this process (Table 2-3).  
Table 2-3 Reaction between lactone 2-2 and indolo-indoline dimer 2-38 
 
entry additive yield  
1 none 46% 
2 2,4,6-trichlorophenol 52% 
3 2,6-di-tert-butyl-4-methylpyridine 56% 
 
The reaction without Lewis acids afforded only diene 2-41 in moderate yield. Not much of a 
difference was observed in the yields of 2-42 when 2,4,6-trichlorophenol and 2,6-di-tert-butyl pyridine 
were introduced into the reaction. At this point, it was rationalized that the role of the Lewis acid such as 
BF3·OEt2 is to catalyze the dimer formation of indole 2-37 and the isomerization of the diene 2-42 when 
using indole 2-37 as the starting material. When indolo-indoline dimer 2-38 was used, Lewis acid only 
served to catalyze the isomerization. In this process, strong Lewis acids such as BF3·OEt2 may be too 
harsh, leading to low yields of the product because of substantial decomposition. As no obvious changes 
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in product yields and reacting rate were observed, the role of proton transfer in this reaction may not be as 
important.  
A potential mechanism of the reaction is represented in the Scheme 2-15. Conjugate addition of 
indolo-indoline dimer 2-38 and tautomerization of the cyclobutene system can open up the lactone to 
form 2-43 after proton transfer. Conjugate diene 2-42 may be obtained after a retro-[2+2]-cycloaddition 
of the cyclobutene moiety. Subsequent Lewis catalyzed conjugate-addition can generate fused ring 
carboxylic acid 2-36 (Scheme 2-15). 
 
Scheme 2-15 Proposed mechanism for the reaction to generate 2-36 
 
In order to validate this proposed mechanism, lactone 2-2 was treated with indolo-indoline dimer 
2-38 at room temperature for 10 min to smoothly obtain diene acid 2-42 in moderate yield. Purification 
and isolation using Florisil
TM
 provided a clean sample of diene acid 2-42, and it was subsequently treated 
with 10 weight equivalents of silica gel in CH2Cl2 at room temperature for 18 h.  Formation of fused ring 
system 2-36 was observed according to LCMS characterization of the reaction mixture together with 
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unreacted diene acid 2-42. The mixture was converted to the TIPS-ester by treatment with TIPSCl and 
triethylamine (Scheme 2-16). This shows evidence to support the proposed mechanism (Scheme 2-15). 
When diene acid 2-42 was stirred with 10 weight equivalents of silica gel at room temperature for 18 h, a 
substantial amount of starting material was observed to have decomposed during this process and 
therefore low yields for 2-39 and 2-41 were obtained (8%). The protocol could be further optimized by 
refluxing 2-42 with silica gel in CH2Cl2 for 1 h to largely avoid such decomposition. 
 
Scheme 2-16 Conversion of isolated diene acid 2-42 to spiro ring system 2-39 and 2-41 
2.2.6 Control Experiments 
It is unknown whether the use of triethylamine in the TIPS esterification step will cause the isomerization 
between 2-39 and 2-40. In order to clarify the role of triethylamine in the final TIPS esterification step, 2-
39 was treated with triethylamine in CH2Cl2 at room temperature for 12 h. No isomerization was observed, 
which indicates triethylamine only serves as a base in the TIPS esterification step (Scheme 2-17).  
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Scheme 2-17 Clarification of the role of triethylamine 
The driving force for the ring opening of lactone 2-2 with indolo-indoline dimer 2-38 to generate 
diene acid 2-42 is presumed to be its inherent ring strain. In support of this hypothesis, no reaction was 
observed when methyl coumalate 2-1 was treated with indolo-indoline dimer 2-38 in CH2Cl2 at room 
temperature for 13 h. Addition of 1 equivalent of BF3·OEt2 did not affect any transformation over another 
36 h (Scheme 2-18).  
 
Scheme 2-18 Control reaction with methyl coumalate 2-1 
2.2.7 Substrate Scope 
Several other starting materials were prepared and tested in order to expand the substrate scope of the 
established reaction condition, including 1-adamantyl coumalate 2-44, 2-oxo-2H-pyran-5-carbonitrile 2-
45, and methyl 1-(((ethoxycarbonyl)oxy)methyl)-6-oxo-1,6-dihydropyridine-3-carboxylate 2-46 (Scheme 
2-19).  
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Scheme 2-19 Other starting materials 
1-Adamantyl coumalate 2-44 was prepared and explored in the reaction with indole dimer 2-38 to 
investigate the influence of the bulky adamantyl group on the reaction yield. Commercially available 
coumalic acid 2-33 was first converted to 1-adamantyl coumalate 2-44 in 48% yield using a Steglich 
esterification
92
. Lactone 2-47 was obtained quantitatively by irradiation for 29 h. A solution of lactone 2-
47 in CH2Cl2 (1 mg/mL) was treated with indole dimer 2-38 and was immediately consumed to generate a 
diene carboxylic acid (not shown) after lactone opening and retro-[2+2] process. The resulting reaction 
mixture was heated at reflux for 8 h until all diene acid was consumed to cleanly afford its corresponding 
cyclized acid. The resulting acid with ring fusion was converted to its TIPS-ester 2-48 by treatment with 
TIPSCl and triethylamine with an overall yield of 11% from 2-47 (Scheme 2-20). 
 
Scheme 2-20 (3S,8'R,9a'S)-(3S,5S,7S)-adamantan-1-yl 8'-(2-oxo-2-((triisopropylsilyl)oxy)ethyl)-9a',10'-
dihydro-8'H-spiro[indole-3,9'-pyrido[1,2-a]indole]-7'-carboxylate 2-48 
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2-Oxo-2H-pyran-5-carbonitrile 2-45 was prepared from 2-33
93
 via an acid chloride (not shown) 
as a cyano group is similarly electron withdrawing as an ester group in methyl coumalate 2-1. However, 
when nitrile 2-49 was irradiated for 64 h, it was converted to a complicated mixture that contained a small 
amount of desired [2+2] cycloaddition product 2-50 characterized by 
1
H NMR of the concentrated sample. 
The complexity of product formation was probably due to the interference of the cyano group during 
cycloaddition because the cyano group might also absorb energy while it was irradiated. The crude 2-50 
was directly used in the following reaction with indole dimer 2-38. A diene acid (not shown) was 
immediately generated and was treated with TIPSCl and triethylamine to generate its TIPS ester in 4% 
yield from nitrile 2-49 (Scheme 2-21). 
 
Scheme 2-21 (2E,4E)-triisopropylsilyl 5-((S)-2-(1H-inden-3-yl)indolin-1-yl)-4-cyanopenta-2,4-dienoate 2-
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Lactam 2-46 was prepared as it was envisioned to be more stable than lactone 2-2, whose 
instability might be the primary reason why the yield of its reaction with indole dimer 2-38 was always 
low. Fischer esterification of commercially available acid 2-52 gave methyl ester 2-53
94
, which was 
treated with paraformaldehyde and K2CO3 to generate its hydroxymethyl derivative 2-54. In situ trapping 
of 2-54 with propionic anhydride afforded lactam 2-46
95
 in moderate yield (Scheme 2-22). 
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Scheme 2-22 Methyl 1-(((ethoxycarbonyl)oxy)methyl)-6-oxo-1,6-dihydropyridine-3-carboxylate 2-46 
A solution of lactam 2-46 in acetonitrile was irradiated in flow reactor for 5 d and was converted 
to an inseparable mixture of desired [2+2] cycloaddition product 2-55 and starting material 2-46 in 21% 
yield (Scheme 2-23). The low yield was probably due to the inherent inactivity of lactam 2-46. However, 
when this mixture containing 2-47 was treated with indole dimer 2-38 and a variety of Lewis acids, no 
reaction was observed (Table 2-4). With these results it was concluded that though 2-55 is considerably 
more stable than lactone 2-2 in presence of a Lewis acid, it is substantially less reactive than lactone 2-2 
when treated with indole dimer 2-38.  
 
Scheme 2-23 Methyl 3-oxo-2-((propionyloxy)methyl)-2-azabicyclo[2.2.0]hex-5-ene-6-carboxylate 2-47 
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Table 2-4 Reaction between methyl 3-oxo-2-((propionyloxy)methyl)-2-azabicyclo[2.2.0]hex-5-ene-6-
carboxylate 2-55 and indole dimer 2-38 
 
entry catalyst solvent temperature time result 
1 NA CH2Cl2 rt 4 h no reaction 
2 silica gel CH2Cl2 0 °C to rt 26 h unknown product 
3 1 eq. BF3-OEt2 CH2Cl2 30 °C to rt 32 h no reaction 
4 4 eq. BF3-OEt2 CH2Cl2 30 °C; rt 1.5 h; 7.5 h decomposition 
5 ScTf3 THF -30 °C to rt 24 h no reaction 
6 BiCl3 THF 0 °C to rt 24 h no reaction 
7 Pd(OAc)2 THF 0 °C to rt 24 h no reaction 
8 Pd(PPh3)4 THF 0 °C to rt 24 h no reaction 
9 HNTf2 THF 0 °C to rt 24 h no reaction 
10 Montmorillonite KSF CH2Cl2 0 °C to rt 24 h no reaction 
11 Montmorillonite K10 CH2Cl2 0 °C to rt 36 h no reaction 
12 NH4Cl CH2Cl2 rt 27 h no reaction 
13 Alumina CH2Cl2 rt 24 h no reaction 
 
Reactions using a different indole dimer 2-57 with lactone 2-2 were also attempted. Indole dimer 
2-57 was prepared from 5-methoxy-1H-indole 2-56 in 33% yield using BF3·OEt2.  Subsequent treatment 
of indolo-indoline dimer 2-57 with lactone 2-2 in CH2Cl2 at 0 °C for 1 h resulted in diene acid 2-58. 
Purification and isolation using Florisil
TM
 provided a clean sample of 2-58, which was treated with 
TIPSCl and triethylamine to afford fused ring compound 2-59 in 27% yield over 3 steps (Scheme 2-24). 
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Scheme 2-24 Reactions using indole dimer 2-57 
2.2.8 Further Functionalizations 
Compounds 2-39 and 2-40 provide interesting scaffolds which can be further modified and used in the 
total synthesis of related natural products such as spiroindimicins A and B
96
 (Scheme 2-25).  Therefore, 
further functionalizations of the obtained spiro compounds 2-39 and 2-40 were attempted, such as the 
allylation, reduction, and Diels Alder reaction of the imine moiety. 
 
Scheme 2-25 Related natural products 
Spiro compound 2-39 was treated with allyltrimethylsilane
97,98
 or allyltributyltin
99-101
 as allylating 
reagents in presence of a series of Lewis acids. Unfortunately, the formation of detectable quantities of 
desired allylation product 2-62 was never observed (Table 2-5).  
56 
Table 2-5 (2S,3R,8'R,9a'S)-methyl 2-allyl-8'-(2-oxo-2-((triisopropylsilyl)oxy)ethyl)-9a',10'-dihydro-8'H-
spiro[indoline-3,9'-pyrido[1,2-a]indole]-7'-carboxylate 2-62 
 
entry catalyst reagent temperature time result 
1
97
 BF3-OEt2 allyltrimethylsilane -78 °C to rt 25 h trace 
2
99,100
 BF3-OEt2 allyltributyltin -78 °C to rt 25 h decomposition 
3
101
 ScTf3 allyltributyltin -78 °C to rt 57 h 
30% 2-40, 35% 2-
63, SM mixture 
4
98
 TiCl4 allyltributyltin -78 °C 24 h decomposition 
 
Fused ring compound 2-36 was envisioned to be a good substrate toward reduction as its 
structural features include a methyl ester, a carboxylic acid, and an imine. When 2-36 was generated from 
the reaction between lactone 2-2 and indole dimer 2-38, it was purified and isolated using Florisil
TM 
and 
was immediately treated with strong reducing reagents including BH3-THF, BH3-Me2S, and LAH. 
Unfortunately, complete decomposition of 2-36 was observed for all experiments conducted (Table 2-6). 
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Table 2-6 Reduction of 2-((3S,8'R,9a'S)-7'-(methoxycarbonyl)-9a',10'-dihydro-8'H-spiro[indole-3,9'-
pyrido[1,2-a]indole]-8'-yl)acetic acid 2-36 
 
entry reagent temperature time result 
1 BH3-Me2S, B(OMe)3 0 °C to rt 14 h decomposition 
2 BH3-THF rt 12 h decomposition 
3 LAH -30 °C to 0 °C 12 h decomposition 
 
The imine functionality in spiro compound 2-39 was envisioned to be a potential dienophile in 
Diels-Alder reaction with Denishefsky’s diene 2-65102-105. Several reaction conditions were attempted 
with Lewis acids including Yb(OTf)3
102
, AlCl3
104
  and HBF4
105
, and none of them gave desired 
cycloaddition product 2-66 (Table 2-7).  
Table 2-7 Diels-Alder reaction with Danishefsky' diene 2-65 
 
entry catalyst solvent temperature time yield 
1
102
 Yb(OTf)3 CH2Cl2 -78 °C to rt 22 h No reaction 
2
103
 NA  MeOH rt 24 h No reaction 
3
104
 AlCl3 MeOH rt 48 h No reaction 
4
105
 HBF4 MeOH rt 24 h decomposition 
58 
 
 
2.3 CONCLUSION 
Reactions involving methyl 3-oxo-2-oxabicyclo[2.2.0]hexane-6-carboxylate 2-2 and indole-related 
nucleophiles have been investigated. The formation of cyclobutane-containing product 2-35 was not 
observed in the presence of Lewis acids. Instead, tricyclic-fused system 2-36 was isolated. When lactone 
2-2 was treated with indolo-indoline 2-38 with BF3·OEt2, a mixture of products was isolated in low yields. 
Diene product 2-42 was obtained in moderate yields when lactone 2-2 was treated with indolo-indoline 2-
38 in the absence of Lewis acid and diene 2-42 could be converted to tricyclic-fused system 2-36 by 
heating at reflux with silica gel in CH2Cl2 in low to moderate yield. A potential mechanism has been 
proposed for the generation of 2-36, which involves a ring opening process of lactone 2-2, a retro-[2+2] 
cycloaddition, and a Lewis acid-catalyzed conjugate addition from the indole fragment.  
Expansion of substrate scope was attempted for the reaction between indolo-indoline 2-38 and 
lactone 2-2 to generate fused ring acid 2-36, and substrates giving successful results included 1-adamantyl 
coumalate 2-44 and indolo-indoline dimer 2-57. Further functionalizations of fused ring product 2-39, 
including allylation, reduction, and Diels Alder reaction of the imine moiety, were also attempted. 
However, none of the products from further functionalization reactions were observed.  
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2.4 EXPERIMENTAL PART 
General: All reactions were performed under an N2 atmosphere and all glassware was dried in an oven at 
140 °C for 2 h prior to use. Reactions carried out at -78 °C employed a CO2/acetone bath. THF and Et2O 
were distilled over sodium/benzophenone ketyl, Et3N was distilled from CaH2, and CH2Cl2 and toluene 
were purified using an alumina column filtration system. All other reagents and solvents were used as 
received unless otherwise noted. Reactions were monitored by TLC analysis (pre-coated silica gel 60 F254 
plates, 250 μm layer thickness) and visualization was accomplished with a 254 nm UV light and by 
staining with a PMA solution (5 g of phosphomolybdic acid in 100 mL of 95% EtOH), p-anisaldehyde 
solution (2.5 mL of p-anisaldehyde, 2 mL of AcOH, and 3.5 mL of conc. H2SO4 in 100 mL of 95% 
EtOH), Vaughn’s reagent (4.8 g of (NH4)6Mo7O24•4H2O and 0.2 g of Ce(SO4)2 in 100 mL of a 3.5 N 
H2SO4 solution) or a KMnO4 solution (1.5 g of KMnO4 and 1.5 g of K2CO3 in 100 mL of a 0.1% NaOH 
solution). Flash chromatography on SiO2 was used to purify the crude reaction mixtures. 
NMR spectra were recorded using XWIN-NMR software. 
 1
H NMR spectra were obtained at 300, 
400, 500, 600 or 700 MHz in CDCl3. Chemical shifts were reported in parts per million with the residual 
solvent peak used as an internal standard. 
1
H NMR spectra were obtained and are tabulated as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), number of 
protons, and coupling constant(s). 
13
C NMR spectra were obtained using a proton-decoupled pulse 
sequence with a d1 of 3 sec, and are tabulated by observed peak unless otherwise noted. Melting points 
were determined on a Mel-Temp II and are uncorrected. High-resolution mass spectrometry (HRMS) data 
(ESI/APCI technique) were recorded using a Waters Q-Tof Ultima API-US instrument. HRMS data (EI 
technique) were recorded using a Micromass Autospec instrument. Mass spectrometry data were also 
recorded using an Applied Biosystems MDS SCIEX API 2000 LC/MS/MS system. 
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Methyl coumalate (2-1).
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 With a 100 mL round bottom flask with 2-33 (2.08 g, 14.8 mmol) in NMP (40 
mL) was added DIPEA (1.93 g, 15.0 mmol) dropwise over 10 min. The reaction mixture was allowed to 
stir for 30 minutes at room temperature during which dimethyl sulfate (1.89 g, 15.0 mmol) was slowly 
added over a period of 15 min. The reaction mixture was allowed to stir for an additional 2 h at room 
temperature. The reaction was quenched with the dilution of toluene (30 mL) followed by the addition of 
water (50 mL), and the two layers were allowed to separate. The aqueous layer was extracted with toluene 
(3×30 mL), The combined organic layers were washed with saturated NaHCO3 (20 mL) and water (20 
mL). The solution was concentrated in vacuo, and the resulting residue was purified by chromatography 
on SiO2 (EtOAc:hexanes, 1:4) to afford 2-1 (1.47 g, 9.52 mmol, 64%) as white flakey crystals: 
1
H NMR 
(300 MHz, CDCl3) δ 8.16 (dd, J = 2.4, 0.9 Hz, 1 H), 7.64 (dd, J = 9.9, 2.7 Hz, 1 H), 6.18 (dd, J = 9.9, 0.6 
Hz, 1 H), 3.71 (s, 1 H). 
 
Methyl 3-oxo-2-oxabicyclo [2.2.0] hex-5-ene-6-carboxylate (2-2). A solution of 2-1 (926 mg, 6.01 
mmol) dry CH2Cl2 (1.0 L) was transferred to a photoreactor (ACE glass, 1 L jacketed reaction vessel with 
a quartz immersion well). The reaction mixture was purged with argon. The vessel was irradiated using a 
450W Hanovia lamp through a pyrex filter at 15 °C for 37 hours while keeping the temperature at 15 °C. 
A small aliquot (1 mL) of solution was removed, concentrated afford 2-2 as colorless oil (quantitative 
yield): 
1
H NMR (300 MHz, CDCl3) δ 7.32 (dd, J = 4.2, 0.9 Hz, 1 H), 5.51 (dd,  J = 4.2, 2.1 Hz, 1 H), 4.48 
(dd,  J = 1.8, 1.2 Hz, 1 H), 3.82 (s, 3 H). 
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2-((3S,8'R,9a'S)-7'-(Methoxycarbonyl)-9a',10'-dihydro-8'H-spiro[indole-3,9'-pyrido[1,2-a]indol]-8'-
yl)acetic acid (2-36). To a flame dried 100 mL round bottom flask was added 2-37 (188 mg, 1.60 mmol), 
and was purged with N2 (3×). 2-2 (82.4 mg, 0.535 mmol, 50 mL 0.0107 mol/L solution) was added to the 
flask via syringe. The flask was cooled to -23 °C and BF3•OEt2 (0.020 µL, 22.8 mg, 0.161 mmol) was 
added to the flask via syringe. The reaction mixture was stirred at -23 °C and was allowed to warm to 
5 °C for 2 h. The reaction was quenched with sat. NaHCO3 solution (10 mL), and the organic layer was 
extracted with sat. NaHCO3 solution (3×30 mL). Then the aqueous layer was combined and cooled to 
0 °C. 1 M citric acid was slowly added to the aqueous solution until pH is around 3. The aqueous solution 
was then extracted with EtOAc (3×50 mL), dried (NaSO4) and concentrated in vacuo. The reaction 
mixture was purified by chromatography on SiO2 (MeOH: CH2Cl2, 1:10) to afford 2-36 as yellow solid 
(5.0 mg, 0.013 mmol, 2%): (The spectra are not good enough but the X-ray crystallographic analysis 
suggests the structure of the product.); HRMS (ESI negative) m/z calcd for C23H19N2O4 ( [M-H]
-
) 
387.1345, found 387.1340. 
 
 
(3R,8'R,9a'S)-Methyl 8'-(2-oxo-2-((triisopropylsilyl)oxy)ethyl)-9a',10'-dihydro-8'H-spiro[indole-
3,9'-pyrido[1,2-a]indole]-7'-carboxylate (2-40); (3S,8'R,9a'S)-methyl 8'-(2-oxo-2-
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((triisopropylsilyl)oxy)ethyl)-9a',10'-dihydro-8'H-spiro[indole-3,9'-pyrido[1,2-a]indole]-7'-
carboxylate (2-39); (2E,4E)-5-methyl 1-(triisopropylsilyl) 4-(((S)-2-(1H-indol-3-yl)indolin-1-
yl)methylene)pent-2-enedioate (2-41). To a flame dried 100 mL round bottom flask purged with N2 (3×) 
was added 2-2 (80.4 mg, 0.533 mmol, 60 mL 0.0087 mol/L CH2Cl2 solution)was added via syringe. The 
reaction mixture was cooled to -23 °C and 2-38 (165 mg, 0.702 mmol), BF3·OEt2 (19 µL, 0.157 mmol) 
was added into the flask via syringe. The reaction mixture was stirred at -23 °C for 5 h. The reaction was 
quenched by adding sodium potassium tartrate and the mixture was stirred for 5 min. The solid was 
filtered and the filtrate was concentrated under vacuum and purified by chromatography  on Florisil
TM 
(MeOH: CH2Cl2, 1: 10 to remove impurities; MeOH to collect product). The MeOH solution was 
concentrated in vacuo. The residue was dissolved in CH2Cl2 (40 mL),treated with TEA (264 mg, 2.61 
mmol) and TIPSCl (110 mg, 0.574 mmol). The reaction mixture was stirred for 22 h at room temperature. 
The reaction mixture was concentrated in vacuo and the residue was purified by chromatography on SiO2 
(EtOAc:hexanes, 1:4 with 1% TEA) to afford 2-40 (35.4 mg, 0.0650 mmol, 12%) as light yellow solid, 2-
39 (22.3 mg, 0.0409 mmol, 8%) as light yellow solid, and 2-41 (33.8 mg, 0.0620 mmol, 12%) as yellow 
solid. 2-40: IR (neat) 3441, 2945, 2887, 2869, 1700, 1612, 1586, 1493, 1461, 1385, 1379, 1241, 1191, 
1109, 1072, 1027, 1008, 995, 884, 802 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.20 (s, 1 H), 8.07 (s, 1 H), 
7.70 (d, J = 7.5 Hz, 1 H), 7.42 (m, 1 H), 7.33 (d, J = 4.2 Hz, 2 H), 7.15 (t, J = 7.5 Hz, 1 H), 6.94 (m, 2 H), 
6.83 (t, J = 7.5 Hz, 1 H), 4.64 (t, J = 9.3 Hz, 1 H). 3.94 (s, 1 H), 3.71 (s, 3 H), 2.63 (dd, J = 16.5, 9.6 Hz, 1 
H), 2.29 (dd, J = 18.3, 6.0 Hz, 1 H), 1.98 (dd, J = 16.5,9.6 Hz, 1 H), 1.75 (dd, J = 18.3, 6.0 Hz, 1 H), 1.25 
(m, 3 H), 0.95 (m, 18 H);
 13
C NMR (100 MHz, CDCl3) δ 172.4, 167.5, 156.1, 143.0, 137.7, 136.2, 135.3, 
129.3, 128.9, 128.2, 127.6, 125.6, 122.5, 122.4, 121.6, 119.7, 107.8, 103.5, 63.2, 51.1, 36.4, 34.4, 29.8, 
17.8, 12.4; HRMS (ESI) m/z calcd for C32H41N2O4Si ([M+H]
+
) 545.2836, found 545.2848. 2-39: IR (neat) 
3385, 3064, 2945, 2869, 1705, 1612, 1586, 1493, 1467, 1435, 1411, 1366, 1310, 1236, 1103, 1185, 1016, 
995, 915, 910, 908, 882, 843 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.21 (s, 1H), 8.09 (br s, 1H), 7.66 (d, J 
= 7.5 Hz, 1 H), 7.33 (t, J = 7.5 Hz, 2 H), 7.11 (m, 3 H), 6.96 (d, J = 8.0 Hz, 1 H), 6.86 (d, J = 7.5 Hz, 1 H), 
6.78 (t, J = 7.5 Hz, 1 H), 4.77 (t, J = 9.0 Hz, 1 H), 4.10 (m, 1 H), 3.71 (s, 3 H), 2.83 (dd, J = 16.0, 9.5 Hz, 
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1 H), 2.44 (dd, J = 18.0, 6.0 Hz, 1 H), 1.83 (br s, 2 H), 1.75 (dd, J = 16.0, 9.5 Hz, 1 H), 1.34 (dd, J = 18.0, 
5.0 Hz, 1 H), 1.24 (m, 3 H), 1.04 (m, 18 H);
 13
C NMR (100 MHz, CDCl3) δ 174.4, 172.8, 157.2, 143.2, 
135.5, 129.2, 129.2, 128.0, 127.1, 125.5, 125.1, 122.2, 121.5, 107.4, 101.5, 62.4, 61.2, 51.0, 35.1, 34.6, 
29.8, 29.6, 17.8, 12.4; HRMS (ESI) m/z calcd for C32H40N2O4SiNa ([M+Na]
+
) 567.2655, found 567.2650. 
2-41: IR (neat) 3359, 3057, 2941, 2889, 2863, 1691, 1609, 1586, 1489, 1459, 1433, 1407, 1359, 1338, 
1312, 1271, 1230, 1182, 1109, 1096, 882, 837 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 8.30 (s, 1 H), 8.14 (s, 
1 H), 7.82 (d, J = 15.5 Hz, 1 H), 7.31 (m, 2 H), 7.26 (m, 2 H), 7.13 (m, 3 H), 7.02 (m, 1 H), 6.96 (m, 1 H), 
6.22 (d, J = 15.5 Hz, 1 H), 6.02 (t, J = 4.5 Hz, 1 H), 3.76 (m, 1 H), 3.68 (s, 3 H), 3.42 (m, 1 H), 1.30 (m, 3 
H), 1.08 (m, 18 H); 
 13
C NMR (100 MHz, CDCl3) δ 168.4, 168.2, 145.3, 142.3, 139.3, 137.1, 130.3, 128.2, 
125.5, 124.4, 124.1, 124.0, 122.4, 120.0, 119.1, 117.4, 114.8, 111.7, 110.8, 101.7, 60.6, 51.5, 37.7, 18.0, 
12.2; δ ; HRMS (ESI) m/z calcd for C32H41N2O4Si ([M+H]
+
) 545.2836, found 545.2841. 
 
3-(Indolin-2-yl)-1H-indole (2-38). To a solution of 2-37 (1.00 g, 8.54 mmol) in CH2Cl2 (50 mL) was 
added BF3·OEt2 (541 µL, 606 mg, 4.27 mmol) dropwise over 30 min at 0 °C.  The reaction mixture was 
slowly warmed to room temperature and stirred overnight. The reaction mixture was concentrated in 
vacuo, and quenched with sat. aqueous NaHCO3. The aqueous solution was back-extracted with EtOAc 
(3×30 mL). The organic layer was concentrated in vacuo, and  purified chromatography on SiO2 
(EtOAc:hexanes, 1:3 with 0.5% Et3N) to afford 2-38 (679 mg, 2.90 mmol, 68%) as a white solid: 
1
H 
NMR (400 MHz, CDCl3) δ 7.99 (br s, 1 H), 7.61 (d, J = 8.0 Hz, 1 H), 7.37 (d, J = 8.0 Hz, 1 H), 7.22 (t, J 
= 7.6 Hz, 1 H), 7.16 (d, J = 6.0 Hz, 2 H), 7.09 (m, 2 H), 6.77 (t, J = 7.2 Hz, 1 H), 6.69 (d, J = 8.0 Hz, 1 H), 
5.27 (t, J = 8.4 Hz, 1 H), 4.12 (brs, 1 H), 3.49 (dd, J = 15.6, 9.2 Hz, 1 H), 3.23 (dd, J = 15.6, 9.2 Hz, 1 H).  
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(2E,4E)-5-((S)-2-(1H-Indol-3-yl)indolin-1-yl)-4-(methoxycarbonyl)penta-2,4-dienoic acid (2-42). To 
a flame-dried 250 mL round bottom flask was added 2-2 (114 mg, 0.740 mmol, 50 mL, 0.0148 mol/L) 
and 2,6-di-tert-butyl-4-methyl-pyridine (152 mg, 0.74 mmol), and was cooled to -20 °C. Then 2-38 (182 
mg, 0.777 mmol) was added into the flask via syringe. The reaction mixture immediately turned yellow. 
The reaction mixture was stirred at -20 °C for 2 h and concentrated in vacuo and purified by flash 
chromatography on Florisil
TM
(100% EtOAc) until the eluent became completely clean by TLC. The 
yellow fraction remaining on the column was then eluted with MeOH. The product was dissolved in 
CH2Cl2 (100 mL), and filtered through a short plug of celite and concentrated in vacuo to give 2-42 (161 
mg, 0.416 mmol, 56%) as a brown solid: IR (neat) 3372, 3064, 2951, 2498, 1672, 1614, 1573, 1551, 1525, 
1486, 1456, 1434, 1417, 1363, 1355, 1331, 1320, 1290, 1266, 1245, 1221, 1208, 1185, 1167, 1113, 1096, 
982, 740 cm
-1
; 
1H NMR (500 MHz, MeOD) δ 7.97 (s, 1 H), 7.37 (d, J = 16.0 Hz, 1 H), 7.25 (m, 5 H), 
7.00 (m, 3 H), 6.80 (d, J = 8.0 Hz, 1 H), 6.74 (td, J = 7.0, 1.0 Hz, 1 H), 6.05 (dd, J = 10.5, 4.5 Hz, 1 H), 
5.90 (d, J = 16.0 Hz, 1 H), 3.73 (m, 2 H), 3.58 (s, 3 H), 3.27 (m, 1 H); 
13C NMR (125 MHz, MeOD) δ 
176.7, 170.7, 147.1, 140.5, 138.7, 135.7, 131.7, 129.0, 127.0, 126.2, 126.0, 125.6, 124.3, 122.5, 120.0, 
119.8, 115.2, 112.6, 110.8, 103.7; HRMS (ESI) m/z calcd for C23H21N2O4 ([M+H]
+
) 389.1501, found 
389.1528.  
 
(3S,5S,7S)-Adamantan-1-yl 2-oxo-2H-pyran-5-carboxylate (2-44). To a suspension of  coumalic acid 
2-33 (600 mg, 4.28 mmol) in CH2Cl2 (30 mL) were added 1-adamantanol (685 mg, 4.50 mmol) and 
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DMAP (52.3 mg, 0.428 mmol), and the mixture was cooled to -20 °C. DCC (884 mg, 4.28 mmol) was 
added to the reaction mixture and  the mixture was slowly warmed to room temperature and stirred for 
overnight. The dark brown reaction mixture was concentrated in vacuo and purified by chromatography 
on SiO2 (EtOAc: hexanes, 1:6 ) to afford 2-44  (566 mg, 2.06 mmol, 48%) as a white solid: IR (neat) 
3055, 2911, 2852, 1750, 1709, 1637, 1553, 1456, 1426, 1333, 1322, 1282, 1266, 1232, 1116, 1103, 1087, 
1048, 966, 844, 829, 770, 733, 703 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.17 (dd, J = 2.7, 1.2 Hz, 1 H), 
7.71 (dd, J = 9.6, 2.4 Hz, 1 H), 6.26 (dd, J = 9.6, 1.2 Hz, 1 H), 2.15 (s, 9 H), 1.66 (s, 6 H); 
13
C NMR (100 
MHz, CDCl3) δ 161.7, 160.2, 157.7, 142.1, 115.0, 113.5, 82.7, 41.4, 36.1, 30.9; HRMS (ESI) m/z calcd 
for C16H19O4 ([M+H]
+
) 275.1283, found 275.1256. 
 
(3S,5S,7S)-Adamantan-1-yl 3-oxo-2-oxabicyclo[2.2.0]hex-5-ene-6-carboxylate (2-47). A solution of 2-
44 (825 mg, 3.01 mmol) dry CH2Cl2 (1.0 L) was transferred to a photoreactor (ACE glass, 1 L jacketed 
reaction vessel with a quartz immersion well). The reaction mixture was purged with argon. The vessel 
was irradiated using a 450W Hanovia lamp through a pyrex filter at 15 °C for 29 hours while keeping the 
temperature at 15 °C. A small aliquot (1 mL) of solution was removed, concentrated afford colorless oil 
2-47 (quantitative yield): 
1
H NMR (300 MHz, CDCl3) δ 7.19 (dd, J = 3.9, 0.9 Hz, 1 H), 5.45 (dd, J = 4.2, 
2.1 Hz, 1 H), 4.40 (dd, J = 1.8, 0.9 Hz, 1 H), 2.15 (m, 9 H), 1.68 (s, 6 H). 
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(3S,8'R,9a'S)-(3S,5S,7S)-Adamantan-1-yl 8'-(2-oxo-2-((triisopropylsilyl)oxy)ethyl)-9a',10'-dihydro-
8'H-spiro[indole-3,9'-pyrido[1,2-a]indole]-7'-carboxylate (2-48). To a flame-dried 250 mL round 
bottom flask was purged with N2 for 3 times. Then 2-47 (65.8 mg, 0.24 mmol, 30 mL, 0.008 mol/L) was 
added via syringe and was cooled to -20 °C. 2-38 (59.0 mg, 0.252 mmol, dissolved in 2 mL of CH2Cl2) 
was added into the flask via syringe. The reaction mixture immediately turned yellow. The reaction 
mixture was stirred at room temperature for 10 min and then refluxed in CH2Cl2 for 8 h. The reaction 
mixture was concentrated in vacuo and purified by flash chromatography on Florisil
TM
 (EtOAc:hexanes, 
1:1) until the eluent became completely clean by TLC.  The yellow fraction remaining on the column was 
then eluted with MeOH.  The MeOH solution was concentrated in vacuo and redissolved in CH2Cl2 (30 
mL), and TIPSCl (46.2 mg, 0.24 mmol), TEA (121 mg, 1.2 mmol) were added. The reaction mixture was 
then stirred at room temperature for 16 h, and concentrated in vacuo, purified by chromatography on SiO2 
(EtOAc: hexanes, 1:5 with 0.5% TEA) to afford 2-48 (17.5 mg, 0.0263 mmol, 11%) as light yellow oil: 
1
H NMR (400 MHz, CDCl3) δ 8.09 (s, 2 H), 7.64 (s, 1 H), 7.34 (s, 1 H), 7.12 (m, 3 H), 6.88-6.85 (m, 2 H), 
6.76 (m, 1 H), 4.73 (t, J = 9.2 Hz, 1 H), 4.04 (s, 1 H), 2.83 (dd, J = 16.0, 9.2 Hz, 1 H), 2.54 (dd, J = 18.0, 
4.0 Hz, 1 H), 2.17 (s, 9 H), 1.75 (dd, J = 16.0, 9.2 Hz, 1 H), 1.67 (s, 6 H), 1.34 (dd, J = 18.0, 5.0 Hz, 1 H), 
1.25 (m, 3 H), 1.04 (m, 18 H). 
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(2E,4E)-Triisopropylsilyl 5-((S)-2-(1H-inden-3-yl)indolin-1-yl)-4-cyanopenta-2,4-dienoate (2-51). To 
a flame-dried 250 mL round bottom flask was added 2-50 (24.0 mg, 0.198 mmol, 60 mL, 0.0033 mol/L) 
and was cooled to -20 °C. Then 2-38 (48.7 mg, 0.0.208 mmol, dissolved in 2 mL of CH2Cl2) was added 
into the flask via syringe. The reaction mixture immediately turned yellow. The reaction mixture was 
stirred at -20 °C for 4 h and was concentrated under vacuum and was purified by flash chromatography 
on Florisil
TM
 (100% EtOAc) until the eluent became completely clean by TLC. The yellow fraction 
remained on the column was then washed with MeOH until all yellow fraction on column was washed 
out. The yellow fraction was collected, concentrated in vacuo. The residue was redissolved in 100 mL 
CH2Cl2, added TEA (100 mg, 139 µL, 0.990 mmol) and TIPSCl (84.0 mg, 77.8 µL, 0.436 mmol), and 
reaction mixture was then stirred for 12 h at room temperature. The reaction mixture was concentrated in 
vacuo and purified by chromatography on SiO2 (EtOAc:hexanes, 1:5 with 0.5% TEA) to afford 12 ( 4.1 
mg, 0.0080 mmol, 4%) as pale yellow oil: IR (neat) 3346, 3057, 2939, 2922, 2896, 2863, 2199, 1674, 
1603, 1579, 1486, 1461, 1376, 1316, 1282, 1271, 1247, 1223, 1178, 1159, 1012, 999, 882, 854, 744 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 8.18 (s, 1 H), 7.43-7.41 (m, 2 H), 7.37-7.29 (m, 3 H), 7.18 (d, J = 6.0 Hz, 1 
H), 7.15-7.12 (m, 2 H), 7.03-6.98 (m, 1 H), 6.96-6.87 (m, 2 H), 5.88 (d, J = 15 Hz), 3.82 (dd, J = 16.2, 9.9 
Hz, 1 H), 3.31 (dd, J = 16.5, 1.8 Hz, 1 H), 1.28-1.25 (m, 3 H), 1.08-1.05 (m, 18 H); 
13
C NMR (100 MHz, 
CDCl3) δ 167.0, 143.6, 142.5, 137.1, 130.7, 128.6, 126.2, 125.0, 124.9, 124.2, 122.6, 120.2, 119.3, 114.9, 
114.6, 111.7, 109.2, 58.3, 53.6, 37.6, 29.9, 18.0, 12.2; HRMS (ESI) m/z calcd for C31H37N3O2SiNa 
([M+Na]
+
) 534.2553, found 534.2555.  
 
Methyl 6-oxo-1-((propionyloxy)methyl)-1,6-dihydropyridine-3-carboxylate (2-46). A mixture of 2-53 
(1.30 g, 8.49 mmol), paraformaldehyde (1.4 g) and K2CO3 (1.73 g, 12.5 mmol) in H2O (4 mL) was treated 
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under sonication for 3 h at room temperature. The aqueous solution was then extracted with CHCl3(3×20 
mL). The combined organic layer was concentrated in vacuo to give a white solid, which was used for the 
next step. 
The white solid was dissolved in CH2Cl2 (30 mL) and propionic anhydride (1.66 g, 12.7 mmol) 
and pyridine (1.34 g, 17.0 mmol) were added to the mixture. The reaction mixture was stirred at room 
temperature for 24 h, concentrated in vacuo, and the residue was dissovled in CH2Cl2 (30 ml). The 
solution was washed successively with saturated aq. NaHCO3, aq. HCl (1 mol/mL), and brine. The 
organic layer was dried (MgSO4), concentrated in vacuo, and purified with chromatography on SiO2 
(EtOAc:hexanes, 1;1) to a afford 2-46 (900 mg, 3.76 mmol, 44% over two steps) as a white solid: IR 
(neat) 3081, 2988, 2951, 2248, 1743, 1719, 1666, 1616, 1543, 1441, 1344, 1303, 1294, 1260, 1225, 1191, 
1139, 1118, 1107, 1079, 1061, 1044, 1014, 971, 915, 836, 772, 725 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
8.34 (s, 1 H), 7.81 (dd, J = 9.2, 1.2 Hz, 1 H), 6.51 (d, J = 9.6 Hz, 1 H), 5.84 (s, 2 H), 3.82 (s, 3 H), 2.36 (q, 
J = 7.6 Hz, 2 H), 1.09 (t, J = 7.6 Hz, 3 H); 
13
C NMR (100 MHz, CDCl3) δ 174.2, 164.4, 162.0, 143.5, 
139.6, 120.5, 110.1, 70.8, 52.2, 27.2, 8.7; HRMS (ESI) m/z calcd for C11H14NO5 ([M+H]
+
) 240.0872, 
found 240.0851.  
 
Methyl 3-oxo-2-((propionyloxy)methyl)-2-azabicyclo[2.2.0]hex-5-ene-6-carboxylate (2-55). `2-46 
(884 mg, 3.70 mmol) was dissolved in CH3CN (20 mL) and sonicated for 15 min. The solution was 
irradiated (450 W, Hanovia lamp) in a two layer FEP at a flow rate of 1 mL/min in the flow 
photochemical reactor. The solution was pumped, irradiated for 5 d and the collected solution was 
concentrated in vacuo. The resulting residue was purified with column chromatography on SiO2 
(EtOAc:hexanes, 1:2 with 0.5% Et3N) to afford 2-55 (66.9 mg, 0.280 mmol, 8%) and a mixture of 2-55 
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and 2-46 (ratio 4:1, 184 mg, 0.767 mmol, 21%): IR (neat) 3027, 2980, 2949, 2902, 2891, 2882, 2945, 
1763, 1720, 1601, 1596, 1435, 1370, 1344, 1312, 1273, 1251, 1219, 1184, 1139, 1079, 1012, 997, 960, 
939, 803, 749 cm
-1
; 
1
H NMR (300 MHz, CDCl3) δ 7.08 (dd, J = 2.7, 0.9 Hz, 1 H), 5.26, 5.23 (AB, J = 
11.1 Hz, 1 H), 5.09, 5.05 (AB, J = 11.1 Hz, 1 H), 4.66 (t, J = 2.4 Hz, 1 H), 4.19 (dd, J = 2.1, 0.9 Hz, 1 H), 
3.74 (s, 3 H), 2.24 (q, J = 7.5 Hz, 2 H), 1.06 (t, J = 7.5 Hz, 3 H); 
13
C NMR (75 MHz, CDCl3) δ 173.6, 
167.3, 161.5, 146.0, 144.2, 66.0, 55.5, 53.8, 51.9, 27.2, 8.7; HRMS (ESI) m/z calcd for C11H13NO5Na 
([M+Na]
+
) 262.0691, found 262.0702. 
 
 
Methyl (3S,8'R,9a'S)-2',5-dimethoxy-8'-(2-oxo-2-((triisopropylsilyl)oxy)ethyl)-9a',10'-dihydro-8'H-
spiro[indole-3,9'-pyrido[1,2-a]indole]-7'-carboxylate (2-59). To a flame-dried 250 mL round bottom 
flask was added silica gel (400 mg) and 2-57 (76.4 mg, 0.260 mmol). 2-2 (40.0 mg, 0.260 mmol, 40 mL, 
0.00649 mol/L) was added and was cooled to 0 °C. The reaction mixture immediately turned yellow. The 
reaction mixture was stirred at 0 °C for 1 h and then heated under reflux for 2 h. The reaction mixture was 
concentrated in vacuo purified with column chromatography on Florisil
TM
 (EtOAc:hexanes, 1:1) until all 
impurities and starting material were washed out (characterized by TLC). The Florisil
TM
 column was then 
washed with MeOH until all yellow fractions on the column were washed out (characterized by TLC). 
The MeOH solution was concentrated in vacuo and redissolved in 1,2-dichloroethane (10 mL). 
To this solution was added TIPSCl (50.0 mg, 0.260 mmol) and Et3N (131 mg, 1.30 mmol) and 
the reaction mixture was stirred at room temperature for 3 h. The reaction mixture was concentrated in 
vacuo and purified by column chromatography on SiO2 (EtOAc:hexenes, 1:5 with 0.5% Et3N) to afford 2-
70 
59 (42.0 mg, 0.0694 mmol, 27% over 3 steps) as yellow oil: IR (neat) 2943, 2891, 2865, 2833, 1707, 
1685, 1607, 1597, 1555, 1495, 1465, 1433, 1404, 1368, 1355, 1335, 1277, 1225, 1202, 1193, 1180, 1146, 
1115, 1085, 1051, 1029, 999, 910, 882, 805, 911, 880 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 8.14 (s, 1 H), 
7.93 (s, 1 H), 7.55 (d, J = 8.4 Hz, 1 H), 6.88-6.83 (m, 2 H), 6.68-6.65 (m, 2 H), 6.49 (d, J = 2.4 Hz, 1 H), 
4.74 (t, J = 9.6 Hz, 1 H), 4.05-4.02 (m, 1 H), 3.69 (s, 3 H), 3.68 (s, 3 H), 3.66 (s, 3 H), 2.82 (dd, J = 16.6, 
9.2 Hz, 1 H), 2.48 (dd, J = 18.0, 6.0 Hz, 1 H), 1.80 (dd, J = 16.6, 9.6 Hz, 1 H), 1.35 (dd, J = 18.0, 4.8 Hz, 
1 H), 1.29-1.21 (m, 3 H), 1.04-1.02 (m, 18 H); 
13
C NMR (100 MHz, CDCl3) δ172.9, 172.3, 167.5, 158.9, 
155.6, 150.9, 137.3, 137.1, 135.7, 130.7, 121.7, 113.1, 112.9, 112.2, 112.0, 107.7, 99.7, 62.3, 61.3, 55.8, 
55.7, 50.9, 35.1, 34.4, 29.8, 17.8, 12.1; HRMS (ESI) m/z calcd for C34H45N2O6Si ([M+H]
+
) 605.30414, 
found 605.30663. 
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3.0  TOTAL SYNTHESIS OF HAOUAMINE A 
3.1 INTRODUCTION 
3.1.1 Haouamines: A Unique Aza-Paracyclophane System 
In 2003, Salva et al. discovered alkaloids haouamine A 3-1 and B 3-2/3-3 (Scheme 3-1) from a tunicate 
Aplidium haouarianum residing off Tarifa Island on the southern coast of Spain.
106
 Unique structural 
features of both natural products include a congested and highly oxygenated indeno-tetrahydropyridine 
ring system and a highly-strained aza-cyclophane, which was elucidated via NMR spectroscopy. The 
structure of haouamine A was also confirmed by X-ray crystallographic analysis,
107,108
 while the structure 
of naturally-isolated haouamine B was later revised in comparison with a synthetic sample.
109,110
 
Haouamine A and B were found to be biologically active. Haouamine A exhibits selective activity in the 
human colon carcinoma cell line HT-29 (IC50 0.1 µg/mL)
106
 and has moderate activity against the human 
prostate cancer cell line PC3 (IC50 29±2 µM)
107
. The atropisomer of haouamine A, however, shows only 
moderate activity against human prostate cancer cell line PC3 (IC50 32±3 µM)
107
, and haouamine B only 
shows weak toxicity in MS-1 cell line MS-1 (IC50 5 µg/mL)
106
. 
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Scheme 3-1 Structures of haouamine A and B 
The structures of haouamine A and B contain a strained aza-cyclophane-an architecturally-
unprecedented feature that makes them fascinating targets for total synthesis. 
1
H and 
13
C NMR 
spectroscopy show typical aromatic chemical shifts for B ring in haouamine A and its carbon-carbon 
bonds in the ring are around 1.395 Å (Figure 7). These features all match those of planar aromatic 
systems, despite a strained boat-like conformation in the B ring (Figure 8).
107,108,111
  
 
Figure 7 Chemical shifts (ppm) and bond lengths (Å) of B-ring in haouamine A 
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Figure 8 X-ray structure of haouamine A and its boat-like B-ring
107,108 
When dissolved in organic solvent, haouamine A was found to consist of two equilibrating 
atropisomers which are inseparable by chromatography.
106,112
 The ratio of the two atropisomers is solvent 
dependent (e.g. 1:3 in DMSO-d6, 2:1 in acetone-d6), and a mixture of atropisomers were still observed by 
dissolving a crystal of haouamine A with a single definite molecular geometry in an organic solvent.
106,112
 
The fact that haouamine A exists as two interconverting atropisomers was rationalized to arise from either 
rotation of the phenol B ring or from inversion of geometry at the nitrogen center.
106
 The latter one was 
confirmed by Baran et al.
107
 by synthesizing a pair of separable atropisomers of haouamine A, and 
additional computational studies supported the rationalization that the N-inversion gives rise to the 
presence of two atropisomers (Figure 9).
112
 
 
Figure 9 Proposed atropisomerism and N-inversion in haouamines 
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A biosynthetic pathway of haouamine A was proposed by Baran et al. involving a tetramerization 
route of meta-hydroxylated phenylacetaldehydes 3-7 with ammonia followed by oxidative coupling, 
though in vitro it was ascertained that this route is unlikely to take place without enzymatic intervention 
(Scheme 3-2).
108,113
  
 
Scheme 3-2 Biosynthesis of haouamine A proposed by Baran et al. 
3.1.2 Total Synthesis of Haouamine A: Previous Work 
3.1.2.1 Previous Work from Other Groups  
The architectural novelty of haouamine A has aroused the interest of the synthetic community. To date, 
the most common strategy used in constructing the strained aza-cyclophane in haouamine A was 
established by Baran et al. in 2006, as they reported the first racemic total synthesis of haouamine A.
108
  
75 
 
Scheme 3-3 Baran’s total synthesis of haouamine A: preparation of intermediate 3-16 
The synthesis started with allylation of indanone 3-8, which was prepared in 4 steps from 7-
methoxyindanone, with allyl iodide 3-9 and subsequent condensation of the ketone with hydroxylamine. 
The resulting oxime 3-10 underwent a 5-exo-trig cyclization to trap the bromonium ion generated in situ 
when exposed to a bromide source 3-11. Reduction of nitrone 3-12 using NaBH4 afforded hydroxylamine 
3-13, which upon heating was converted to N-hydroxyl enamine 3-15 via N-hydroxyaziridinium 3-14. 
The key piperidine intermediate 3-16 was obtained by selective reduction of N-hydroxylamine 3-15 using 
In
0 
(Scheme 3-3).
108
  
Construction of the strained aza-paracyclophane moisty was accomplished exploiting an 
intramolecular pyrone-alkyne Diels-Alder reaction. It was envisioned that a boat configuration of 
cyclohexadiene with an embedded CO2 generated resembles that of the bent aromatic ring in the aza-
cyclophane.
108
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Scheme 3-4 Baran’s total synthesis of haouamine A: completion by Diels-Alder reaction 
The Diels-Alder precursor 3-21 was prepared from the Boc-protected piperidine 3-17 by Stille 
coupling with pyrone 3-18, Boc removal and alkylation with 4-tosyloxybutyne 3-20. The methyl groups 
in 3-21 were swapped for acetate groups to increase the thermal stability at elevated temperature, and the 
resulting alkyne 3-22 was heated at 250 °C to effect the Diels-Alder macrocyclization. Acetate removal 
furnished a mixture of haouamine A 3-1 (dr 10:1) and uncyclized staring material (Scheme 3-4).
108
  
An asymmetric total synthesis of (+)-haouamine A was later accomplished by Baran et al. by 
establishing the absolute stereochemistry at C-26 (haouamine numbering) in key ketone intermediate 3-31 
via a diastereoselective pinacol rearrangement. Diol 3-25 was generated by a Sharpless asymmetric 
dihydroxylation of aryl indene 3-24. Enantio-enrichment by crystallization and subsequent oxidation 
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furnished ɑ-hydroxy ketone 3-26. Treatment of ketone 3-26 with allyl tributyltin 3-27 in presence of 
indium triflate afforded allyllation product diol 3-29 via chair-like transition state 3-28, the 
diastereoselectivity of allyltin species generated by transmetalation of tributyltin 3-27 with indium triflate. 
BF3-OEt2 initiated pinacol rearrangement of diol 3-29 afforded ketone 3-31 via cation 3-30, and ketone 3-
31 was carried through in steps according to established reaction sequence and was converted to (+)-
haouamine A (+)-3-1, whose CD spectra were opposite to those of the isolated natural product (Scheme 
3-5).
113
 
 
Scheme 3-5 Baran’s total synthesis of (+)-haouamine A 
Baran et al. improved their total synthesis of haouamine A by employing tosylate 3-32, whose sp
3 
tertiary carbon greatly lowers the strain built up in the macrocyclic intermediates 3-34 and 3-35. In 
addition, the point chirality of this sp
3
 tertiary carbon determines the planar chirality of the cyclophane 
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macrocycle in the natural product, which helps eliminate the possibility that the two interconverting 
isomers in solution are caused by atropisomerism of the boat-like phenol ring.  
Their updated total synthesis commenced with borylation of the lithiated aryl bromide 3-17 and 
palladium-catalyzed cross coupling of the in situ generated aryl borate with enone iodide 3-32. The 
coupled product 3-33 was obtained as an inseparable mixture of diastereomers. Conversion to the 
corresponding iodide and heating in the presence of Hünig’s base was effected after N-Boc deprotection. 
Two macrocycles 3-34 and 3-35 were separated and each of them existed as interconverting isomers in 
solution, which demonstrates that the two isomers of haouamine A in solution arise from N-inversion of 
piperidine ring. Subsequent aromatization was accomplished using N-tert-butylbenzenesulfinimidoyl 
chloride followed by removal of methyl ethers afforded haouamine A 3-1 and its atropisomer 3-38 
(Scheme 3-6). 
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Scheme 3-6 Baran’s updated total synthesis of haouamine A 
Several formal total syntheses
114-116
 of haouamine A have been reported based on the first 
generation
108
 of Baran’s total synthesis and two total syntheses of haouamine B109,110 have been reported 
based on the second generation
107
 of Baran’s total synthesis. The targets in the formal total syntheses of 
haouamine A include key aryl bromide intermediate 3-16 or Diels-Alder precursor 3-21. 
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Scheme 3-7 Weinreb’s formal total synthesis of haouamine A 
The target of Weinreb’s formal total synthesis of haouamine A was piperidine 3-16. The 
synthesis started with lactone 3-39
117
, which was converted to aldehyde 3-40. Condensation of aldehyde 
3-40 with N-benzylhydroxylamine furnished nitrone 3-41, which underwent an intramolecular dipolar 
cycloaddition to generate isoxazolidine 3-42.  This was further elaborated to amine 3-43 by reductive N-O 
bond cleavage, debenzylation and subsequent silylation of alcohol. Amide coupling of amine 3-43 with 
acid 3-44 afforded amide 3-45, whose TBS group was deprotected and the resulting alcohol was oxidized 
with DMP to provide aldehyde 3-46. Lactam 3-47 was obtained from aldehyde 3-46 via an intramolecular 
aldol condensation and was reduced to converge with Baran’s intermediate 3-16 (Scheme 3-7).114  
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Scheme 3-8 Fürstner’s formal total synthesis of haouamine A 
Fürstner et al. chose Diels-Alder precursor 3-21 as their target for their formal total synthesis of 
haouamine A. Enone 3-49, synthesized from aldehyde 3-48 in a few steps, underwent a Heck cyclization 
to furnish tricycle 3-50 which was then converted to tetracycle 3-51 via the conjugate addition of an 
organocuperate. Nitrogen deprotection and alkylation were conducted to form 3-52. This sequence was 
necessary to ensure the regioselective formation of an enol triflate in the following step. Stille coupling 
with trimethyltin 3-53 and desilylation then afforded Baran’s Diels-Alder precursor 3-21. After a 
protecting group swap, the key Diels-Alder reaction in Baran’s total synthesis was attempted but the 
desired Diels-Alder product was obtained in much lower yields than those reported by the Baran group 
(Scheme 3-8).
115
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Scheme 3-9 Ishibashi’s formal total synthesis of haouamine A 
Ishibashi et al. completed their formal total synthesis of haouamine A with key aryl bromide 
intermediate 3-16 as the target. An efficient intramolecular cascade Mizoroki-Heck reaction built up the 
diaryl quaternary carbon in tetracycle 3-56 from aryl iodide 3-55. Ozonolysis and enol triflate formation 
afforded 3-57, which was subjected to a Suzuki coupling, reduction, and debenzylation to afford 3-16, the 
key intermediate in Baran’s synthesis (Scheme 3-9).116 
3.1.2.2 Previous Work from the Wipf Group: a Model System 
Initial synthetic work involving haouamine A in the Wipf group was attempted by Dr. Markus Furegati 
who completed the synthesis of the model 3-aza-[7]-paracyclophane 3-67. The phenol moiety in the aza-
paracyclophane was constructed via a base-promoted aromatization of 5-methoxy-cyclohex-2-en-1-one 
functionality in intermediate 3-65. This particular aromatization method of using β-elimination of MeOH 
was discovered before the oxidative method reported by Baran et al  to form 3-32.
107,109,110,113
.
111
 
83 
 
Scheme 3-10 Wipf’s synthesis of 3-67: the 3-aza-[7]-paracyclophane core of haouamine A 
The synthesis of model system 3-67 commenced with a Suzuki-Miyaura coupling of boronic ester 
3-61 and enol triflate 3-62, followed by desilylation to generate alcohol 3-63. After heat-promoted Boc 
removal, a Mitsunobu cyclization furnished macrocycle 3-64. Key enone 3-65 was obtained from 3-64 via 
a three-step reaction sequence including epoxidation, acid-promoted epoxide opening, and oxidation of 
the resulting allylic alcohol.  Aromatization was effected by heating and afforded model system 3-67, 
whose structure was confirmed by X-ray crystallographic analysis of its HCl salt (Scheme 3-10).
111
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Figure 10 X-ray structure of 3-1 and 3-67-HCl
107,108,111
 
              
The B ring of haouamine A in model system 3-67 adopts a boat-like conformation (Figure 10, 
right) as shown in the X-ray structure, which bears a close resemblance to that of the natural product 
(Figure 10, left). The successful synthesis of model system 3-67 sets a good foundation for the total 
synthesis of haouamine A, using the unique base-promoted aromatization of enone 3-65.
111
  
3.1.2.3 Previous Work from the Wipf Group: Total Synthesis of Haouamine A 
The total synthesis of haouamine A was attempted by Dr. Chenbo Wang in the Wipf group and using the 
model system as a guide. The distorted B-ring in the aza-paracyclophane would be formed from methoxy 
cyclohexene 3-68 as it was in the model system 3-67. The A and B rings of haouamine A could be joined 
via a Suzuki coupling which to construct the macrocycle. The tetrahydropyridine moiety in haouamine A 
could be accessible from 3-68 by reduction of the lactam, which is derived from intramolecular aldol 
condensation of aldehyde 3-69. The tertiary amide moiety in 3-69 is obtained from amine 3-70 by 
reductive amination and subsequent amide coupling.  The amine and carboxylic acid functionalities in 3-
70 would be accessible through hydrolytic decarboxylation and dehalogenation from 3-71, which should 
be the product of a Beckmann rearrangement of dichlorocyclobutanone 3-72. 3-72 would be constructed 
85 
via a [2+2] cycloaddition involving indene 3-73, which could be derived from known dihydroindinone 3-
74
118
 via nucleophilic addition of a Grignard reagent and dehydration (Scheme 3-11).
119
 
 
Scheme 3-11 Retrosynthetic analysis of haouamine A 
The total synthesis commenced with a Knoevenagel−Doebner condensation120,121 of commercially 
available aldehyde 3-75 with malonic acid and piperidine in pyridine at reflux. Catalytic hydrogenation of 
resulting ɑ, β-unsaturated acid 3-76, followed by bromination to block the para-position, afforded aryl 
bromo acid 3-78 that underwent a Friedel–Crafts cyclization in hot PPA to furnish indanone 3-74 
(Scheme 3-12).
118
 
86 
 
Scheme 3-12 Preparation of indanone 3-74 
Indanone 3-74 was subjected to nucleophilic attack by Grignard reagent 3-79, and the resulting 
tertiary alcohol was heated in toluene at reflux with catalytic p-TsOH-H2O to effect dehydration.
122
 A 
[2+2] cycloaddition
123-125
 of indene 3-73 with in situ generated dichloroketene afforded cyclobutanone 3-
72, which was treated with mesitylene sulfonyl hydroxylamine 3-80
126-128
 to promote a Beckmann 
rearrangement.
129,130
 Regioselective insertion of a nitrogen atom furnished dichlorolactam 3-81 with 
retention of configuration at the adjacent quaternary carbon. The geminal dichloro moiety was hydrolyzed 
to a carbonyl using a methanolysis-hydrolysis sequence. Boc-protected ɑ-keto lactam was subjected to 
oxidative hydrolytic decarboxylation
131-135
, and the resulting carboxylate was immediately methylated to 
give the Boc-amino methyl ester 3-83. Amine 3-85 was smoothly obtained from 3-83 in two steps 
including hydrogenative debromination and Boc removal (Scheme 3-13).
119
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Scheme 3-13 Preparation of amine 3-85 
The secondary amine 3-89 was prepared from 3-85 and aldehyde 3-88 by reductive amination. 
The inseparable mixture of diastereomers was carried through the subsequent steps. Ketone 3-86
111
 
underwent enol triflate formation and dihydroxylation/oxidative cleavage to give aldehyde 3-88, which 
was immediately used in a reductive amination due to its instability. Suzuki coupling precursor 3-93 was 
synthesized from secondary amine 3-89 using peptide coupling conditions with acid 3-92, which was 
prepared from known acid 3-90 (Scheme 3-14).
111
.
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Scheme 3-14 Preparation of amine 3-93 for Suzuki cyclization 
 
 
Scheme 3-15 Preparation of macrocycle 3-94 by Suzuki cyclization 
The key intramolecular Suzuki coupling to build the macrocycle 3-94 was successfully carried 
out with great efficiency, reproducibility, and scalability. Addition of three equivalents of water was 
crucial as it was envisioned to play an important role in promoting the generation of hydroxide ion in 
89 
transmetalation process or basic hydrolysis of boronic ester before transmetalation. More water in the 
reaction led to deboronation that hampered the yield (Scheme 3-15).
119
 
However, intramolecular aldol reactions to construct the tetrahydropyridine moiety in haouamine 
A proved to be difficult. In order to minimize interference from the cyclohexene moiety to possible 
reactions involved in tetrahydropyridine formation, the methoxyl cyclohexene moiety was aromatized.  
 
Scheme 3-16 Epoxidation of 3-94 to generate a mixture of diastereomers 3-95 and 3-96 
According to aromatization protocols developed in the model system study, the cyclohexene 
moiety in 3-91 was epoxidized efficiently to generate a mixture of easily separable diastereomers. Both of 
them were carried through the following reaction sequence as not much information was known at this 
stage in terms of stereochemical configuration in comparison with that of haouamine A.
119
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Scheme 3-17 Aromatization sequence from 3-95 to generate 3-99 
 
Scheme 3-18 Aromatization sequence from 3-96 to generate 3-102 
A base-promoted aromatization sequence was carried out separately for 3-95 and 3-96, including 
epoxidation (Scheme 3-17), acid-promoted epoxide opening, oxidation of the resulting allylic alcohol and 
base-promoted aromatization at elevated temperature (Scheme 3-18). Amide 3-99 was later characterized 
91 
by X-ray crystallography to confirm the correct atropisomerism to be consistent with haouamine A. This 
material was used in the final steps of the total synthesis.
119
 
 
Scheme 3-19 Formation of 3-107 
An intramolecular aldol reaction was carried out under relatively harsh conditions with aldehyde 
3-101, which was prepared from aromatized lactam 3-96 in two steps. The aldol product 3-102 was 
characterized as a single diastereomer by X-ray crystallography. After extensive experimentation, it was 
discovered that the deeply buried amide moiety 3-105 was reduced, providing amino alcohol 3-106 as the 
major product and desired tertiary amine 3-107 as the minor product. Activation of the hydroxyl group in 
amino alcohol 3-106 with mesylate and an intramolecular substitution smoothly furnished desired tertiary 
amine 3-107 (Scheme 3-19).
119
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Scheme 3-20 Attempted dehydration of alcohol 3-107 to generate 3-108 
However, dehydration of alcohol 3-107 to generate tetrahydropyridine 3-108 proved to be 
challenging. Numerous conditions including activation of the hydroxyl group (MsCl, SOCl2, POCl3, Tf2O, 
NaH/PhNTf2, thiocarbonyldiimidazole, TsOH/PhMe, DEAD/PPh3) and dehydration (Martin’s sulfurane, 
Burgess reagent, P2O5/PhMe) were conducted and met with no success.  The hydroxyl group was deeply 
buried in the cavity formed by the aza-cyclophane moiety in 3-107 and it was too hindered to be activated 
with reagents even as small as mesylate chloride. The structure of 3-107 was also discovered to be rather 
sensitive as it underwent complete decomposition upon slight heating. Methylation of the hydroxyl group 
in 3-107 was found to be quantitative using methyl iodide, but the elimination of MeOH from ensuing 3-
109 using a sterically less demanding base such as potassium hydride or methyl lithium gave starting 
material as the proton next to methoxyl group was discovered to be completely shielded. Likewise slight 
heating of 3-109 with base led to complete decomposition (Scheme 3-20). 
Thus, although the late stage intermediate 3-107 was synthesized based on a route featuring 
intramolecular Suzuki cyclization, aromatization, and intramolecular aldol reaction, the sequence was two 
steps away from haouamine A 3-1.   
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3.2 RESULTS AND DISCUSSION 
3.2.1 1st Generation Approach: Intramolecular Aldol Condensation of Epoxide Substrate  
Chenbo’s thorough and elaborate work on the total synthesis of haouamine A has shown that the late 
stage intermediate  3-104 bearing a hindered hydroxyl group formed in the intramolecular aldol reaction 
was difficult to functionalize. Therefore, it was assumed that the tetrahydropyridine should be formed 
earlier to avoid manipulations on a rigid aza-paracyclophane intermediate.  
It was envisioned that an intramolecular aldol condensation of a less hindered and strained 
intermediate similar to Weinreb’s formal synthesis114 should be ideal for the direct formation of the 
tetrahydropyridine moiety. In this way, the challenging dehydration from 3-107 to 3-108 should be 
bypassed in the early steps. Similar transformations were attempted in Chenbo’s work119 on substrates 3-
104 and 3-110 with no success, which was attributed to the rigid nature of both molecules caused by 
conjugated sp
2
 carbons present in the phenol or cyclohexene functionalities (Scheme 3-21).  
It was anticipated that the conversion of the sp
2
 carbons in 3-110 to sp
3
 carbons via epoxidation 
should greatly reduce the strain present in the pre-formed macrocycle structure, making it more flexible 
for an intramolecular aldol condensation. Epoxide 3-112 could, therefore, serve as a substrate for 
intramolecular aldol condensation.  
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Scheme 3-21 Substrates for intramolecular aldol condensation 
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Scheme 3-22 Retrosynthetic analysis based on intramolecular aldol condensation of 3-112 
 
The tetrahydropyridine moiety in haouamine A 3-1 could be constructed by reduction of lactam 
3-111. Epoxide 3-110 was envisioned to be the precursor of aromatized 3-111 and could be derived from 
aldehyde 3-109 through an intramolecular aldol condensation. Aldehyde 3-109 could be accessed from 
Chenbo’s key intermediate macrocycle 3-91 after sequential reduction of ester 3-91, epoxidation of 
cyclohexene 3-113 and oxidation of ensuing alcohol 3-112 (Scheme 3-22). 
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Scheme 3-23 Selective reduction of methyl ester 3-91 
The new approach commenced with a selective reduction of sterically-hindered methyl ester 3-91 
in the presence of the lactam macrocycle. Although LiBH4 in THF smoothly reduced a similar substrate 
3-99 to 3-103
119
, only a trace of desired alcohol 3-116 was obtained. According to literature 
precedence
136,137
, the use of low polarity Et2O and catalytic B(OMe)3 greatly accelerates the reductions 
with LiBH4. Therefore, methyl ester 3-91 was exposed to LiBH4 with B(OMe)3 in Et2O, and the reduction 
was brought to completion in two days. Formation of two separable diastereomers was observed, each in 
moderate yields and they could be well separated by chromatography on SiO2. Both diastereomers were 
carried through the route individually and their yields for each step were presented separately, as it was 
not certain as to which diastereomer led to the natural product or its atropisomer at the current stage 
(Scheme 3-23).   
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Scheme 3-24 Intramolecular aldol condensation of epoxide 3-112 
As discussed previously, the use of epoxide 3-112 as intramolecular aldol condensation precursor 
was desirable for the direct formation of lactam 3-113, as two newly generated sp
3
 carbons by the 
formation of epoxide were envisioned to greatly reduce the strain present in the macrocycle. Therefore, 
precursor 3-112 was synthesized in two steps from alcohol 3-116 including epoxidation and oxidation of 
ensuing alcohol 3-115. Epoxidation was accomplished by in situ generated DMDO. Oxidation of 3-115 
was accomplished with Dess-Martin periodinane. Intermediate 3-112 was isolated as mixtures of 
diastereomers, and were directly used without characterization (Scheme 3-24).  
For the formation of the lactam moiety in 3-47 in Weinreb’s formal total synthesis of haouamine 
A, aldehyde 3-46 was treated with K2CO3 in MeOH heated at 60 °C. However, aldehyde 3-112 did not 
react under the same conditions. This may be attributed to the macrocycle present in 3-112, making it a 
much more hindered and rigid system than aldehyde 3-46. The desired condensation product 3-113 was 
obtained in moderate yields (68%; 46%) when the reaction mixture was stirred for two months at 60 °C or 
11 days at 100 °C.
119
 Though the reaction time was exceedingly long, this was encouraging because both 
3-112 and 3-113 showed good stability at elevated temperature. As a result, a microwave assisted aldol 
98 
condensation condition was attempted on aldehyde 3-112. Within 6 hours at 125 
o
C aldehyde 3-112 was 
smoothly converted to lactam 3-113 in a moderate yield over 3 steps (Scheme 3-24). 
 
Scheme 3-25 Aromatization to generate phenol 3-118 and its subsequent methylation 
Based on the well-established protocol developed in the model system, epoxide 3-113 was 
envisioned to be converted to the key aromatization precursor 3-117. Epoxide 3-113 was anticipated to be 
considerably more rigid than epoxidation product of 3-64 in model system synthesis or 3-95/3-96, and 
therefore it showed substantially less reactivity in the acid-induced opening of the epoxide to generate 
allylic alcohol upon treatment of H2SO4 in a mixture of H2O and DMSO. For one diastereomer, the 
epoxide was not completely consumed after 4 days, for the other one, the reaction took 5 days to complete. 
The allylic alcohol products, which existed as a mixture of diastereomers and showed complicated spectra, 
were oxidized in 2 h with Dess-Martin periodinane to smoothly furnish aromatization precursor 3-117 in 
20% (40% brs) and 72% yields over 2 steps (Scheme 3-25).  
Aromatization of enone 3-117 was readily accomplished in good yield as previously described as 
3-65 or 3-98/3-101 under microwave irradiation for 1.5 hours at 100 °C together with Hünig’s base in 
2,2,2-trifluoroethanol. Phenol moiety formed during aromatization in 3-115 was methylated by refluxing 
with MeI in presence of NaH, in order to increase the stability of the compound during the subsequent 
lactam reduction step (Scheme 3-25). 
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Scheme 3-26 Attempted reduction of lactam 3-114 
Haouamine A 3-1 was anticipated to be accessed from lactam 3-114 via remaining steps 
including its reduction to tetrahydropyridine and subsequent global demethylation to generate the free 
phenol. However, the reduction step was confronted with unexpected difficulties which were not present 
with similar substrates in Chenbo’s route. Reduction conditions using AlH3 or AlH2Cl in THF at -78 °C, 
which smoothly converted lactam 3-105 to amine 3-106/3-107, turned out to be ineffective after 
considerable experimentation. Though the [M+18] peak indicating the probable presence of amino 
alcohol 3-119 was often detected by mass spectrometry from the reaction mixture after AlH3 or AlH2Cl 
reduction, its corresponding spot was extremely nonpolar by TLC and the material could not be isolated.  
If the amino alcohol 3-119 was indeed generated under AlH3/AlH2Cl reduction conditions as suggested 
by mass spectrometry data, it would be merely a trace amount because no available NMR data confirmed 
it. Extensive optimization was conducted to the reaction time and stoichiometry and no positive result was 
obtained. It was discovered that the reaction was extremely rapid as the complete disappearance of lactam 
3-114 on the TLC plate to generate a nonpolar spot with a mass corresponding to amino alcohol 3-119 
happened almost immediately after AlH3/AlH2Cl was added into the reaction mixture. Other reduction 
conditions with aluminum, boron, and silicon-based reagents also generated decomposed material or 
afforded unreacted starting material. Attempts to convert lactam 3-114 to the corresponding thiolactam 
were made. However, thionating reagents were not reactive on lactam 3-114 (Scheme 3-26). 
100 
The less reactive nature of lactam 3-114 in comparison with its counterpart 3-105 was somewhat 
expected. The pre-established ɑ, β-unsaturated lactam moiety in 3-114 created a more rigid and hindered 
environment. This not only prevented most reductive reagents from accessing the carbonyl functionality 
but was also triggered complete decomposition when the material was treated with AlH3/AlH2Cl. 
As the lactam moiety in 3-114 was deeply buried and difficult to reduce in the very last step in 
the proposed route, efforts to reduce it at an earlier stage were attempted under the presumption that early 
intermediates in this route were not as rigid and sterically hindered as lactam 3-114. Since the amide 
carbonyl functionality in intermediates throughout this route is needed, possible intermediates for amide 
reduction could only be found in the steps following the aldol condensation. Reduction attempts were 
conducted on allylic alcohol 3-120 using AlH3/AlH2Cl and other reducing agents but resulted in a mostly 
decomposed material (Scheme 3-27).  
 
Scheme 3-27 Attempted reduction of lactam 3-117 
At this point, the failure to accomplish the last step in the two routes explored (dehydration in 
Chenbo’s route and reduction in the current route) led to the conclusion that manipulation at central 
tetrahydropiperidine moiety at the last stage of the total synthesis seemed quite undesirable as the whole 
molecule is more rigid and sterically hindered. Therefore, an alternative route exploiting Baran’s strategy 
to construct the macrocycle was explored. 
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3.2.2 2nd Generation Approach: Intramolecular Substitution 
3.2.2.1 Cross-coupling Involving Iodo-enone 3-124 
 
Scheme 3-28 Retrosynthetic analysis exploiting Baran’s strategy 
Enone 3-122 was envisioned to be the precursor of aromatized late stage intermediate 3-66/3-67 in 
Baran’s synthesis107,113 and could be further derived from amino iodide 3-123 through an intramolecular 
substitution to construct the macrocycle. Amino iodide 3-123 could be accessed by assembling the two 
building blocks enone iodide 3-124 which could be synthesized from the known ketal 3-125
111
 and 
Baran’s key intermediate 3-16 via Suzuki coupling107,108,113 (Scheme 3-28).  
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Scheme 3-29 Synthesis of intermediate 3-127 
According to Chenbo’s work, amino methyl ester 3-85 was reduced by LAH to generate an 
alcohol intermediate (not shown), which was coupled with acid 3-44 in presence of EDC in CH2Cl2 to 
smoothly afford amide 3-126. This approach bypassed the protecting group manipulations in Weinreb’s 
formal total synthesis.
114
 Similarly, the resulting alcohol 3-126 was oxidized with DMP to provide 
aldehyde 3-46, which was converted to lactam 3-47 via an intramolecular aldol condensation.
114
 
Reduction of lactam 3-47 with TMDS in presence of Ru3(CO)12 in toluene
138
 was found to be superior to 
previously reported conditions. The resulting amine was then protected to afford 3-127 (Scheme 3-29). 
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Scheme 3-30 Synthesis of iodo-enone 3-135 
The synthesis of iodo-enone 3-135 commenced with ozonolysis of alkene 3-125 followed by 
reductive quenching with NaBH4 to furnish a primary alcohol 3-128. Ketal hydrolysis afforded ketone 3-
129 and its hydroxyl group was protected with MOM group. Treatment of ketone 3-130 with TBSOTf 
and 2.6-lutidine gave a silyl enol ether
139
 (not shown), and under osmium-promoted dihydroxylation 
conditions
140
, was converted to a ɑ-hydroxyl ketone which was silylated to generate silyloxy ketone 3-131.   
An enol triflate was obtained from silyloxy ketone 3-132 by treating it with LiHMDS and Comins’ 
reagent
141,142
, and catalytic hydrogenolysis using formic acid as a hydride source
143
 removed the triflate 
group to furnish 3-133. Desilylation with TBAF followed by an oxidation with Dess-Martin 
periodinane
144
 provided enone 3-134, which upon treatment of I2 and pyridine was iodinated
145
 to give 
iodo-enone 3-135 (Scheme 3-30).  
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Scheme 3-31 Cross-coupling reactions between iodo-enone 3-135 and model systems 
Suzuki or Stille coupling reactions between iodo-enone 3-135 and boronic acid 3-136 or 
tributyltin 3-137 were attempted to model the coupling needed to form 3-141. However, the desired cross-
coupling product 3-139 was never observed. Instead, the only isolable product was phenol 3-138. After 
extensive experimentation, it was realized that it was difficult to avoid such aromatization during the 
reaction, and therefore iodo-enone 3-135 was not suitable to be engaged in cross-coupling reactions 
(Scheme 3-31). 
 
Scheme 3-32 Cross-coupling reaction between iodo-allylic alcohol 3-135 and boronic acid generated from 
3-127 
In order to prevent this aromatization during the cross-coupling, iodo-enone 3-135 was reduced to 
iodo-allylic alcohol 3-140. However, the reduction was challenging. The iodine was prone to reduction, 
and the allylic alcohol 3-140 was relatively unstable upon storage. It was discovered that NaBH4 with 
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CeCl3-7H2O cleanly reduced iodo-enone 3-135 to allylic alcohol 3-140, which after purification was 
immediately treated with the boronic acid generated from 3-127. No desired cross-coupling product was 
observed, which could be attributed to the instability of 3-140 or inefficient palladium insertion to allylic 
alcohol 3-135 (Scheme 3-32). 
Failures in key cross-coupling reactions that were envisioned to connect the two building blocks 
3-127 and 3-140 in the strategy similar to Baran’s total synthesis suggested the presence of the hydroxyl 
group in 3-140 might be undesirable for this process. Therefore, the synthetic plan was further modified 
as the carbonyl/hydroxyl group in 3-140 was anticipated to be introduced after the cross-coupling reaction. 
3.2.2.2 Late-Stage Formation of Enone Functionality 
 
Scheme 3-33 Retrosynthetic analysis with late-stage formation of enone functionality 
Macrocycle 3-142 was envisioned to be the precursor of enone 3-122 through an epoxidation, epoxide 
opening, an oxidation reaction sequence. This could be further derived from amino iodide 3-143 via an 
intramolecular substitution. Similarly, amino iodide 3-143 was anticipated to be constructed by a cross-
coupling reaction between building blocks 3-16 and 3-144 (Scheme 3-33).  
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Scheme 3-34 Synthesis of alkenyl iodide 3-147 
The synthesis of cross-coupling building block 3-147 commenced with a dihydroxylation and 
oxidative cleavage, and reduction sequence to smoothly furnish primary alcohol 3-145. Enol triflate 3-146 
was obtained after TBS protection of hydroxyl group and was further converted to alkenyl iodide 3-147 
via a stannyl intermediate (Scheme 3-34). 
 
Scheme 3-35 Cross-coupling reactions between 3-149/3-150 and aryl bromide 3-127 
Suzuki cross-coupling reactions were carried out with alkenyl iodide 3-147 and an in situ 
generated boronic acid from aryl bromide 3-127. Though the desired coupling product was indeed 
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isolated in several attempts, the yield was inconsistent and low, with debromination product from 3-127 
as the major side product as well as unreacted alkenyl iodide. Alkenyl iodide 3-147 was presumed to be 
more electron rich than to iodo-enone 3-32
107
 in Baran’s total synthesis and therefore was not considered 
to be a good cross-coupling component in this reaction (Scheme 3-35). 
Stille and Suzuki cross-coupling reactions were also explored using aryl bromide 3-127 and 
trimethyltin 3-149/pinacolborate 3-150 generated from enol triflate 3-146. Though the yield was still low, 
debromination product from 3-127 was the major species obtained. The formation of debromination 
product from 3-127 can be rationalized due to the electron-rich para-methoxy group and the relative 
bulky ortho-substitution, which might damper its reactivity in cross-coupling reactions. 
 
Scheme 3-36 Synthesis of aryl iodide 3-152 via an aromatic Finkelstein reaction from aryl bromide 3-127 
In this regard, aryl iodide 3-152 was envisioned to be more reactive in comparison to aryl 
bromide 3-123 in cross-coupling reactions. Aryl bromide 3-127 was smoothly converted to iodide 3-152 
in good yield when exposed to CuI and NaI in presence of 1,2-dimethyldiamine 3-151 (Scheme 3-36).
146
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Scheme 3-37 Synthesis of aryl iodide 3-152 from amino ester 3-85 
Aryl iodide 3-152 was synthesized in a similar way to aryl bromide 3-127. Aminomethyl ester 3-
85 was reduced by LAH to generate an alcohol intermediate (not shown), and amide coupling with acid 3-
153 in presence of EDC in CH2Cl2 to smoothly afford amide 3-154, which bypassed the protecting group 
manipulations in Weinreb’s formal total synthesis.114 Similarly, the resulting alcohol 3-154 was oxidized 
with DMP to provide an aldehyde (not shown), which was converted to lactam 3-155 via an 
intramolecular aldol condensation.
114
  Reduction of lactam 3-155 with TMDS in presence of Ru3(CO)12 in 
toluene
138
 generated the desired tetrahydropyridine (not shown), which was protected to give aryl iodide 
3-152 (Scheme 3-37). 
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Scheme 3-38 Synthesis of macrocycle 3-142 
The key Suzuki coupling between aryl iodide 3-152 and pinacolborate 3-150 proceeded smoothly 
when treated with PdCl2(dppf) in a mixture of THF and 10% aqueous NaOH
147
. Silyl ether 3-148 was 
converted to iodide 3-156 through desilylation with TBAF, mesylate activation, and iodide substitution.
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The free amine was generated using TFA, and a cyclization to construct the macrocycle was effected via 
an intramolecular substitution by heating a dilute solution of the amine in CH3CN with Hünig’s base.
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Macrocycle 3-142 was isolated in moderate yield over two steps as a mixture of diastereomers (Scheme 
3-38). 
 
Scheme 3-39 Attempted epoxidation of 3-142 
Epoxidation of alkenes bearing tertiary amines 
148
 has been carried out by treating alkenes with 
boron trifluoride at -78 °C to generate a boron trifluoride adduct, followed by epoxidation with DMDO 
110 
under mild neutral conditions.  This particular condition was attempted with alkene 3-142. Though the 
adduct formation step of alkene 3-142 with boron trifluoride went smoothly as indicated by TLC, desired 
epoxidation product 3-157 was never observed upon treatment of DMDO in the second step. Despite the 
fact that an [M+16] peak was observed by mass spectrometry indicating the probable trace amount of 
desired epoxide 3-157 formation, it was noticed the boron trifluoride adduct quickly underwent 
decomposition as soon as DMDO was introduced according to crude 
1
H NMR characterization (Scheme 
3-39). 
 
Scheme 3-40 Attempted epoxidation of 3-148 
As epoxidation of the delicate and complicated alkene in 3-157 bearing the tertiary amine moiety 
was found to be unsuccessful, the possibility to conduct epoxidation at an earlier stage when the tertiary 
amine was still Boc-protected was explored. Therefore, the cross-coupling product was treated with 
DMDO, only to discover the formation of a mixture of mono- and di-epoxidized products 3-158 and 3-
159, even though the amount of DMDO used was strictly restricted to one equivalent. Considering the 
open structure of 3-148 compared to 3-142, the alkene in the tetrahydropyridine moiety was much more 
accessible to epoxidation reagents (Scheme 3-40).  
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3.2.2.3 Pinacolborate 3-161 with Preinstalled ɑ-Hydroxyl Group 
 
Scheme 3-41 Retrosynthetic analysis involving pinacolborate 3-161 with preinstalled ɑ-hydroxyl group 
Since the epoxidation of cross-coupling product 3-148 or macrocycle 3-142 appeared difficult, it was 
envisioned that the problematic epoxidation could be avoided by conducting cross-coupling reactions 
between aryl iodide 3-152 and ɑ-siloxy pinacolborate 3-161. A preinstalled ɑ-hydroxyl group would 
provide opportunities for further functionalization to generate the requisite enone required for 
aromatization (Scheme 3-41). 
112 
 
Scheme 3-42 Attempted synthesis of pinacolborate 3-161 
The attempted synthesis of pinacolborate 3-161 commenced with silylation of primary alcohol 3-
129 with TBDPS group, leading to ketone 3-163. Formation of ɑ-silyloxy ketone 3-165 was 
accomplished from ketone 3-163 after silyl enol ether formation to afford 3-164, followed by osmium-
promoted dihydroxylation to furnish ɑ-hydroxyl ketone functionality, which was protected with a TBS 
group. ɑ-silyloxy ketone 3-165 was converted efficiently to enol triflate 3-166 by treatment of LiHMDS 
and Comins’ reagent141,142 in good yield (Scheme 3-42). 
However, the borylation step seemed problematic. Literature precedence showed very few 
examples of palladium-catalyzed borylations of such silyloxy triflates. One closely related silyloxy triflate 
3-162
149
 used a condition employing (PPh3)2PdCl2, PPh3 and K2CO3 in dioxane at 80 °C. This condition 
was applied to 3-166, and nevertheless only generated the desired pinacolborate 1-161 in trace amounts or 
extremely low yield with aromatized or base-line material as the side product. Considerable efforts were 
made to optimize the reaction conditions and no positive results were obtained. Other typical palladium-
catalyzed borylation
150
 conditions were also attempted with generated similar results (Scheme 3-42). 
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3.2.3 Dehydroxyl Cyclophane  
The total synthesis of haouamine A appeared thwarted at this point. If the phenol moiety in aza-
paracyclophane had to be constructed via a base-promoted aromatization of 5-methoxy-cyclohex-2-en-1-
one (3-65 in Scheme 3-11), manipulations to generate the central tetrahydropiperidine moiety 
(dehydration in Chenbo’s route or reduction in the aldol condensation route) and phenol B ring in aza-
cyclophane (epoxidation or cross-coupling) inevitably interfered. 
 
Scheme 3-43 Retrosynthetic analysis of dehydroxy haouamine A 
In this regard, the structure of haouamine A was simplified to 3-167 where the B ring phenol in 
the aza-cyclophane was simplified to a phenyl ring. Readily available macrocycle 3-142 was envisioned 
to be the precursor of 3-167 through a Lewis acid-catalyzed aromatization and demethylation (Scheme 3-
43). 
 
Scheme 3-44 Attempted elimination of MeOH from 3-142 to generate cyclohexadiene 3-168 
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Aromatization of methoxy cyclohexene moiety in 3-142 was envisioned to proceed via an auto–
oxidation of cyclohexadiene 3-168, which could be synthesized from 3-142 by a Lewis acid catalyzed-
elimination of MeOH. A variety of Lewis acids were screened, including BF3-OEt2, 
hexafluoroisopropanol, ZnCl2, and EtAlCl2, with no desired cyclohexadiene 3-168 formation. In almost 
all cases, no reaction occurred at room temperature. When the temperature was slightly increased to 
facilitate any possible elimination, only complete decomposition occurred. The presence of the strained 
macrocycle in 3-142 likely made it difficult for the methoxy cyclohexene moiety to adopt a conformation 
to promote elimination (Scheme 3-44). 
 
Scheme 3-45 Attempted synthesis of trifluoroethyl ether 3-170 
One of the ways to promote elimination is to use better leaving groups than the methyl ether in 3-
142. A trifluoroethyl group was considered because of it larger electronegativity, rendering it a better 
leaving group. Therefore attempts were made to form the trifluoroethyl ether of tertiary alcohol 3-169 
under acidic conditions (2,2,2-trifluoroethanol in TFA) or basic conditions (2,2,2-trifluoroethyl triflate/2-
iodo-1,1,1-trifluoroethane in presence of NaOH). However, no desired ether product was observed, with 
only clean starting alcohol 3-169 isolated in every case. Lack of reactivity of tertiary alcohol 3-169 in the 
ether formation probably resulted from dioxolane moiety which further increased the steric hindrance of 
hydroxyl group (Scheme 3-45). 
A benzoate was also considered to be a good leaving group to generate cyclohexadiene 3-168. 
However, it should be noted that a tertiary benzoate ester with a primary alcohol present may undergo a 
1,3-acyl transfer process after ozonolysis and reductive quenching with NaBH4 (similar process as 3-128 
115 
to 3-129).  Therefore, the reaction sequence
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 leading to pinacol borate 3-177 was slightly modified to 
ensure there was no primary alcohol present when benzoate ester was formed. 
 
Scheme 3-46 Synthesis of pinacol borate 3-177 
The synthesis of pinacol borate 3-177 commenced with the silylation of tertiary alcohol 3-169, 
followed by ozonolysis and reductive quenching using NaBH4 to efficiently furnish alcohol 3-171. 
Removal of the TBS group on the tertiary alcohol and subsequent selective silylation on primary alcohol 
with the less acid labile TBDPS group furnished tertiary alcohol 3-173 in good yield. Benzoate ester 3-
174 was obtained by treating the lithiated tertiary alcohol 3-173 with benzoyl chloride, which was 
converted to ketone 3-175 after ketal hydrolysis. Treatment of ketone 3-175 with PhNTf2 in presence of 
LiHMDS provided enol triflate 3-176, which was transformed into pinacol boronate 3-177 using 
palladium catalyzed borylation
150
 conditions (Scheme 3-46). 
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Scheme 3-47 Synthesis of macrocycle 3-183 
Pinacol boronate 3-177 was coupled with aryl iodide 3-152 under the previously established 
Suzuki conditions to cleanly afford the desired coupling product 3-178. Silyl group removal, however, 
furnished the 1, 3-acyl transfer product 3-179. Despite the fact that the primary benzoate ester 3-179 was 
undesired, it was still utilized in order to explore whether a tertiary hydroxyl group might facilitate 
aromatization of the haouamine biphenyl core as the last step of the synthesis. Thus, benzoate ester 3-179 
was saponified with K2CO3 to provide diol 3-180 and the primary alcohol was selectively mesylated to 
afford 3-181. Formation of iodide 3-182 was effected by treating mesylate 3-183 with LiI in THF at 60 °C. 
The free amine was generated using TFA, and a cyclization to construct the macrocycle was effected via 
an intramolecular substitution by heating a dilute solution of the amine in CH3CN with Hünig’s base. 
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Macrocycle 3-183 was isolated in good yield over two steps as a complex mixture of diastereomers 
(Scheme 3-47). 
Desilylation of 3-178 was also attempted using HF-pyridine in THF in order to avoid 1, 3-acyl 
transfer of the benzoyl group under basic TBAF conditions (Scheme 3-48). Primary alcohol 3-184 was 
obtained in good yield. However, activation of alcohol 3-184 with a mesylate group resulted in a complex 
mixture derived from a 1, 3-acyl transfer of the benzoyl group. This was difficult to avoid since basic 
triethylamine was inevitably used in mesylation step (Scheme 3-48). 
 
Scheme 3-48 Selective desilylation of 3-178 
Therefore, the reaction sequence leading to diol 3-180 was further optimized to avoid 1, 3-acyl 
transfer of benzoyl group on intermediates such as 3-184. In this regard, the primary and the tertiary 
hydroxyl group in 3-172 were sequentially benzoylated, and acidic hydrolysis of resulting ketal 3-186 
gave ketone 3-187. Treatment of ketone 3-187 with PhNTf2 in presence of LiHMDS provided enol triflate 
3-188 and was transformed into pinacol borate 3-189 under palladium catalyzed borylation conditions. 
Coupling product 3-190 was saponified with K2CO3 in MeOH to afford diol 3-180 (Scheme 3-49). 
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Scheme 3-49 Optimized synthesis of diol 3-180 
The remaining steps toward the preparation of dehydroxy haouamine A 3-167 involved the 
aromatization of the cyclohexene moiety in 3-183 and global demethylation. When hydroxy cyclohexene 
3-183 was heated at reflux with p-TSA in toluene (a typical condition for dehydration/aromatization of 
compounds bearing hydroxy cyclohexene moiety
151
), the unexpected aromatized product 3-191 was 
generated in good yield. This new product 3-191 was found to have formed a new bond linking the amine 
nitrogen to the para-position of the angular anisole ring (Scheme 3-50). The structural assignment of 3-
191 was confirmed by X-ray crystallographic analysis (Figure 11). 
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Scheme 3-50 Unexpected formation of 3-191 
 
Figure 11 X-ray crystallographic analysis of 3-191 
The formation of the interesting product 3-191 from γ-amino alcohol 3-183 is related to other 
Grob-fragmentations. Chao
152
 et al. conducted a mass spectrometry study to elucidate the fragmentation 
rules of a variety of diterpenoid alkaloids using an electrospray ionization technique. In this study, the 
firstly-generated protonated molecular ions of alkaloids were further fragmented by collision-induced 
dissociation and their tandem mass spectrometry MS/MS data provided useful information on 
fragmentation pathways. For example, the pseudomolecular ion peaks [M+H]
+
 3-193 of γ-amino alcohol 
karakoline 3-192 could be observed under low collision energy. When the collision energy was increased, 
the [M+H-H2O]
+ 
ions 3-194 were produced and detected with high intensity. This ion should correspond 
to the elimination of the hydroxyl group at the C1 position. It was postulated that the elimination was 
accompanied by a Grob fragmentation, leading to the formation of an iminium and an alkene moiety in 
the resulting product 3-194 (Scheme 3-51). 
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Scheme 3-51 Fragmentation pathway of karakoline 3-192 
Charette
153
 et al. developed a novel methodology to prepare 2,3,6-trisubstituted 
tetrahydropyridines 3-198 from the aza-bicyclo[2.2.2]octene 3-195 bearing a γ-amino hydroxide moiety. 
In this methodology, the hydroxyl functionality of the aza-bicyclo[2.2.2]octene 3-195 was activated by 
conversion to triflate 3-196. A dihydropyridinium salt 3-197 was immediately generated after addition of 
triethylamine, which promoted a rapid Grob fragmentation. An array of substituted tetrahydropyridines 3-
198 was furnished in high yields and with high diastereoselectivities shortly after the dihydropyridinium 
salt 3-197 was trapped with a wide variety of Grignard reagents (Scheme 3-52). 
 
Scheme 3-52 Synthesis of 3-198 via Tf2O mediated Grob fragmentation 
The work from the Chao group and the Charette group supports a similar reaction mechanism to 
form 3-191 from 3-183. The benzylic methylene group present in 3-191 suggested a γ-amino hydroxide 
Grob fragmentation in 3-183 promoted by protonation of the tertiary hydroxy group and subsequent 
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elimination of H2O. This led to the breaking of the aliphatic chain in 3-183, and the formation of an 
iminium moiety in the intermediate 3-200 (Scheme 3-53). 
The anisole substituent trapped the iminium functionality in 3-200 in a Friedel-Crafts manner to 
construct the new polycyclic system in 3-191 (Scheme 3-53). The methylene-cyclohexene moiety in 3-
200 aromatized when exposed to air, and furnished phenyl group in 3-191. 
 
Scheme 3-53 Possible mechanism for the formation of 3-191 
Although 3-191 was not the desired aromatization product that led to dehydroxy haouamine A 3-
167, it was still considered an interesting substrate for demethylation. Thus, 3-191 was treated with excess 
BBr3 in CH2Cl2 at 0 °C in an attempt to remove three methyl groups.  Surprisingly, after extended stirring, 
the clean formation of bis-demethylated product 3-203 was observed. The remaining methyl group was 
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presumed to be located at the D anisole moiety, because, according to X-ray crystallographic analysis of 
3-191, this methyl group was shielded by the C anisole moiety. Its slightly more downfield chemical shift 
(3.95 ppm compared to 3.77 ppm and 3.82 ppm for A, C anisole methyl moiety) in 
1
H NMR supported a 
subtle deshielding effect from the neighboring C anisole moiety. 
In contrast to haouamine A 3-1 and B 3-2/3-3, 3-191 was a single diastereomer. Increasing the 
equivalents of BBr3 used or the reaction temperature did not yield any improvement. At this time, 
conditions to promote the demethylation of 3-203 to give complete demethylation of 3-191 have not been 
identified. (Scheme 3-54). 
 
Scheme 3-54 Incomplete removal of methyl groups to generate 3-203 
3.3 CONCLUSION 
Two approaches towards the total synthesis of haouamine A have been explored. One approach exploited 
an intramolecular aldol condensation to construct a late stage lactam 3-114, which was within two 
synthetic steps of haouamine A (reduction and global methyl deprotection). The other approach employed 
an intramolecular substitution to build the macrocycle in 3-142 with remaining oxidation/epoxidation 
steps to generate an enone moiety that could lead to aromatization (Scheme 3-55).  
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Scheme 3-55 Summary of the remaining synthetic transformations towards haouamine A 3-1 
The synthesis of dehydroxy haouamine A 3-167 was attempted via macrocycle intermediate 3-
183, which rearranged to 3-191 when treated with p-toluenesulfonic acid. Removal of two of the methyl 
groups occurred with ease, and a procedure needs to be developed to facilitate the deprotection of the 
remaining methyl ether. If this problem can be solved, we could demonstrate access to the analog 3-204 
(Scheme 3-56). 
 
Scheme 3-56 Remaining steps towards 3-204 
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3.4 EXPERIMENTAL PART 
General: All reactions were performed under an N2 atmosphere and all glassware was dried in an oven at 
140 °C for 2 h prior to use. Reactions carried out at -78 °C employed a CO2/acetone bath. THF and Et2O 
were distilled over sodium/benzophenone ketyl, Et3N was distilled from CaH2, and CH2Cl2 and toluene 
were purified using an alumina column filtration system. All other reagents and solvents were used as 
received unless otherwise noted. Reactions were monitored by TLC analysis (pre-coated silica gel 60 F254 
plates, 250 μm layer thickness) and visualization was accomplished with a 254 nm UV light and by 
staining with a PMA solution (5 g of phosphomolybdic acid in 100 mL of 95% EtOH), p-anisaldehyde 
solution (2.5 mL of p-anisaldehyde, 2 mL of AcOH, and 3.5 mL of conc. H2SO4 in 100 mL of 95% 
EtOH), Vaughn’s reagent (4.8 g of (NH4)6Mo7O24•4H2O and 0.2 g of Ce(SO4)2 in 100 mL of a 3.5 N 
H2SO4 solution) or a KMnO4 solution (1.5 g of KMnO4 and 1.5 g of K2CO3 in 100 mL of a 0.1% NaOH 
solution). Flash chromatography on SiO2 was used to purify the crude reaction mixtures. 
NMR spectra were recorded using XWIN-NMR software. 
 1
H NMR spectra were obtained at 300, 
400, 500, 600 or 700 MHz in CDCl3. Chemical shifts were reported in parts per million with the residual 
solvent peak used as an internal standard. 
1
H NMR spectra were obtained and are tabulated as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), number of 
protons, and coupling constant(s). 
13
C NMR spectra were obtained using a proton-decoupled pulse 
sequence with a d1 of 3 sec, and are tabulated by observed peak unless otherwise noted. Melting points 
were determined on a Mel-Temp II and are uncorrected. High-resolution mass spectrometry (HRMS) data 
(ESI/APCI technique) were recorded using a Waters Q-Tof Ultima API-US instrument. HRMS data (EI 
technique) were recorded using a Micromass Autospec instrument. Mass spectrometry data were also 
recorded using an Applied Biosystems MDS SCIEX API 2000 LC/MS/MS system. 
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3-((1R,2S)-1-(Hydroxymethyl)-7-methoxy-1-(3-methoxyphenyl)-2,3-dihydro-1H-inden-2-yl)-6,12-
dimethoxy-4,5,6,7-tetrahydro-1H-6,9-ethanobenzo[d][1]azacycloundecin-2(3H)-one (3-116). 15 dry 
flasks containing 3-91 (10.0 mg, 0.014 mmol) each were purged with N2 for three times and was added 
Et2O (0.2 mL) each, LiBH4 (5.3 mg, 0.25 mmol, 61 uL 4 M solution in THF) each, and B(OMe)3 (4.2 mg, 
0.041 mmol, 4.6 µL) each. The reaction mixture was stirred at room temperature for 48 h. It was noticed 
that the Et2O gradually evaporated during this period and it was finally residue stirred at bottom of the 
flask. 
The reaction mixture was quenched with 10% NaHSO4 solution (10 mL), extracted with EtOAc 
(3x10 mL), washed with brine (10 mL) and dried (Na2SO4). The EtOAc solution was concentrated in 
vacuo and purified with column chromatography on SiO2 (EtOAc:hexanes, 1:2 to 1:1) to afford starting 
material 3-91 (4.0 mg, 0.065 mmol, 3%), product 3-116 (diastereomer 1) (40.0 mg, 0.0685 mmol, 28%) 
and (diastereomer 2) (58.2 mg, 0.0997 mmol, 41%) as pale yellow oil:  
diastereomer 1: IR (neat) 3377, 3055, 3047, 3038. 2990, 2932, 2852, 2833, 1733, 1717, 1683, 
1605, 1586, 1540, 1534, 1497, 1478, 1459, 1437, 1374, 1342, 1290, 1260, 1236, 1219, 1195, 1184, 1152, 
1139, 1117, 1077, 1053, 1005, 979, 910, 874, 870, 854, 809, 781, 766, 731, 705 cm
-1
; 
1
H NMR (700 MHz, 
CDCl3) δ 7.24 (t, J = 7.7 Hz, 1 H), 7.18 (t, J = 7.7 Hz, 1 H), 6.97 (d, J = 8.4 Hz, 1 H), 6.85 (d, J = 7.0 Hz, 
1 H), 6.817 (d, J = 2.8 Hz, 1 H), 6.77 (dd, J = 8.4, 2.8 Hz, 1 H), 6.74 (td, J = 7.0, 2.1 Hz, 2 H), 6.71 (dd, J 
= 4.2, 2.8 Hz, 2 H), 5.44 (d, J = 4.9 Hz, 1 H), 4.39 (dd, J = 9.1, 4.9 Hz, 1 H), 4.32 (dd, J = 15.4, 10.5 Hz, 
1 H), 4.25-4.20 (m, 1 H), 4.13 (d, J = 14.7 Hz, 1 H), 4.08 (t, J = 14.0 Hz, 1 H), 3.79 (s, 3 H), 3.78 (d, J = 
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2.1 Hz, 1 H), 3.75 (s, 3 H), 3.74 (m, 2 H), 3.54 (s, 3 H), 3.21 (s, 3 H), 3.03 (dd, J = 14.7, 8.4 Hz, 1 H), 
2.99 (d, J = 14.0 Hz, 1 H), 2.80 (s, 1 H), 2.65 (dt, J = 12.6, 2.1 Hz, 1 H), 2.55-2.47 (m, 1 H), 2.47-2.40 (m, 
2 H), 2.21 (dd, J = 16.1, 5.6 Hz, 1 H), 2.03-1.95 (m, 2 H), 1.95-1.90 (m, 1 H), 1.65 (br s, 1 H), 1.51 (dd, J 
= 15.4, 3.5 Hz, 1 H), 1.25 (s, 2 H), 1.24-1.21 (m, 2 H); 
13
C NMR (100 MHz, CDCl3) δ 176.2, 159.5, 158.9, 
155.8, 149.0, 143.7, 135.7, 135.5, 134.9, 131.5, 129.3, 129.2, 128.8, 127.1, 118.5, 116.9, 116.8, 112.8, 
110.7, 109.3, 74.1, 69.9, 63.0, 60.8, 55.3, 55.3, 55.1, 48.8, 48.5, 39.1, 37.8, 34.7, 34.6, 31.2, 29.8; HRMS 
(ESI) m/z calcd for C36H42NO6  ([M+H]
+
) 584.30066, found 584.30011;  
diastereomer 2: IR (neat) 3385, 2992, 2928, 2852, 2835, 1735, 1719, 1702, 1685, 1676, 1670, 
1635, 1605, 1588, 1541, 1521, 1495, 1478, 1463, 1437, 1374, 1335, 1290, 1260, 1238, 1217, 1184, 1159, 
1079, 1053, 1007, 988, 911, 869, 809, 783, 768, 731, 705 cm
-1
; 
1
H NMR (700 MHz, CDCl3) δ 7.68 (dd, J 
= 7.0, 1.4 Hz, 1 H), 7.66 (dd, J = 8.4, 1.4 Hz, 1 H), 7.55 (td, J = 7.7, 1.4 Hz, 1 H), 7.46 (td, J = 7.7, 3.5 Hz, 
2 H), 7.23 (t, J = 7.7 Hz, 1 H), 7.18 (t, J = 7.7 Hz, 1 H), 6.99 (d, J = 8.4 Hz, 1 H), 6.89 (d, J = 2.8 Hz, 1 
H), 6.83 (d, J = 7.7 Hz, 1 H), 6.79 (dd, J = 8.4, 2.8 Hz, 1 H), 6.75 (td, J = 7.0, 2.8 Hz, 1 H), 6.73 (t, J = 
2.1 Hz, 1 H), 6.71 (d, J = 7.7 Hz, 1 H), 5.51-5.47 (m, 1 H), 4.53 (dd, J = 10.5, 4.9 Hz, 1 H), 4.48 (d, J = 
13.3 Hz, 1 H), 4.27 (t, J = 11.2 Hz, 1 H), 4.24-4.20 (m, 2 H), 4.20-4.14 (m, 1 H), 3.99 (dd, J = 14.7, 9.8 
Hz, 1 H), 3.80 (s, 3 H), 3.76 (s, 3 H), 3.74-3.70 (m, 2 H), 3.65 (s, 1 H), 3.60 (s, 1 H), 3.54 (s, 3 H), 3.34 (d, 
J = 18.9 Hz, 1 H), 3.18 (s, 3 H), 3.09 (d, J = 14.0 Hz, 1 H), 2.87 (dd, J = 15.4, 9.1 Hz, 1 H), 2.66 (dd, J = 
14.7, 7.7 Hz, 1 H), 2.44 (d, J = 17.5 Hz, 1 H), 2.36 (dd, J = 18.9, 6.3 Hz, 1 H), 2.20-2.09 (m, 2 H), 2.01-
1.95 (m, 1 H), 1.84 (dd, J = 15.4, 9.1 Hz, 1 H), 1.78 (dd, J = 11.2, 7.0 Hz, 1 H), 1.72 (br s, 1 H), 1.60 (dd, 
J = 16.1, 7.7 Hz, 1 H), 1.39 (d, J = 16.1 Hz, 1 H), 1.37-1.31 (m, 1 H), 1.30-1.19 (m, 4 H); 
13
C NMR (175 
MHz, CDCl3) δ 174.9, 159.5, 158.7, 155.9, 148.9, 143.4, 139.3, 135.9,  132.8, 132.2, 132.2, 132.2, 132.1, 
132.0, 131.3, 129.3, 129.2, 128.6, 128.6, 128.5, 124.0,  118.4, 117.0, 116.8, 113.0, 112.5, 110.6, 109.3, 
71.4, 62.9, 60.7, 55.3, 55.1, 49.1, 48.7, 39.3, 38.3, 34.7, 33.7, 32.5, 29.9; HRMS (ESI) m/z calcd for 
C36H42NO6  ([M+H]
+
) 584.30152, found 584.29945.  
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(10aS,15bS)-2,7,15-Trimethoxy-15b-(3-methoxyphenyl)-5a,6,7,8,9,10a,11,15b-octahydro-4b,7-
ethano-10,17-methanobenzo[f]indeno[2,1-b]oxireno[2,3-h][1]azacyclotridecin-18-one (3-113).  
(Diastereomer 1) To a flask was added 3-116 (40.0 mg, 0.0685 mmol), Oxone (63.2 mg, 0.103 mmol) and 
NaHCO3 (23.0 mg, 0.274 mmol). The flask was the cooled to 0 
o
C with ice-water bath and was added 
acetone (1.6 mL) and H2O (1.0 mL). The ice-water bath was removed and the reaction mixture was stirred 
at room temperature for 10 h. The reaction was diluted with H2O and was extracted with EtOAc (3x5 mL). 
The organic layer was washed with brine (5 mL), dried (Na2SO4) and was concentrated in vacuo.  
To a solution of the obtained residue in CH2Cl2 (1.6 mL) was added Dess-Martin periodinane 
(87.1 mg, 0.206 mmol) and H2O (1.2 mg, 0.069 mmol) at 0 
o
C and the reaction mixture was stirred at 
room temperature for 3 h. The reaction was quenched by adding saturated NaHCO3 solution (2 mL) and 
was extracted with EtOAc (3x5 mL). The EtOAc solution was concentrated in vacuo and purified with 
column chromatography on SiO2 (EtOAc:hexanes, 1:1) to afford a clear oil. 
To a solution of the obtained clear oil in MeOH (1.26 mL) in a microwave vial was added K2CO3 
(94.7 mg, 0.685 mmol). The vial was microwaved at 125 
o
C for 6 h, quenched by pouring into H2O (20 
mL), extracted with EtOAc (3x20 mL), concentrated in vacuo and purified by column chromatography on 
SiO2 (EtOAc:hexanes, 2:3) to afford 3-113 (15.0 mg, 0.0259 mmol, 38%) as colorless oil: IR (neat) 2993, 
2930, 2833, 2240. 1664, 1623, 1603, 1568, 1478, 1463, 1435, 1368, 1349, 1340, 1308, 1290, 1266, 1249, 
1215, 1191, 1176, 1154, 1137, 1100, 1077, 1044, 1007, 982, 966, 952, 941, 910, 865, 846, 824, 796, 779, 
757, 729 cm
-1
; 
1
H NMR (700 MHz, CDCl3) not provided because of complex spetrum of mixture of two 
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diastereomers; 
13
C NMR (175 MHz, CDCl3, mixture of two diastereomers)  167.6, 164.4, 159.9, 159.8, 
159.3, 159.1, 156.4, 155.9, 146.3, 146.0, 142.5, 141.6, 140.5, 139.4, 137.1, 136.1, 135.7, 131.8, 131.6, 
131.5, 131.0, 130.5, 130.2, 129.9, 129.8, 129.5, 126.7, 119.7, 119.0, 117.4, 117.2, 114.6, 114.3, 114.0, 
113.9, 112.8, 112.4, 112.0, 111.9, 110.5, 110.3, 74.6, 73.4, 73.4, 67.6, 62.8, 60.8, 59.8, 58.8, 56.3, 56.0, 
55.7, 55.5, 55.3, 55.3, 55.2, 48.9, 48.5, 47.2, 39.0, 38.4, 35.8, 35.7; HRMS (ESI) m/z calcd for C36H38NO6  
([M+H]
+
) 584.27005, found 580.26842. 
(Diastereomer 2) To a flask was added 3-116 (43.2 mg, 0.0740 mmol), Oxone (136 mg, 0.222 
mmol) and NaHCO3 (49.7 mg, 0.592 mmol). The flask was the cooled to 0 
o
C with ice-water bath and 
was added acetone (1.73 mL) and H2O (1.08 mL). The ice-water bath was removed and the reaction 
mixture was stirred at room temperature for 3 h. The reaction was diluted with H2O and was extracted 
with EtOAc (3x5 mL). The organic layer was washed with brine (5 mL), dried (Na2SO4) and was 
concentrated in vacuo.  
To a solution of the resulting residue in CH2Cl2 (1.7 mL) was added Dess-Martin periodinane 
(94.1 mg, 0.222 mmol) and H2O (1.3 mg, 0.0.074 mmol) at 0 
o
C and the reaction mixture was stirred at 
room temperature for 3 h. The reaction was quenched by adding saturated NaHCO3 solution (2 mL) and 
was extracted with EtOAc (3x5 mL). The EtOAc solution was concentrated in vacuo and purified by 
column chromatography on SiO2 (EtOAc: hexanes, 1:1) to afford a clear oil. 
To a solution of the obtained oil in MeOH (1.5 mL) in a microwave vial was added K2CO3 (205 
mg, 1.48 mmol). The resulting mixture was heated under microwave at 125 
o
C for 6 h. The reaction 
mixture was poured into water (5 mL) and the mixture was extracted with EtOAc (3x20 mL) and the 
combined organic layear was washed with H2O (5 mL) and brine (5 mL). The organic layer was dried 
(MgSO4), concentrated in vacuo. The resulting residue was purified with column chromatography on SiO2 
(EtOAc:hexanes, 2:3) to afford 3-113 (16.0 mg, 0.0276 mmol, 37% over 3 steps) as colorless oil: : IR 
(neat) 3441, 3046, 2999, 2995, 2930, 2855, 2833, 1716, 1700, 1666, 1625, 1603, 1569, 1541, 1478, 1465, 
129 
1435, 1374, 1349, 1344, 1290, 1266, 1251, 1215, 1195, 1176, 1154, 1133, 1118, 1103, 1079, 1062, 1040, 
1010, 995, 984, 966, 949, 861, 846, 833, 824, 796, 775, 747, 734, 716, 706 cm
-1
; 
1
H NMR (700 MHz, 
CDCl3) δ 7.44 (d, J = 8.4 Hz, 1 H), 7.28 (t, J = 7.7 Hz, 1 H), 7.22 (t, J = 7.7 Hz, 1 H), 6.88 (dd, J = 8.4, 
2.8 Hz, 2 H), 6.82 (d, J = 8.4 Hz, 1 H), 6.78 (dd, J = 8.4, 2.8 Hz, 1 H), 6.73 (d, J = 2.8 Hz, 1 H), 6.71 (s, 1 
H), 6.56 (d, J = 7.7 Hz, 1 H), 6.39 (t, J = 2.1 Hz, 1 H), 4.30 (d, J = 4.9 Hz, 1 H), 3.82 (s, 3 H), 3.81 (s, 1 
H), 3.79 (s, 1 H), 3.78 (s, 3 H), 3.75 (d, J = 6.3 Hz, 1 H), 3.70 (s,3 H), 3.57 (td, J = 14.7, 2.8 Hz, 1 H), 
3.20 (s, 3 H), 3.18 (d, J = 16.8 Hz, 1 H),  3.05 (dd, J = 16.1, 4.9 Hz, 1 H), 2.95 (td, J = 14.0, 2.1 Hz, 1 H), 
2.41 (td, J = 12.6, 5.6 Hz, 1 H), 2.33 (dd, J = 16.1, 4.9 Hz, 1 H), 2.26 (ddd, J = 15.4, 5.6, 2.1 Hz, 1 H), 
2.04 (d, J = 15.4 Hz, 1 H), 1.71-1.65 (m, 2 H), 1.58 (s, 1 H), 1.43 (dt, J = 12.6, 2.8 Hz, 1 H), 1.27-1.23 (m, 
1 H); 
13
C NMR (175 MHz, CDCl3) δ 165.2, 159.9, 159.3, 156.3, 145.4, 141.8, 138.1, 138.0, 137.3, 132.1, 
130.7, 130.3, 130.0, 129.9, 119.9, 117.4, 114.4, 114.0, 113.7, 111.7, 110.2, 73.6, 73.4, 60.7, 57.0, 55.4, 
55.3, 49.1, 46.3, 36.3, 31.3, 30.5, 27.9; HRMS (ESI) m/z calcd for C36H38NO6  ([M+H]
+
) 580.26936, 
found 580.26876. 
 
(11aS,16bS)-2,8,16-Trimethoxy-16b-(3-methoxyphenyl)-8,9,10,11a,12,16b-hexahydro-7H-5,8-
ethano-11,18-methanobenzo[f]indeno[2,1-b][1]azacyclotridecine-19,21-dione (3-117).  
(Diastereomer 1) A solution of 3-113 (10.0 mg, 0.017 mmol) in DMSO (20 mL) was added 10% aqueous 
H2SO4 (3.38 g 10% aqueous solution, 3.45 mmol) at rt. Stirring was continued for 4 d at room 
temperature. The reaction was quenched by adding Sat. NaHCO3 solution (10 mL) and the mixture was 
extracted with EtOAc (3x10 mL). The organic layer was washed with brine (10 mL), dried (MgSO4), 
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concentrated in vacuo, and purified with column chromatography on SiO2 (EtOAc:hexanes, 1:1 to 4:1) to 
afford the desired product allylic alcohol and starting material 3 (5.0 mg, 0.0086 mmol, 50%). 
The isolated allylic alcohol was dissolved in CH2Cl2 (3 mL) and was added Dess-Marin 
periodinane (14.6 mg, 0.0345 mmol) and the reaction mixture was stilled at room temperature for 2 h. 
The reaction was quenched by adding sat. NaHCO3 solution (5 mL), and the resulting mixture was stirred 
at room temperature for 15 min. The mixture was partitioned in the sep funnel, and the aqueous layer was 
extracted with CH2Cl2 (3x5 mL). The combined organic layer was washed with brine (5 mL), dried, and 
concentrated in vacuo. The resulting residue was purified with column chromatography on SiO2 
(EtOAc:hexanes, 1:1) to afford 3-117 (2.0 mg, 0.0035 mmol, 20%) as clear oil: IR (neat) 3068, 2059, 
3049, 3042, 3016, 2992, 2936, 2867, 2859, 2833, 2257, 2246, 1743, 1735, 1719, 1700, 1672, 1648, 1623, 
1601, 1560, 1480, 1465, 1433, 1420, 1376, 1353, 1292, 1266, 1249, 1238, 1217, 1171, 1156, 1111, 1079, 
1062, 1046, 1040, 1008, 997, 911, 898 cm
-1
; 
1
H NMR (700 MHz, CDCl3) δ 7.32 (d, J = 9.1 Hz, 1 H), 7.23 
(dd, J = 16.8, 8.4 Hz, 1 H), 7.02 (dd, J = 7.0, 2.1 Hz, 1 H), 6.90-6.88 (m, 2 H), 6.84 (d, J = 7.0 Hz, 1 H), 
6.81-6.77 (m, 3 H), 6.55 (d, J = 7.7 Hz, 1 H), 6.44 (t, J = 2.1 Hz, 1 H), 4.17 (d, J = 4.9 Hz, 1 H), 3.83 (s, 3 
H), 3.81 (s, 3 H), 3.79 (d, J = 4.2 Hz, 1 H), 3.72 (s, 3 H), 3.28 (s, 3 H), 3.12-3.06 (m, 2 H), 3.00 (dd, J = 
16.1 Hz, 1 H), 2.90 (t, J = 12.6 Hz, 1 H),  2.80 (dd, J = 7.0, 2.1 Hz, 1 H), 2.78 (t, J = 2.8 Hz, 1 H), 2.65 (d, 
J = 15.4 Hz, 1 H), 2.56 (ddd, J = 18.2, 7.0, 2.8 Hz, 1 H), 1.86 (dd, J = 16.8, 4.2 Hz, 1 H); 
13
C NMR (175 
MHz, CDCl3) δ 195.7. 165.4, 159.9, 159.3, 156.5, 145.9, 145.8, 141.8, 140.5, 137.9, 137.5, 137.0, 131.9, 
131.1, 130.3, 129.9, 126.0, 119.8, 117.4, 115.1, 114.3, 112.4, 111.6, 110.3, 72.8, 56.8, 55.6, 55.4, 55.3, 
50.5, 49.6, 44.2, 36.0, 35.0, 30.2; HRMS (ESI) m/z calcd for C36H36NO6  ([M+H]
+
) 578.25368, found 
578.25377. 
(Diastereomer 2) A solution of 3-113 (10.0 mg, 0.017 mmol) in DMSO (20 mL) was added 10% 
aqueous H2SO4 (3.38 g 10% aqueous solution, 3.45 mmol) at rt. Stirring was continued for 5 d at room 
temperature. The reaction was quenched by adding Sat. NaHCO3 solution (10 mL) and the mixture was 
extracted with EtOAc (3x10 mL). The organic layer was washed with brine (10 mL), dried (MgSO4), 
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concentrated in vacuo. The isolated allylic alcohol was dissolved in CH2Cl2 (3 mL) and was added Dess-
Marin periodinane (14.6 mg, 0.0345 mmol) and the reaction mixture was stilled at room temperature for 2 
h. The reaction was quenched by adding sat. NaHCO3 solution (5 mL), and the resulting mixture was 
stirred at room temperature for 15 min. The mixture was partitioned in the sep funnel, and the aqueous 
layer was extracted with CH2Cl2 (3x5 mL). The combined organic layer was washed with brine (5 mL), 
dried, and concentrated in vacuo. The resulting residue was purified with column chromatography on 
SiO2 (EtOAc:hexanes, 1:1) to afford 3-117 (7.2 mg, 0.0125 mmol, 72%) as clear oil: IR (neat) 3075, 3066, 
3057, 3046, 3023, 2932, 2833, 1750, 1735, 1719, 1676, 1618, 1601, 1560, 1534, 1527, 1523, 1506, 1480, 
1465, 1431, 1374, 1351, 1340, 1288, 1266, 1232, 1219, 1176, 1139, 1117, 1081, 1062, 1040, 997, 977, 
962, 932, 867, 852, 820, 796, 779, 761, 731, 716, 697 cm
-1
; 
1
H NMR (700 MHz, CDCl3) δ 7.28 (t, J = 7.7 
Hz, 2 H), 7.23 (d, J = 8.4 Hz, 1 H), 7.16 (t, J = 7.7 Hz, 1 H), 7.14 (d, J = 2.8 Hz, 1 H), 6.92 (d, J = 7.7 Hz, 
1 H), 6.88 (dd, J = 8.4, 2.8 Hz, 1 H), 6.81-6.78 (m, 2 H), 6.76 (d, J = 8.4 Hz, 1 H), 6.74 (dd, J = 8.4, 2.1 
Hz, 1 H), 6.52 (dd, J = 7.0, 2.1 Hz, 1 H), 6.31 (d, J = 1.4 Hz, 1 H), 4.03 (t, J = 8.4 Hz, 1 H), 3.97 (ddd, J = 
14.7, 7.7, 2.8 Hz, 1 H), 3.84 (s, 3 H), 3.80 (d, J = 7.7 Hz, 1 H), 3.70 (s, 3 H), 3.57 (dd, J = 14.7, 7.7 Hz, 1 
H), 3.54 (s, 3 H), 3.29 (s, 3 H), 3.22 (dd, J = 14.7, 10.5 Hz, 1 H), 3.01 (ddd, J = 16.8, 9.8, 2.8 Hz, 1 H), 
2.93 (dd, J = 16.1, 2.1 Hz, 1 H), 2.88 (ddd, J = 14.0, 9.8, 2.8 Hz, 1 H), 2.79 (ddd, J = 17.5, 7.0, 2.1 Hz, 1 
H), 2.70 (dd, J = 17.5, 2.1 Hz, 1 H), 2.64 (d, J = 16.8 Hz, 1 H); 
13
C NMR (175 MHz, CDCl3) δ 195.1, 
166.8, 159.6, 159.2, 155.8, 145.8, 142.6, 141.6, 139.7, 138.3, 137.9, 131.7, 131.5, 130.6, 129.7, 129.3, 
127.1, 118.9, 117.0, 114.0, 112.9, 112.7, 111.9, 110.5, 73.2, 55.8, 55.6, 55.2, 55.2, 49.3, 49.1, 45.3, 37.3, 
35.0, 34.4; HRMS (ESI) m/z calcd for C36H36NO6  ([M+H]
+
) 578.25361, found 578.25387. 
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(11aS,16bS)-21-Hydroxy-2,16-dimethoxy-16b-(3-methoxyphenyl)-10,11a,12,16b-tetrahydro-9H-5,8-
etheno-11,18-methanobenzo[f]indeno[2,1-b][1]azacyclotridecin-19-one (3-118).  
(Diastereomer 1) 3-117 (2.0 mg, 0.0035 mmol) was dissolved in a mixture of DIPEA (742 mg, 5.75 
mmol, 1.0 mL) and CF3CH2OH (1.39 g, 13.9 mmol, 1.0 mL). The reaction mixture was heated in 
microwave at 100 
o
C for 1.5 h. The reaction mixture was concentrated in vacuo and purified with column 
chromatography on SiO2 (EtOac:hexanes,1:2) to afford 3-118 (1.5 mg,0.003 mmol, 79%) as pale yellow 
oil: IR (neat) 3252, 2993, 2923, 2852, 2837, 1733, 1718, 1702, 1691, 1683, 1659, 1597, 1560, 1534, 1523, 
1517, 1506, 1478, 1456, 1430, 1418, 1376, 1284, 1266, 1226, 1169, 1158, 1120, 1102, 1079, 1059, 1044, 
1021, 997, 951, 870, 861, 824, 802, 772, 757, 734, 718, 706 cm
-1
;  
1
H NMR (600 MHz, CDCl3) δ 7.54 (d, 
J = 8.4 Hz,1 H), 7.22 (td, J = 7.8, 1.8 Hz, 2 H), 7.14 (d, J = 8.4 Hz, 1 H), 6.98-6.95 (m, 2 H), 6.85-6.82 
(m,3 H), 6.80 (dd, J = 7.8, 1.8 Hz, 2 H), 6.75 (d, J = 8.4 Hz, 1 H),  6.62 (s, 1 H), 6.60-6.57 (m, 2 H), 5.32 
(br s, 1 H), 4.31 (tdd, J = 12.6, 4.8, 1.2 Hz, 1 H), 4.13 (d, J = 7.2 Hz, 1 H), 3.81 (s, 3 H), 3.80-3.77 (m, 1 
H), 3.76 (s, 3 H), 3.76 (s, 3 H), 3.05 (dd, J = 11.4, 4.2 Hz, 1 H), 3.02 (d, J = 9.6 Hz, 1 H), 2.88 (dd, J = 
16.2, 4.8 Hz, 1 H), 2.81 (dd, J = 12.6, 4.8 Hz, 1 H), 2.66 (td, J = 13.2, 4.8 Hz, 1 H);  
13
C NMR (125 MHz, 
CDCl3) δ 163.2, 159.9, 159.6, 158.5, 156.4, 146.5, 144.0, 142.9, 139.8, 135.4, 133.4, 129.9, 129.7, 128.4, 
123.2, 120.8, 119.6, 117.5, 117.4, 113.8,  112.6, 112.2, 110.0, 67.5, 56.6, 55.4, 55.2, 45.0, 35.5, 33.3; 
HRMS (ESI) m/z calcd for C35H32NO5  ([M+H]
+
) 546.22684, found 546.22754. 
(Diastereomer 2) 3-117 (5.0 mg, 0.0087 mmol) was dissolved in a mixture of DIPEA (928 mg, 
7.18 mmol, 1.25 mL) and CF3CH2OH (1.74 g, 17.3 mmol, 1.25 mL). The reaction mixture was heated in 
microwave at 100 
o
C for 1.5 h. The reaction mixture was concentrated in vacuo and purified with column 
chromatography on SiO2 (EtOac:hexanes,1:2) to afford 3-118 (3.5 mg,0.0064 mmol, 74%) as pale yellow 
oil: IR (neat) 3299, 3066, 3059, 3047, 3021, 3014, 2995, 2988, 2930, 2869, 2857, 2848, 2833, 1683, 1653, 
1646, 1597, 1560, 1478, 1465, 1448, 1437, 1420, 1363, 1349, 1323, 1284, 1264, 1226, 1217, 1178, 1137, 
1118, 1077, 1044, 1018, 956, 911, 887, 869, 835, 816, 802, 792, 779, 759, 731 cm
-1
; 
1
H NMR (700 MHz, 
CDCl3) δ 7.51 (d, J = 8.4 Hz,1 H), 7.26 (t, J = 7.7 Hz,1 H), 7.17 (s,1 H), 7.09 (t, J = 8.4 Hz,1 H),  6.97 (d, 
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J = 8.4 Hz,1 H), 6.95 (d, J = 7.0 Hz,1 H), 6.89 (s,1 H), 6.86 (d, J = 7.7 Hz,1 H), 6.78 (d, J = 7.7 Hz,1 H), 
6.72 (d, J = 7.7 Hz,1 H), 6.70 (d, J = 7.7 Hz,1 H), 6.65 (d, J = 8.4 Hz,1 H),  6.62 (s, 1 H), 6.20 (s,1 H), 
5.07 (br s,1 H), 4.47 (td, J = 13.3, 5.6 Hz,1 H), 3.91 (dd, J = 14.0, 10.5 Hz,1 H), 3.86 (s, 3 H), 3.85-3.80 
(m, 2 H), 3.75-3.67 (m, 1 H), 3.66 (s, 3 H), 3.50 (s, 3 H), 3.18 (dd, J = 14.4, 7.0 Hz, 1 H), 2.99 (dd, J = 
12.6, 5.6 Hz, 1 H),  2.70 (td, J = 12.6, 5.6 Hz, 1 H), 2.50 (dd, J = 14.0, 5.6 Hz, 1 H); 
13
C NMR (125 MHz, 
CDCl3) δ 164.1, 159.6, 158.3, 156.0, 146.2, 143.2, 142.9, 140.7, 140.0, 133.2, 131.2, 131.1, 129.6, 129.5, 
129.4, 129.2, 127.4, 123.6, 122.2, 119.0, 118.3, 117.1, 112.6, 112.4, 111.9, 110.3, 74.2, 56.3, 55.7, 55.3, 
55.3, 49.5, 37.0, 36.9; HRMS (ESI) m/z calcd for C35H31NO5  ([M]
+
) 545.2202, found 545.2210. 
 
(11aS,16bS)-2,16,21-Trimethoxy-16b-(3-methoxyphenyl)-10,11a,12,16b-tetrahydro-9H-5,8-etheno-
11,18-methanobenzo[f]indeno[2,1-b][1]azacyclotridecin-19-one (114).  
(Diastereomer 1) A solution of 3-118 (1.5 mg, 0.0027 mmol) in THF(0.4 mL) is added dropwise at 0 °C. 
to a suspension of NaH (1.1 mg 60 wt percent dispersion in mineral oil, prewashed with hexane, 0.027 
mmol) in tetrahydrofuran (0.1 mL). The resulting yellow solution is stirred for 10 minutes, and 
iodomethane (3.9 mg, 0.027 mmol) is added rapidly. The reaction is warmed to ambient temperature and 
further heated at reflux for 16 h, cooled, diluted with water (20 mL) and extracted with EtOAc (3x5 mL). 
The organic layer is dried (Na2SO4), filtered and concentrated in vacuo. The resulting residue was purified 
with column chromatography on SiO2 (EtOAc:hexanes, 1:2) to afford 3-114 (1.0 mg, 0.0018 mmol, 65%) 
as pale yellow oil: IR (neat) 3014, 2995, 2977, 2949, 2936, 2908, 2893, 2869, 2863, 2859, 2855, 2848, 
2833, 1661, 1627, 1603, 1592, 1564, 1560, 1478, 1463, 1405, 1322, 1286, 1266, 1245, 1228, 1187, 1169, 
1158, 1126, 1079, 1059, 1046, 1034, 1020, 999, 911, 870, 859, 826, 822, 803, 772, 742, 710, 701 cm
-1
; 
134 
1
H NMR (700 MHz, CDCl3) δ 7.57 (d, J = 8.4 Hz, 1 H), 7.22 (t, J = 8.4 Hz, 1 H), 7.20 (d, J = 7.7 Hz, 1 
H), 7.14 (d, J = 7.7 Hz, 1 H), 6.99 (d, J = 7.7 Hz, 1 H), 6.94 (d, J = 8.4 Hz, 1 H), 6.82-6.77 (m, 3 H), 6.76 
(s, 1 H), 6.74 (d, J = 8.4 Hz, 1 H), 6.62-6.57 (m, 3 H), 4.33 (td, J = 13.3, 4.9 Hz, 1 H), 4.10 (d, J = 4.2 Hz, 
1 H), 3.79 (s, 3 H), 3.78 (s, 3 H), 3.76 (s, 3 H), 3.75 (s, 3 H), 3.04 (dd, J = 13.3, 3.5 Hz, 1 H), 3.01 (d, J = 
16.1 Hz, 1 H), 2.86 (dd, J = 16.1, 3.5 Hz, 1 H), 2.83 (d, J = 13.3, 4.9 Hz, 1 H), 2.71 (td, J = 12.6, 4.2 Hz, 
1 H); 
13
C NMR (175 MHz, CDCl3) δ 163.3, 162.2, 159.9, 158.9, 156.4, 146.6, 143.4, 143.0, 141.7, 139.4, 
135.9, 133.9, 131.7, 131.3, 129.8, 129.7, 129.6, 125.7, 122.6, 119.6, 117.3, 116.0, 114.2, 113.7, 112.4, 
112.2, 110.0, 67.6, 56.5, 55.5, 55.4, 55.2, 44.8, 35.5, 33.6; HRMS (ESI) m/z calcd for C36H34NO5  
([M+H]
+
) 560.24315, found 560.24410. 
(Diastereomer 2)  A solution of 3-118 (3.5 mg, 0.0064 mmol) in THF(0.8 mL) is added dropwise 
at 0° C. to a suspension of NaH (2.6 mg 60 wt percent dispersion in mineral oil, prewashed with hexane, 
0.064 mmol) in tetrahydrofuran (0.4 mL). The resulting yellow solution is stirred for 10 minutes, and 
iodomethane (9.1 mg, 0.064 mmol) is added rapidly. The reaction is warmed to ambient temperature and 
further heated at reflux for 16 h, cooled, diluted with water (20 mL) and extracted with EtOAc (3x5 mL). 
The organic layer is dried (Na2SO4), filtered and concentrated in vacuo. The resulting residue was purified 
with column chromatography on SiO2 (EtOAc:hexanes, 1:2) to afford 3-114 (2.5 mg, 0.0045 mmol, 70%)： 
IR (neat) 3020, 3016, 3005, 2997, 2993, 2988, 2969, 2964, 2956, 2934, 2904, 2896, 2880, 2861, 2854, 
2846, 2831, 1657, 1599, 1590, 1560, 1480, 1465, 1439, 1413, 1400, 1325, 1301, 1286, 1277, 1264 1226, 
1215, 1200, 1176, 1156, 1137, 1122, 1077, 1036, 1016, 911, 880, 872, 861, 854, 833, 805, 794, 777, 757, 
742, 731, 705, 693 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.52 (d, J = 6.6 Hz, 1 H), 7.25 (d, J = 7.2 Hz, 1 
H), 7.11 (s, 1 H), 7.07 (d, J = 6.6 Hz, 1 H), 6.94 (d, J = 6.0 Hz, 1 H), 6.88 (d, J = 6.6 Hz, 1 H), 6.86 (s, 1 
H), 6.81 (d, J = 6.6 Hz, 1 H), 6.71 (d, J = 7.2 Hz, 1 H), 6.67 (t, J = 6.0 Hz, 2 H), 6.63 (s, 1 H), 6.17 (s, 1 
H), 4.49 (td, J = 10.8, 4.2 Hz, 1 H), 3.91 (t, J = 9.6 Hz, 1 H), 3.85 (s, 3 H), 3.80 (s, 3 H), 3.73 (d, J = 4.8 
Hz, 1 H), 3.65 (s, 3 H), 3.49 (s, 3 H), 3.17 (dd, J = 12.0, 6.0 Hz, 1 H), 3.02 (dd, J = 10.8, 4.2 Hz, 1 H), 
2.75 (td, J = 10.8, 4.8 Hz, 1 H), 2.50 (dd, J = 12.0, 4.2 Hz, 1 H); 
13
C NMR (175 MHz, CDCl3) δ 164.5, 
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161.9, 159.6, 158.9, 146.3, 142.9, 142.7, 140.5, 139.4, 132.6, 131.6, 131.4, 130.3, 129.5, 129.1, 126.8, 
125.5, 119.1, 117.0, 116.9, 115.0, 112.9, 111.5, 110.2, 56.2, 55.7, 55.3, 55.2, 49.4, 37.3, 36.8; HRMS 
(ESI) m/z calcd for C36H34NO5  ([M+H]
+
) 560.24315, found 560.24461. 
 
tert-Butyl(2-(4-iodo-1-methoxycyclohex-3-en-1-yl)ethoxy)dimethylsilane (3-147). A stirring solution 
of 3-146 (200 mg, 0.478 mmol), LiCl (142 mg, 3.34 mmol) and hexamethylditin (172 mg, 526 mmol) in 
THF (3 mL) was degassed with freeze-pump-thaw cycle for three times. A solution of Pd(PPh3)4 (11.0 mg, 
0.00956 mmol) in THF (4.7 mL, degassed with freeze-pump-thaw cycle for three times) at room 
temperature was added into the reaction mixture via syringe. The reaction mixture was heated to 60 °C 
for 24 h. TLC showed the starting material was completely consumed. The reaction mixture was 
subsequently cooled to 0 °C, and N-iodosuccinimide (161 mg, 0.717 mmol) was added in one portion. 
After 3 h the reaction was allowed to warm to room temperature, then the mixture was concentrated in 
vacuo. The residue was suspended in Et2O (2 mL), and a solution of KF (278 mg, 4.78 mmol) MeOH (2 
mL) was added. The reaction mixture was stirred at room temperature for 2 h, then was concentrated in 
vacuo. The residue was suspended in Et2O and filtered through celite. The filtrate was concentrated and 
purified by silica gel flash chromatography (EtOAc:hexanes, 1:12) to yield 3-147 (162 mg, 0.409 mmol, 
86%) as colorless oil: IR (neat) 2926, 2893, 2885, 2882, 2854, 2822, 2242, 1469, 1461, 1439, 1428, 1389, 
1359, 1251, 1180, 1048, 1036, 1005, 936, 911, 882, 835, 811, 774, 740, 712 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) 6.17-6.14 (m, 1 H), 3.70 (t, J = 7.0 Hz, 2 H), 3.18 (s, 3 H), 2.67-2.56 (m, 1 H), 2.51-2.43 (m, 1 H), 
2.16-2.19 (m, 1 H), 2.19-2.04 (m, 1 H), 1.86-1.77 (m, 2 H), 1.77-1.62 (m, 2 H), 1.56 (s, 2 H), 1.25 (s, 3 
H), 0.89 (s, 9 H), 0.05 (s, 6 H); 
13
C NMR (125 MHz, CDCl3) δ134.2, 95.5, 72.3, 58.5, 49.0, 38.8, 38.0, 
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36.9, 33.0, 26.1, 26.1, 18.4, 1.2, -5.2; HRMS (ESI) m/z calcd for C15H30O2SiI ([M+H]
+
) 397.10543, found 
397.10466. 
 
4-Methoxy-4-(2-(methoxymethoxy)ethyl)cyclohexan-1-one (3-130). To a solution of 3-129 (70.0 mg, 
0.406 mmol) in CH2Cl2 (2 mL) at 0 °C was added DIPEA (68.2 mg, 0.528 mmol, 92.0 µL) and the 
reaction mixture was stirred at 0 °C for 10 min. To this mixture was added MOMCl (49.1 mg, 0.610 
mmol, 46.3 µL) at 0 °C and the reaction mixture was warmed to room temperature and stirred for 12 h. 
The reaction was quenched by adding sat. NH4Cl aqueous solution (10 mL) and was extracted with Et2O 
(3x10 mL). The combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
concentrated in vacuo. The residue was purified with column chromatography on SiO2 (EtOAc:hexanes, 
1:1) to afford 3-130 (80.0 mg, 0.370 mmol, 91%) as colorless oil: IR (neat) 2941, 2887, 2826, 1713, 1466, 
1442, 1415, 1392, 1323, 1232, 1216, 1181, 1149, 1125, 1107, 1067, 1035, 966, 917, 890, 806, 760, 728, 
703 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 4.57 (s, 2 H), 3.59 (t, J = 7.1 Hz, 2 H), 3.32 (s, 3 H), 3.23 (s, 3 
H), 2.53 (td, J = 14.0, 6.0 Hz, 2 H), 2.20-2.04 (m, 4 H), 1.84 (t, J = 7.1 Hz, 2 H), 1.67 (td, J = 14.4, 5.5 Hz, 
2 H); 
13
C NMR (100 MHz, CDCl3) δ 211.7, 96.6, 73.1, 63.2, 55.3, 49.0, 36.7, 35.3, 33.8; HRMS (ESI) 
m/z calcd for C11H21O4 ([M+H]
+
) 217.14344, found 217.14347. 
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2-((tert-Butyldimethylsilyl)oxy)-4-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-4-methoxycyclohexan-1-one 
(3-131). To a solution 3-130 (80.0 mg, 0.370 mmol) and 2, 6-lutidine (79.2 mg, 0.740 mmol) in THF (1 
mL) at 0 °C was added TBSOTf (108 mg, 0.407 mmol). The reaction mixture was stirred at 0 °C for 4 h. 
The reaction was quenched by adding sat. NH4Cl solution (5 mL) and the mixture was extracted with 
EtOAc (3x10 mL). The combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
concentrated in vacuo. The resulting residue was run through a short pad of silica gel.  
To a stirred solution of resulting residue in THF/water (3:1, 3.1 mL in total) were added 4-
methylmorpholine-N-oxide (56.3 mg, 0.481 mmol) followed by K2OsO4-2H2O (0.3 mg, 0.0007 mmol). 
The resulting solution was stirred for 4 h at room temperature. The mixture was diluted with EtOAc (30 
mL) and the aqueous layer was extracted with EtOAc (5x5 mL). The combined organic layer was washed 
with brine (10 mL), dried (MgSO4) and concentrated in vacuo. The residue was purified with silica gel 
column chromatography (EtOAc: hexanes, 1:4) to afford the desired alpha hydroxy ketone as colorless oil. 
The resulting oil was dissolved in THF (1.1 mL) and to this solution was added N-
methylimidazole (91.1 mg, 1.11 mmol), I2 (188 mg, 0.740 mmol) and the mixture was stirred at room 
temperature for 1 min. To this mixture was added TBSCl (61.3 mg, 0.407 mmol) and the mixture was 
stirred at room temperature for 2 h until TLC showed the hydroxy ketone was completely consumed. 
The reaction mixture was concentrated in vacuo and the resulting residue was dissolved in EtOAc 
(20 mL), washed with sat. Na2S2O3 solution (10 mL), brine (5 mL), dried (MgSO4) and concentrated in 
vacuo. The resulting residue was purified by column chromatography on SiO2 (EtOAc: hexanes, 1:10) to 
afford 3-131 (91.0 mg, 0.263 mmol, 80% as mixture of diastereomers) as colorless oil: IR (neat, major 
diastereomer) 2929, 2885, 2856, 2826, 1730, 1464, 1389, 1361, 1299, 1252, 1217, 1150, 1137, 1111, 
1068, 1044, 980, 953, 939, 909, 875, 833, 780, 746, 707, 648 cm
-1
;
 1
H NMR (500 MHz, CDCl3, major 
diastereomer) δ 4.59 (s, 2 H), 4.42 (ddd, J = 11.9, 6.5, 0.6 Hz, 1 H),  3.60 (t, J = 7.1 Hz, 2 H), 3.35 (s, 3 
H),  3.27 (s, 3 H), 2.57 (tdd, J = 14.2, 5.9, 0.8 Hz, 1 H), 2.38 (ddd, J =  13.7, 6.6, 3.9 hz, 1 H), 2.24 (ddd,  
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J =  13.9, 4.4, 2.3 Hz, 1 H), 2.18-2.10 (m, 1 H), 1.85 (t, J = 7.4 Hz, 2 H), 1.70 (dd, J = 13.6, 12.1 Hz, 1 H), 
1.64 (td, J = 14.2, 4.5 Hz, 1 H), 0.89 (s, 9 H), 0.12 (s, 3 H), 0.01 (s, 3 H); 
13
C NMR (125 MHz, CDCl3, 
major diastereomer) δ 209.3, 96.7, 75.5, 72.8, 63.2, 55.4, 49.1, 44.4, 35.5, 35.4, 34.4, 25.9, 18.6, -4.5, -5.4; 
HRMS (ESI) m/z calcd for C17H35O5Si ([M+H]
+
) 347.22483, found 347.22310. 
 
6-((tert-Butyldimethylsilyl)oxy)-4-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-4-methoxycyclohex-1-en-1-
yl trifluoromethanesulfonate (3-132). To a stirred solution of 3-131 (470 mg, 1.36 mmol) in THF (3 mL) 
at -78 °C was added LiHMDS (453 mg, 2.71 mmol) in THF (1 mL) via syringe and was stirred at -78 °C 
for 60 min. The reaction mixture was added Comins’ reagent (959 mg, 2.44 mmol) in THF (1 mL). The 
mixture was stirred for 2 h at -78 °C, and was slowly warmed to room temperature and stirred for 22 h. 
The reaction was quenched by the addition of saturated aqueous NH4Cl (15 mL), and the whole was 
extracted with EtOAc (3 x 10 mL). The combined organic layers were washed with brine, dried (MgSO4), 
and concentrated in vacuo. The residue was purified with column chromatography on SiO2 (Et2O:hexanes, 
1:9) to afford 3-132(528 mg, 1.10 mmol, 81%, mixture of diastereomers) as colorless oil: IR (neat, 
mixture of diastereomers) 2932, 2887, 2859, 2828, 16877, 1473, 1464, 1419, 1380, 1363, 1248, 1207, 
1145, 1095, 1041, 1072, 976, 956, 918, 862, 838, 779, 729, 675 cm
-1
; 
1
H NMR (400 MHz, CDCl3, 
mixture of diastereomers) δ 5.77-5.63 (m, 1 H), 4.60 (s, 2 H), 4.49 (td, J = 6.0, 2.8 Hz, 1 H), 3.69-3.57 (m, 
2 H), 3.36 (d, J = 1.7 Hz, 3 H), 3.17 (d, J = 17.6 Hz,  3 H), 2.52-2.15 (m, 3 H), 1.97-1.69 (m, 4 H),  0.91 
(s, 9 H), 0.13 (s, 3 H), 0.11 (s, 3 H); 
13
C NMR (150 MHz, CDCl3, mixture of diastereomers) δ 149.4, 
148.9, 121.8, 119.7, 117.5, 115.8, 115.4, 96.7, 96.6, 74.8, 74.0,  66.7, 65.4, 63.0, 62.7, 55.4, 55.3, 49.3, 
49.2, 41.3, 41.0, 35.4, 34.3, 33.5, 33.4, 25.9, 25.9, 18.1, -4.4, -4.6; HRMS (ESI) m/z calcd for 
C18H34O7SSiF3([M+H]
+
) 479.17411, found 479.17116. 
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tert-Butyl((5-methoxy-5-(2-(methoxymethoxy)ethyl)cyclohex-2-en-1-yl)oxy)dimethylsilane (3-133). 
To a suspension of 3-132 (45.0 mg, 0.0940 mmol), DIPEA (97.1 mg, 0.752 mmol, 131 µL), Pd(OAc)2 
(4.2 mg, 0.0188 mmol), and PPh3 (9.9 mg, 0.0376 mmol) in dry DMF (2 mL) was added 99% formic acid 
(9.5 mg, 0.207 mmol). The resulting pale brown suspension was stirred for 5 h at 60 °C. The reaction 
mixture was cooled to room temperature and was diluted with EtOAc (20 mL), washed with brine (5 mL) 
and concentrated in vacuo. The reaction mixture was purified by column chromatography on SiO2 (Et2O: 
hexanes, 1:6) to afford 3-133 (28.2 mg, 0.0853 mmol, 91%) as colorless oil: IR (neat, mixture of 
diastereomers) 3031, 2929, 2886, 2857, 2824, 1655, 1463, 1389, 1361, 1328, 1253, 1206, 1152, 1110, 
1072, 1033, 1006, 917, 879, 856, 836, 775, 678 cm
-1
; 
1
H NMR (400 MHz, CDCl3, mixture of 
diastereomers) δ 5.57 (dd, J = 10.0, 1.1 Hz, 1 Hz), 4.49 (dd, J = 10.0, 2.6 Hz, 1 Hz), 4.52 (s, 2 H), 4.34-
4.23 (m, 1 H), 3.54-3.44 (m, 2 H), 3.27 (d, J = 2.3 Hz, 3 H), 3.11 (d, J = 6.2 Hz, 3 H), 2.23-2.00 (m, 2 H), 
2.00-1.89 (m, 1 H), 1.89-1.37 (m, 4 H), 0.81 (s. 9 H), 0.00 (s, 3 H), -0.01 (s, 3 H);  
13
C NMR (100 MHz, 
CDCl3, mixture of diastereomers) δ 131.3, 130.5, 125.7, 124.6, 96.7, 96.6, 75.2, 67.9, 66.0, 63.3, 63.2, 
55.4, 55.3, 49.0, 48.7, 40.5, 39.8, 36.3, 35.1, 35.0, 33.6, 26.0, 18.4, 18.3, -4.5; HRMS (ESI) m/z calcd for 
C17H35O4Si ([M+H]
+
) 331.22991, found 331.23054. 
 
5-Methoxy-5-(2-(methoxymethoxy)ethyl)cyclohex-2-en-1-one (1-134). To a solution of 1-133 (20.0 mg, 
0.0605 mmol) in THF (4.0 mL) at 0 
o
C was added TBAF (19.0 mg, 0.0726 mmol, 72.6 µL 1 M solution 
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in THF) and the reaction mixture was slowly warmed to room temperature. The reaction mixture was 
stirred for 9 h. The reaction was quenched by adding sat. NH4Cl solution (10 mL) and was extracted with 
EtOAc (5x3 mL). The combined organic layers were washed with brine (3 mL), dried (MgSO4) and 
concentrated in vacuo. The residue was purified by column chromatography on SiO2 (EtOAc: hexanes, 
1:1) to afford a mixture of two diastereomers. 
The isolated mixture of diastereomers was dissolved in CH2Cl2 (1.2 mL) and was cooled to 0 
o
C 
and was added NaHCO3 (6.1 mg, 0.073 mmol) and DMP (30.8 mg, 0.0726 mmol). The reaction mixture 
was slowly warmed to room temperature and was stirred for 12 h. The reaction was quenched by adding 
sat. NaCHO3 solution (10 mL) and the mixture was stirred at room temperature for 30 min. The mixture 
was washed with sat. Na2SO3 solution (3x5 mL), brine (5 mL), dried (MgSO4) and concentrated in vacuo. 
The resulting residue was purified by column chromatography on SiO2 (EtOAc: hexanes, 1:1) to afford 1-
134 (10.1 mg, 0.0467 mmol, 77%) as colorless oil: IR (neat) 3522, 2939, 2887, 2826, 2124, 1677, 1459, 
1388, 1355, 1292, 1267, 1248, 1217, 1182, 1149, 1105, 1046, 1028, 952, 916, 841, 774, 732, 676 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 6.83 (ddd, J = 10.1, 4.9, 3.3 Hz, 1 H), 6.07 (dt, J = 10.1, 1.7Hz, 1 H), 4.60 
(s, 2 H), 3.62 (td, J = 6.7, 1.4 Hz, 2 H), 3.36 (s, 3 H), 3.15 (s, 3 H), 2.74 (dd, J = 16.1, 1.1 Hz, 1 H), 2.61 
(ddt, J = 18.9, 4.9, 1.6 Hz, 1 H), 2.54-2.47 (m, 2 H), 1.96-1.87 (m, 2 H);  
13
C NMR (150 MHz, CDCl3) δ 
198.1, 145.9, 129.6, 96.7, 62.9, 55.5, 49.6, 47.4, 35.5, 35.5; HRMS (ESI) m/z calcd for C11H19O4 ([M+H]
+
) 
215.12779, found 215.12701. 
 
2-Iodo-5-methoxy-5-(2-(methoxymethoxy)ethyl)cyclohex-2-en-1-one (3-135). To a solution of 3-134 
(10.1 mg, 0.0471 mmol) in CH2Cl2 (130 µL) at 0 
o
C was added pyridine (97.8 mg, 1.24 mmol, 100 µL) 
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and I2 (29.9 mg, 0.118 mmol) and the reaction mixture was warmed to room temperature and stirred for 4 
h. EtOAc (20 mL) was added, and the organics were washed successively with: sat. aq. Na2S2O3 (2 x 5 
mL), H2O (5 mL), 10% aq. CuSO4 (6x5 mL), H2O (5 mL), and brine (5 mL). The organic layer was dried 
over MgSO4, filtered, and concentrated in vacuo.  The resulting residue was purified with column 
chromatography on SiO2 (EtOAc: hexanes, 1:2) to afford 3-135 (12.6 mg, 0.0370 mmol, 79%) as pale 
yellow oil: IR (neat) 3592, 2935, 2886, 2825, 1685, 1599, 1462, 1404, 1328, 1202, 1180, 1149, 1105, 
1064, 1046, 1032, 1007, 958, 918, 869, 818, 771, 671 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.56 (dd, J = 
5.1, 3.7 Hz, 1 H), 4.59 (s, 2 H), 3.61 (t, J = 6.6 Hz, 2 H), 3.35 (s, 3 H), 3.13 (s, 3 H), 3.02 (dd, J = 16.0, 
1.6 Hz, 1 H), 2.68 (d, J = 16.0 Hz, 1 H), 2.64-2.60 (m, 2 H), 1.93-1.88 (m, 2 H);  
13
C NMR (100 MHz, 
CDCl3) δ 191.1, 154.2, 102.6, 96.7, 62.8, 55.5, 49.7, 46.4, 39.4, 35.3; HRMS (ESI) m/z calcd for 
C11H18O4I ([M+H]
+
) 341.02443, found 341.02323. 
 
N-((1R,2S)-1-(hydroxymethyl)-7-methoxy-1-(3-methoxyphenyl)-2,3-dihydro-1H-inden-2-yl)-2-(2-
iodo-5-methoxyphenyl)acetamide (3-154). To a solution of 3-85 (1.58 g, 4.82 mmol) in dry THF (40 
mL) was added LiALH4 (918 mg, 19.3 mmol, 4.83 mL 1 M solution in Et2O) at 0 °C and the reaction 
mixture was stirred at room temperature for 8 h. The reaction was cooled to 0 C and was sequentially 
added H2O (918 µL), 15% NaOH aqueous solution (2.75 mL), H2O (918 µL) and the reaction mixture 
was stirred at room temperature for 15 min. To this mixture was added MgSO4 (20 mg) and the mixture 
was stirred for another 15 min and filtered through a pad of celite. The filtrate was concentrated in vacuo 
and directly used in the next step without further purification.   
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The crude material and 3-153 (987 mg, 3.38 mmol) in CH2Cl2 (31 mL) was treated with EDCI 
(648 mg, 3.38 mmol) at room temperature. The reaction mixture was stirred at the same temperature for 
12 h and quenched with water. The aqueous layer was extracted with EtOAc (3x20 mL). The combined 
organic layers were washed with water (2x5 mL) and brine, dried (Na2SO4), filtered and concentrated in 
vacuo. Purification by chromatography on SiO2 (EtOAc:Hexanes, 1:3) afforded 3-154 (1.54 g, 2.69 mmol, 
56%) as a clear oil.: IR (neat) 3308, 3083, 3072, 3062, 3055, 3051, 3033, 3021, 3006, 2997, 2992, 2954, 
2036, 2930, 2908, 2872, 2867, 2833, 1653, 1546, 1586, 1568, 1540, 1521, 1476, 1465, 1437, 1431, 1389, 
1379, 1359, 1290, 1260, 1238, 1189, 1161, 1148, 1105, 1085, 1079, 1049, 1008, 811, 768, 734, 716, 701 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.66 (d, J = 8.7 Hz, 1 H), 7.32 (dd, J = 15.4 Hz, 2 H), 7.16 (t, J = 8.0 
Hz, 1 H), 6.94 (d, J = 7.7 Hz, 1 H), 6.91 (d, J = 2.8 Hz, 1 H), 6.89 (d, J = 8.1 Hz, 1 H), 6.73 (dd, J = 8.1, 
1.8 Hz, 1 H), 6.64 (d, J = 7.7 Hz, 1 H), 6.55 (dd, J = 8.8, 2.8 Hz, 1 H), 6.53 (d, J = 1.8 Hz, 1 H), 4.91 (t, J 
= 6.0 Hz, 1 H), 4.25 (s, 2 H), 3,77 (s, 3 H ), 3.76 (s, 3 H), 3.70 (s, 3 H), 3.65 (s, 2 H), 3.04 (dd, J = 16.3, 
6.2 Hz, 1 H), 2.81 (d, J = 16.0 Hz, 1 H), 2.58 (br s, 1 H); 
13
C NMR (150 MHz, CDCl3) δ 169.8, 160.2, 
159.7, 156.8, 145.5, 144.2, 140.1, 139.4, 130.0, 129.5, 129.4, 119.2, 118.9, 116.7, 115.5, 113.2, 111.7, 
109.3, 89.7, 66.3, 62.7, 62.3, 55.5, 55.5, 55.2, 48.9, 39.0 cm
-1
; HRMS (ESI) m/z calcd for C27H27O5NI 
([M-H]
+
) 572.09284, found 572.09364.  
 
 
(4aS,9aS)-3-(2-Iodo-5-methoxyphenyl)-5-methoxy-4a-(3-methoxyphenyl)-1,4a,9,9a-tetrahydro-2H-
indeno[2,1-b]pyridin-2-one (3-155). To a solution of 3-154 (123 mg, 0.215 mmol) in CH2Cl2 (16 mL) 
was added DMP (182 mg, 0.429 mmol) at room temperature. The reaction mixture was stirred room 
temperature for 12 h until the starting material was fully consumed (monitored by TLC). The reaction was 
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quenched by adding sat. NaHCO3 solution (5 mL) and stirred for 10 min. The mixture was partitioned in 
the sep funnel and the aqueous layer was extracted with CH2Cl2 (3x5 mL). The combined organic layer 
was washed with brine (3 mL), dried (Na2SO4) and concentrated in vacuo. The residue was purified with 
column chromatography on SiO2 (EtOAc:hexanes, 1:3) to afford the desired aldehyde. 
The aldehyde was dissolved in MeOH (5 mL) and was added K2CO3 (296 mg, 2.15 mmol). The 
reaction mixture was heated at room temperature for 24 h and then at 60 °C for 24 h. The reaction mixture 
was concentrated in vacuo and dissolved in EtOAc (5 mL). The EtOAc solution was washed with brine (5 
mL), dried (Na2SO4) and concentrated in vacuo. The resulting residue was purified with column 
chromatography on SiO2 (EtOAc:hexanes, 1:1 with 0.5% Et3N) to afford 3-155 (60.2 mg, 0.109 mmol, 
51%) as pale oil: IR (neat) 3208, 3059, 3025, 2999, 2937, 2867, 2854, 2835, 2378, 2347, 2235, 1702, 
1670, 1623, 1597, 1586, 1564, 1491, 1478, 1461, 1450, 1405, 1387, 1381, 1308, 1288, 1264, 1240, 1221, 
1174, 1137, 1061, 1031, 766, 733, 699 cm
-1
;
 1
H NMR (300 MHz, CDCl3) δ 7.69 (d, J = 8.6 Hz, 1 H), 7.29 
(t, J = 7,9 Hz, 1 H), 7.23 (t, J = 7.9 Hz, 1 H), 6.95 (d, J = 7.4 Hz, 1 H), 6.83-6.75 (m, 4 H), 6.62 (dd, J = 
8.7, 3.0 Hz, 1 H), 6.01 (br s, 1 H), 4.24 (brs, 1 H),  3.79 (s, 3 H), 3.76 (s, 3 H), 3.62 (s, 3 H), 3.50-3.35 (m, 
2 H), 1.65 (br s, 1 H); 
13
C NMR (75 MHz, CDCl3) δ 163.5, 159.8, 159.8, 156.6, 145.1, 145.5, 143.1, 
139.4, 129.9, 129.8, 129.4, 119.3, 117.6, 117.0, 115.3, 113.2, 112.1, 110.0, 88.4, 64.4, 55.5, 55.4, 55.2, 
53.5, 41.0; HRMS (ESI) m/z calcd for C27H25O5NI ([M+H]
+
) 554.08228, found 554.08000. 
 
 
tert-Butyl (4aS,9aS)-3-(2-iodo-5-methoxyphenyl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-
tetrahydro-1H-indeno[2,1-b]pyridine-1-carboxylate (3-152). To a microwave vial was added 3-155 
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(230 mg, 0.416 mmol) and Ru3(CO)12 (13.3 mg, 0.0208 mmol). The vial was sealed and purged with N2. 
To this vial was added toluene (4.6 mL) and TMDS (880 mg, 6.65 mmol, 1.2 mL) via syringe. The 
reaction mixture was stirred at room temperature for 30 min, and then heated and stirred at 50 °C for 2 h. 
The reaction mixture was cooled to room temperature and was added 1 M NaOH aqueous solution (2 mL) 
and CH2Cl2 (2 mL). The mixture was vigorously stirred for 30 min and partitioned in the sep funnel. The 
aqueous layer was extracted with CH2Cl2 (3x3 mL) and the combined organic layers were washed with 
brine (3 mL), dried (Na2SO4) and concentrated in vacuo. The resulting residue was purified with column 
chromatography on SiO2 (EtOAc: hexanes, 1:2) isolate the resulting spot. 
The isolated material was dissolved in CH2Cl2 (4.6 mL) and was added Boc2O (95.2 mg, 0.436 
mmol). The reaction mixture was stirred at room temperature for 12 h and was quenched by adding H2O 
(5 mL). The mixture was extracted with EtOAc (3x5 mL) and the combined organic layers were washed 
with brine (4 mL), dried (MgSO4) and concentrated in vacuo. The resulting residue was purified with 
column chromatography on SiO2 (EtOAc:hexanes, 1:6) to afford the 3-152 (239 mg, 0.374 mmol, 90%) as 
pale yellow oil: IR (neat) 2934, 2835, 2248, 1691, 1587, 1563, 1480, 1464, 1438, 1416, 1391, 1364, 1343, 
1315, 1288, 1255, 1212, 1164, 1112, 1079, 1053, 1024, 1006, 985, 969, 907, 863, 808, 774, 732, 707 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.75-7.61 (m, 1 H), 7.23 (t, J = 7.9 Hz, 1 H), 7.21-7.15 (m, 1 H), 6.95-6.73 
(m, 5 H), 6.71 (d, J = 8.1 Hz, 1 H), 6.61-6.59 (m, 1 H), 5.92-5.77 (m, 1 H), 5.10-4.94 (m, 1 H), 4.86-4.56 
(m, 1 H), 3.90-3.81 (m, 1 H), 3.79 (s, 3 H), 3.76 (s, 3 H), 3.52 (s, 3 H), 3.42-3.28 (m, 1 H), 3.28-3.13 (m, 
1 H), 3.07 (dd, J = 15.0, 8.2 Hz, 1 H), 1.44-1.36 (m, 3 H), 1.20-1.07 (m, 6 H); 
13
C NMR (100 MHz, 
CDCl3) δ 159.8, 159.4, 156.2, 154.7, 147.3, 145.9, 142.6, 139.8, 138.4, 131.2, 129.1, 128.7, 127.3, 119.4, 
117.3, 115.6, 115.3, 112.6, 111.4, 109.7, 87.0, 79.6, 63.3, 55.5, 55.3, 55.1, 55.0, 42.0, 33.4, 28.4, 28.5, 
28.0, 27.5, 27.4; HRMS (ESI) m/z calcd for C32H35O5NI ([M+H]
+
) 640.15544, found 640.15629. 
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tert-Butyl (4aS,9aS)-3-(4'-(2-((tert-butyldimethylsilyl)oxy)ethyl)-4,4'-dimethoxy-2',3',4',5'-
tetrahydro-[1,1'-biphenyl]-2-yl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-1H-
indeno[2,1-b]pyridine-1-carboxylate (3-148). To a flask was added 3-152 (86.0 mg, 0.134 mmol), 3-
150 (80.0 mg, 0.201 mmol) and PdCl2(dppf) (9.8 mg, 0.0134 mmol) and the flask was purged with N2. To 
this flask were added THF (5.0 mL, degassed with freeze pump thaw cycles for three times) and 10% 
NaOH solution in H2O (2.0 mL, degassed with freeze pump thaw cycles for three times). The reaction 
mixture was stirred at room temperature for 36 h. The reaction was quenched by adding H2O (5 mL). The 
resulting mixture was extracted with EtOAc (3x5 mL). The combined organic layers were washed with 
brine (5 mL), dried (MgSO4) and concentrated in vacuo. The resulting residue was purified with column 
chromatography on SiO2 (EtOAc:hexanes, 1:10) to afford 3-148 (96.0 mg, 0.123 mmol, 91%) as colorless 
oil: IR (neat) 2933, 2856, 1692, 1600, 1480, 1418, 1390, 1365, 1344, 1317, 1288, 1253, 1210, 1164, 1145, 
1079, 954, 896, 836, 810, 774, 733, 707, 695, 663 cm
-1
; 
1
H NMR (600 MHz, CDCl3, mixture of 
diastereomers) δ 7.32 (t, J = 7.6 Hz, 1 H), 7.26-7.19 (m, 3 H), 7.17 (td, J = 7.9, 3.1 Hz, 1 H), 7.03 (d, J = 
10.3 Hz, 1 H), 6.92-6.86 (m, 2 H), 6.86-6.80 (m, 2 H), 6.80-6.73 (m, 3 H), 6.73-6.69 (m, 1 H), 5.95 (s, 0.5 
H), 5.89 (s, 0.5 H), 5.35 (s, 0.5 H), 5.30 (s, 0.5 H), 5.00-4.75 (m, 2 H), 3.80 (s, 3 H), 3.78 (s, 1 H), 3.74 (s, 
2 H), 3.72 (m, 3 H), 3.52 (m, 3 H), 3.27 (s, 1 H), 3.17 (d, J = 10.3 Hz, 3 H), 3.13-2.97 (m, 2 H), 2.57 (td, J 
= 14.2, 6.1 Hz, 1 H), 2.29-2.10 (m, 2 H), 2.10-1.96 (m, 2 H), 1.96-1.76 (m, 2 H), 1.76-1.57 (m, 2 H), 
1.43-1.03 (m, 9 H), 0.92 (d, J = 1.62 Hz, 9 H), 0.04 (d, J = 0.9 Hz, 6 H); 
13
C NMR (100 MHz, CDCl3, 
mixture of diastereomers) 159.5, 158.2, 154.9, 138.0, 133.5, 132.1, 129.7, 129.5, 129.2, 129.2, 128.8, 
126.7, 124.0, 122.9, 119.3, 115.4, 111.1, 109.9, 73.3, 73.2, 58.8, 58.7, 55.7, 55.5, 55.4, 55.2, 55.1, 49.1, 
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48.9, 38.5, 38.1, 36.8, 35.4, 33.9, 33.1, 28.0, 26.1, 26.0, 18.5, 18.4, 8.4, -5.1, -5.2; HRMS (ESI) m/z calcd 
for C47H64O7NSi([M+H]
+
) 782.44466, found 782.44470. 
 
tert-Butyl (4aS,9aS)-3-(4'-(2-iodoethyl)-4,4'-dimethoxy-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-2-yl)-5-
methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-1H-indeno[2,1-b]pyridine-1-carboxylate (3-
156). To a solution of 3-148 (96.0 mg,  0.123 mmol) in THF (3.7 mL) was added TBAF (32.1 mg, 0.246 
mmol, 246 µL 1 M solution in THF) under N2 at 0 °C. The reaction mixture was slowly warmed to room 
temperature and stirred at room temperature for 12 h. The reaction was quenched by adding H2O (5 mL) 
and the mixture was extracted with EtOAc (3x5 mL). The combined organic layers were washed with 
brine (4 mL), dried (MgSO4) and concentrated in vacuo. 
The resulting residue was dissolved in CH2Cl2 (1 mL) and was cooled to 0 °C and was added 
Et3N (62.1 mg, 0.614 mmol) and MsCl (28.1 mg, 0.246 mmol). The reaction mixture was slowly warmed 
to room temperature and stirred at room temperature for 24 h. The reaction was quenched by adding H2O 
(5 mL) and the mixture was extracted with CH2Cl2 (3x5 mL). The combined organic layers were washed 
with brine (4 mL), dried (MgSO4) and concentrated in vacuo. The resulting residue was purified with 
column chromatography on SiO2 (EtOAc:hexanes, 1:2) to afford the desired mesylate as a colorless oil. 
The resulting oil was dissolved in THF (1 mL) and was added LiI (82.1 mg, 0.614 mmol) and the 
reaction mixture was heated at 60 °C for 12 h. The reaction mixture was cooled to room temperature and 
was concentrated in vacuo. The resulting residue was dissolved in EtOAc (6 mL) and was washed with 
sat. NaS2O3 solution (4 mL). The aqueous layer was extracted with EtOAc (3x2 mL) and the combined 
organic layers were washed with brine (3 mL), dried (MgSO4) and concentrated in vacuo. The resulting 
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residue was purified with column chromatography on SiO2 (EtOAc:hexanes, 1:8) to afford 3-156 (75.2 
mg, 0.0967 mmol, 79%) as colorless oil: IR (neat) 2935, 2834, 2244, 1689, 1601, 1587, 1563, 1480, 1465, 
1435, 1417, 1391, 1364, 1344, 1317, 1288, 1254, 1210, 1165, 1112, 1079, 1045, 1021, 968, 909, 856, 826, 
808, 775, 732, 707, 664 cm
-1
; 
1
H NMR (500 MHz, CDCl3, mixture of diastereomers) δ 7.24 (td, J = 7.8, 
4.2 Hz, 1 H), 7.16 (td, J = 7.9, 3.6 Hz, 1 H), 7.04 (d, J = 8.4 Hz, 1 H), 6.88 (t, J = 6.7 Hz, 1 H), 6.84 (dd, J 
= 12.0, 2.2 Hz, 1 H), 6.80-6.69 (m, 5 H), 5.95 (s, 0.5 H), 5.88 (s, 0.5 H), 5.37 (s, 0.5 H), 5.33 (s, 0.5 H), 
4.97-4.78 (m, 2 H), 3.81 (s, 3 H), 3.74 (d, J = s. 1.5 H), 3.73 (s, 1.5 H),  3.52 (s, 3 H), 3.17 (s, 2 H), 3.15 
(s, 3 H), 3.10-2.95 (m,  2 H), 2.35-2.08 (m, 3 H), 2.08-1.75 (m, 3 H), 1.65-1.50 (m, 2 H), 1.43-1.03 (m, 9 
H); 
13
C NMR (100 MHz, CDCl3, mixture of diastereomers) δ159.4, 158.4, 158.2, 156.3, 154.8, 154.8, 
147.9, 147.9, 142.5, 139.9, 138.2, 137.2, 135.1, 135.0, 132.1, 129.2, 129.2, 128.8, 122.5, 119.3, 115.2, 
111.0, 109.9, 79.6, 79.6, 75.4, 55.5, 55.4, 55.2, 49.0, 49.0, 41.1, 34.5, 34.2, 33.2, 33.1, 29.1, 28.0, 27.9, -
1.1; HRMS (ESI) m/z calcd for C41H49O6NI([M+H]
+
) 778.25991, found 778.25669. 
 
(11aS,16bS,E)-2,8,16-Trimethoxy-16b-(3-methoxyphenyl)-7,9,10,11a,12,16b-hexahydro-8H-5,8-
ethano-11,18-methanobenzo[f]indeno[2,1-b][1]azacyclotridecine (3-142). To a solution of 3-156 (70.0 
mg, 0.0900 mmol) in CH2Cl2 (17.7 mL) at 0 °C under N2 was added TFA (1.33 g, 11.7 mmol) and the 
reaction mixture was stirred at 5 °C for 24 h. The reaction mixture was diluted with toluene and the 
mixture was concentrated in vacuo. The resulting residue was added toluene and concentrated in vacuo 
for two more times. The resulting oil was dessolved in CH3CN (88 mL) and the mixture was added 
DIPEA (1.16 g, 9.00 mmol). The reaction mixture was degassed with freeze-pump-thaw cycles for three 
times, and was heated at 80 °C for 24 h. The reaction mixture was cooled to room temperature and was 
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concentrated in vacuo. The resulting residue was added sat. NaHCO3 (10 mL) and the mixture was 
extracted with EtOAc (3x5 mL). The combined organic layers were washed with brine (5 mL), dried and 
concentrated in vacuo.  The resulting residue was purified with column chromatography on SiO2 
(EtOAc:hexanes, 1:3 to 1:2 with 0.5% Et3N) to afford 3-142 (26.9 mg, 0.489 mmol, 54%) as pale yellow 
oil: IR (neat) 2937, 2834, 2240, 1600, 1563, 1480, 1465, 1289, 1263, 1205, 1174, 1114, 1080, 1052, 1022, 
982, 911, 874, 810, 776, 732, 700 cm
-1
; 
1
H NMR (400 MHz, CDCl3, mixture of diastereomers) δ 7.23 (dd, 
J = 7.9, 5.2 Hz, 1 H), 7.17 (t, J = 7.9 Hz, 1 H), 7.04 (t, J = 7.8 Hz, 1 H), 6.93 (dd, J = 7.4, 3.0 Hz, 1 H), 
6.81 (d, J = 2.7 Hz, 1 H), 6.78-6.65 (m, 6 H), 6.38 (s, 1 H), 5.43 (dd, J = 4.0, 2.7 Hz, 1 H), 3.82 (s, 1.5 H), 
3.80 (s, 1.5 H), 3.76 (s, 1 H), 3.73 (s, 3 H), 3.67 (td, J = 5.4, 2. Hz, 1 H), 3.62 (d, J = 14.1 Hz, 3 H), 3.52-
3.42 (m, 2 H), 3.25 (d, J = 1.5 Hz, 3 H), 3.19-3.10 (m, 2 H), 2.89 (td, J = 16.0, 5.1 Hz, 1 H), 2.72-2.65 (m, 
1 H), 2.50 (t, J = 14.0 Hz, 1 H), 2.17 (td, J = 16.2, 4.1 Hz, 1 H), 1.90-1.59 (m, 6 H), 1.53 (dd, J = 9.2, 3.2 
Hz, 1 H), 1.44 (dd, J = 9.8, 4.7 Hz, 1 H); 
13
C NMR (100 MHz, CDCl3, mixture of diastereomers) δ 159.7, 
159.6, 158.5, 158.5, 157.5, 148.1, 148.0, 145.8, 145.6, 143.6, 141.7, 141.4, 139.6, 133.3, 133.2, 132.8, 
132.5, 130.7, 129.5, 129.2, 129.1, 119.5, 119.4, 118.0, 114.9, 113.5, 113.4, 111.9, 111.8, 110.8, 109.7, 
83.0, 82.9, 66.6, 60.5, 55.6, 55.4, 55.2, 55.1, 51.3, 51.3, 45.6, 42.3, 40.4, 39.9, 36.0, 34.0, 33.9, 33.2, 33.1, 
31.7, 22.8, 14.3, 14.3; HRMS (ESI) m/z calcd for C36H40O4N([M+H]
+
) 550.29519, found 550.29303. 
 
 
tert-Butyl(2-(4-(tert-butyldimethylsilyloxy)-1-methoxycyclohex-3-enyl)ethoxy)diphenylsilane (3-164).  
To a solution of 3-163 (2.19 g, 5.33 mmol) and 2,6-lutidine (1.14 g, 10.7 mmol) in THF (28 mL) at 0 °C 
was added TBSOTf (1.83 g, 6.93 mmol). The reaction mixture was stirred at 0 °C for 4 h. The reaction 
was quenched by adding sat. NH4Cl solution (5 mL) and the mixture was extracted with EtOAc (3x10 
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mL). The combined organic layers were washed with brine (5 mL), dried (MgSO4) and concentrated in 
vacuo. The resulting residue was purified with column chromatography on SiO2 (Et2O:heaxnes, 1:14) to 
generate 3-164 (2.68 g, 5.11 mmol, 96%) as colorless oil: IR (neat) 3071, 2930, 2857, 2888, 1674, 1590, 
1472, 1463, 1428, 1290, 1373, 1361, 1252, 1179, 1196, 1111, 1081, 1007, 939, 877, 838, 799, 778, 739 
cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.69 (dd, J = 6.6, 1.3 Hz, 4 H), 7.45-7.36 (m, 6 H), 4.68 (t, J = 3.6 Hz, 
1 H), 3.79 (t, J = 7.3 Hz, 2 H), 3.04 (s, 3 H), 2.16-2.06 (m, 2 H), 2.06-1.97 (m, 1 H), 1.97-1.74 (m, 4H), 
1.65-1.55 (m, 1 H), 1.06 (s, 9 H), 0.93 (s, 9 H), 0.13 (d, J = 0.85 Hz, 6 H); 
13
C NMR (75 MHz, CDCl3) δ 
150.2, 135.7, 134.1, 129.7, 127.8, 100.8, 73.5, 59.9, 48.9, 37.3, 33.5, 31.1, 27.4, 27.0, 25.8, 19.3, 18.1, -
4.3, -4.3; HRMS (ESI) m/z calcd for C31H49O3Si 2([M+H]
+
) 525.32147, found 525.32017. 
 
2-(tert-Butyldimethylsilyloxy)-4-(2-(tert-butyldiphenylsilyloxy)ethyl)-4-methoxycyclohexanone (3-
165). To a stirred solution of 1-164 (400 mg, 0.762 mmol) in THF/water (3:1, 3.1 mL in total) were added 
4-methylmorpholine-N-oxide (134 mg, 1.14 mmol) followed by K2OsO4-2H2O (1.4 mg, 0.0038 mmol). 
The resulting solution was stirred for 8 h at room temperature. The mixture was diluted with EtOAc (30 
mL) and the aqueous layer was extracted with EtOAc (3x10 mL). The combined organic layer was 
washed with brine (10 mL), dried (MgSO4) and concentrated in vacuo. The residue was purified with 
silica gel column chromatography (EtOAc:hexanes, 1:4) to afford the desired alpha hydroxy ketone as 
colorless oil. The resulting oil was dissolved in THF (2.3 mL) and to this solution was added N-
methylimidazole (188 mg, 2.29 mmol), I2 (387 mg, 1.52 mmol) and the mixture was stirred at room 
temperature for 1 min. To this mixture was added TBSCl (126 mg, 0.838 mmol) and the mixture was 
stirred at room temperature for 1 h until TLC showed the hydroxy ketone was completely consumed. The 
reaction mixture was concentrated in vacuo and the resulting residue was dissolved in EtOAc (20 mL), 
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washed with sat. Na2S2O3 solution (10 mL), brine (5 mL), dried (MgSO4) and concentrated in vacuo. The 
resulting residue was purified with column chromatography on SiO2 to 3-165 (349 mg, 0.645 mmol, 85%) 
as a mixture of diastereomers: IR (neat) 3072, 2930, 2886, 2856, 1968, 1730, 1590, 1472, 1463, 1428, 
1390, 1361, 1299, 1251, 1159, 1136, 1111, 1075, 1042, 1007, 974, 938, 925, 908, 875, 832, 779, 737, 688, 
669 cm
-1
;
 1
H NMR (400 MHz, CDCl3, major diastereomer) δ 7.67 (d, J = 7.5 Hz, 5 H), 7.47 (m, 7 H), 
5.63 (t, J = 3.8 Hz, 1 H), 4.46 (t, J = 6.4 Hz, 1 H), 3.74 (t, J = 7.0 Hz, 2 H), 3.02 (s, 3 H),  2.40-2.20 (m, 3 
H), 1.97-1.77 (m, 3 H), 1.72 (dd, J = 13.5, 8.4 Hz, 1 H), 1.05 (s, 9 H), 0.91 (s, 9 H), 0.13 (s, 3 H), 0.09 (s, 
3 H); 
13
C NMR (75 MHz, CDCl3, major diastereomer) δ 209.4, 135.7, 133.8, 129.8, 127.8, 72.8, 59.5, 
49.0, 44.6, 38.4, 35.5, 34.4, 27.0, 25.9, 19.2, 18.6, -4.5, -5.4; HRMS (ESI) m/z calcd for C31H49O4Si 
2([M+H]
+
) 541.31639, found 541.31464. 
 
6-(tert-Butyldimethylsilyloxy)-4-(2-(tert-butyldiphenylsilyloxy)ethyl)-4-methoxycyclohex-1-enyl 
trifluoromethanesulfonate (3-166). To a stirred solution of 3-165 (500 mg, 0.924 mmol) in THF (4.0 
mL) at -78 °C was added LiHMDS (309 mg, 1.85 mmol) in THF (2.0 mL) via syringe and was stirred at -
78 °C for 60 min. The reaction mixture was added Comins’ reagent (690 mg, 1.76 mmol) in THF (1.6 
mL). The mixture was stirred for 2 h at -78 °C, and for 2 h at 0 °C. The reaction was quenched by the 
addition of saturated aqueous NH4Cl (15 mL), and the whole was extracted with EtOAc (3 x 30 mL). The 
combined organic layers were washed with brine, dried (MgSO4), and concentrated in vacuo. The residue 
was purified with column chromatography on SiO2 (Et2O:hexanes, 1:40) to afford 3-166 (526 mg, 0.782 
mmol, 85%, mixture of diastereomers) as colorless oil: IR (neat, mixture of diastereomers) 3072, 2889, 
2932, 2858, 1960, 1685, 1590, 1472, 1463, 1420, 1378, 1362, 1248, 1206, 1144, 1111, 1084, 1007, 973, 
914, 864, 837, 778, 738, 702, 688 cm
-1
; 
1
H NMR (600 MHz, CDCl3, major diastereomer) δ 7.67 (d, J = 
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7.2 Hz, 5 H), 7.46-7.36 (m, 7 H), 5.63 (t, J = 3.8 Hz, 1 H), 4.46 (t, J = 7.4 Hz, 1 H), 3.77-3.68 (m, 2 H), 
3.01 (s, 3 H), 2.33-2.21 (m, 3 H), 2.00-1.77 (m, 3 H), 1.72 (dd, J = 13.4, 8.5 Hz, 1 H), 1.05 (s, 9 H), 0.91 
(s, 9 H), 0.13 (s, 3 H), 0.09 (s, 3 H); 
13
C NMR (150 MHz, CDCl3) δ 149.3, 135.7, 135.7, 133.7, 133.7, 
129.9, 127.8, 119.7, 117.6, 115.9, 74.9, 65.4, 59.4, 49.1, 41.3,38.2, 33.5, 27.0, 26.9, 25.9, 25.8, 19.2, 18.1, 
-4.5, -4.8; HRMS (ESI) m/z calcd for C32H48O6F3SSi2([M+H]
+
) 673.26567, found 673.26378. 
 
8-(2-((tert-Butyldiphenylsilyl)oxy)ethyl)-1,4-dioxaspiro[4.5]decan-8-ol (3-173). To a solution of 3-172 
(282 mg, 1.39 mmol) in CH2Cl2 (5.2 mL) was added DMAP (8.5 mg, 0.070 mmol), TBDPSCl (460 mg, 
1.67 mmol) and Et3N (282 mg, 2.79 mmol, 392 µL). The reaction mixture was stirred at room 
temperature for 12 h. The reaction was quenched by adding H2O (10 mL) and the mixture was extracted 
with EtOAc (3x5 mL). The combined organic layers were washed with brine (3 mL), dried (MgSO4) and 
concentrated in vacuo. The resulting residue was purified with column chromatography on SiO2 
(EtOAc:hexanes, 1:4) to afford 3-173 (470 mg, 1.07 mmol, 77%) as colorless oil: IR (neat) 3508, 3072, 
2932, 2883, 2858, 2244, 1737, 1590, 1472, 1428, 1391, 1370, 1338, 1265, 1228, 11891166, 1103, 1067, 
1038, 1008, 977, 944, 902, 879, 822, 731, 700 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.68 (dd, J = 7.9, 1.4 
Hz, 4 H), 7.47-7.38 (m, 6 H), 3.99-3.91 (m, 4 H), 3.90 (t, J = 5.8 Hz, 2 H), 3.64 (s, 1 H), 2.00 (td, J = 13.4, 
4.0 Hz, 2 H), 1.83-1.77 (m, 2 H), 1.75 (t, J = 5.7 Hz, 2 H), 1.63-1.52 (m, 4 H), 1.05 (s, 9 H); 
13
C NMR 
(125 MHz, CDCl3) δ 135.6, 132.8, 129.9, 127.8, 109.1, 70.4, 64.3, 64.1, 61.5, 42.0, 35.1, 30.4, 26.9, 19.0; 
HRMS (ESI) m/z calcd for C26H37O4Si ([M+H]
+
) 441.24556, found 441.24590. 
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8-(2-((tert-Butyldiphenylsilyl)oxy)ethyl)-1,4-dioxaspiro[4.5]decan-8-yl benzoate (3-174). To a 
solution of 3-173 (470 mg, 1.07 mmol) in THF (10.1 mL) at 0 °C was added nBuLi (208 uL 2.0 M 
solution in hexanes, 1.39 mmol) and the reaction mixture was stirred at 0 °C for 20 min. To this mixture 
at 0 °C was added benzoyl chloride (225 mg, 1.60 mmol) and the reaction mixture was stirred at 0 °C for 
1 h. The reaction mixture was warmed to room temperature and stirred at room temperature for 12 h. The 
mixture was quenched by the addition of an aqueous saturated solution of NH4Cl (10 mL). The resulting 
mixture was extracted with CH2Cl2 (3x5 mL). The combined organic layers were washed with water (5 
mL), dried (MgSO4) and concentrated in vacuo. The resulting residue was purified with column 
chromatography on SiO2 (EtOAc:hexanes, 1:20 to 1:15) to afford 3-174 (390 mg, 0.716 mmol, 67%) as 
colorless oil and starting material 14 (131 mg, 0.297 mmol, 28%): IR (neat) 3071, 2956, 2932, 2884, 
2858, 2251, 1791, 1711, 1585, 1473, 1463, 1450, 1428, 1361, 1340, 1315, 1284, 1250, 1093, 1039, 1026, 
998, 908, 843, 822, 729, 701, 687, 671 cm
-1
; 
1
H NMR (500 MHz, CDCl3) δ 7.98 (d, J = 7.2 Hz, 2 H),  
7.64 (dd, J = 7.9, 1.2 Hz, 4 H), 7.55 (t, J = 7.4 Hz, 1 H), 7.42 (t, J = 7.8 Hz, 2 H), 7.38 (t, J = 7.4 Hz, 2 H), 
7.32 (t, J = 10.5 Hz, 4 H), 3.96 (s, 4 H), 3.78 (t, J = 6.6 Hz, 2 H), 2.62-2.52 (m, 2 H), 2.41 (t, J = 6.6 Hz, 2 
H), 1.90-1.79 (m, 4 H), 1.71-1.62 (m, 2 H), 1.02 (s, 9 H), 
13
C NMR (125 MHz, CDCl3) δ 165.6, 135.6, 
133.7, 132.7, 131.5, 130.7, 129.6, 129.6, 129.0, 128.4, 127.7, 108.3, 82.8, 64.1, 64.3, 59.9, 53.5, 39.8, 
32.8, 30.7, 26.9, 19.1; HRMS (ESI) m/z calcd for C33H41O5Si ([M+H]
+
) 545.27178, found 545.27093. 
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1-(2-((tert-Butyldiphenylsilyl)oxy)ethyl)-4-oxocyclohexyl benzoate (3-175). To a solution of 3-174 
(280 mg, 0.514 mmol) in acetone (60 mL) was added p-TSA-H2O (147 mg, 0.771 mmol) and the reaction 
mixture was heated at 45 °C for 24 h. The reaction was concentrated in vacuo and quenched by adding sat. 
NaHCO3 (20 mL). The mixture was extracted with EtOAc (3x5 mL) and the combined organic layers 
were washed with brine (5 mL) and concentrated in vacuo. The resulting residue was purified with 
column chromatography on SiO2 (EtOAc:hexanes, 1:10) to afford 3-175 (209 mg, 0.417 mmol, 81%) as 
colorless oil. IR (neat) 3071, 2958, 2930, 2888, 2856, 1712, 1600, 1588, 1548, 1488, 1462, 1472, 1450, 
1390, 1427, 1362, 1313, 1285, 1262, 1220, 1175, 1109, 1095, 1070, 1026, 1007, 999, 909, 848, 821, 735, 
687 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.98 (dd, J = 8.4, 1.4 Hz, 2 H), 7.72 (dd, J = 7.5, 1.6 Hz, 1 H), 
7.61 (dd, J = 6.6, 1.5 Hz, 5 H), 7.58-7.53 (m, 1 H), 7.44 (t, J = 7.9 Hz, 2 H), 7.41-7.36 (m, 3 H), 7.33 (d, J 
= 7.5 Hz, 3 H), 7.30 (t, J = 1.4 Hz, 1 H), 3.80 (t, J = 6.4 Hz, 2 H), 2.91-2.82 (m, 2 H), 2.57 (td, J = 14.8, 
6.0 Hz, 2 H), 2.42 (t, J = 6.3 Hz, 2 H), 2.37-2.28 (m, 2 H), 1.96 (td, J = 13.8, 4.9 Hz, 2 H), 1.01 (s, 9 H);  
13
C NMR (100 MHz, CDCl3) δ 210.5, 165.6, 135.6, 134.9, 133.4, 133.2, 131.0, 129.8, 129.8, 129.6, 128.6, 
127.8, 127.8, 127.7, 82.0, 59.8, 39.4, 37.0, 35.0, 26.9, 26.7, 19.2; HRMS (ESI) m/z calcd for C31H37O4Si 
([M+H]
+
) 501.24556, found 501.24430. 
 
1-(2-((tert-Butyldiphenylsilyl)oxy)ethyl)-4-(((trifluoromethyl)sulfonyl)oxy)cyclohex-3-en-1-yl 
benzoate (3-176). To a solution of 3-175 (175 mg, 0.350 mmol) in THF (1 mL) at -78 °C was added 
LiHMDS (76.0 mg, 0.454 mmol) in THF (1 mL). The reaction mixture was stirred at -78 °C for 30 min 
and and PhNTf2 (150 mg, 0.419 mmol) in THF (1 mL) was added into the reaction mixture via syringe. 
The reaction mixture was stirred at -78 °C for 1 h allowed to warm to room temperature and stirred at 
room temperature for 12 h. The reaction was quenched with sat. NH4Cl solution (10 mL) and extracted 
154 
with EtOAc (3x5 mL). The combined organic layers were washed with brine (5 mL), dried (MgSO4) and 
concentrated in vacuo. The residue was purified by chromatography on SiO2 (EtOAc:hexanes, 1:20) to 
yield 3-176 (120 mg, 0.190 mmol, 54%) as colorless oil: IR (neat) 3072, 2931, 2858, 1713, 1601, 1473, 
1451, 1417, 1314, 1284, 1260, 1245, 1207, 1177, 1141, 1111, 1084, 1068, 1026, 969, 938, 864, 823, 738, 
702, 687 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.94 (d, J = 7.3 Hz, 2 H), 7.63 (d, J = 7.7 Hz, 4 H), 7.57 (t, 
J = 7.4 Hz, 1 H), 7.41 (dt, J = 19.9,7.7 Hz, 4 H), 7.33 (t, J = 6.4 Hz, 4 H), 5.70 (m, 1 H), 3.80 (td, J = 6.1, 
1.1 Hz, 2 H), 3.01 (dd, J = 18.2, 2.8 Hz, 1 H), 2.77 (m, 2 H), 2.60 (dd, J = 18.3, 2.2 Hz, 1 H), 2.51 (dt, J = 
14.6, 6.2 Hz, 2 H), 2.42-2.31 (m, 2 H), 2.02-1.95 (ddd, J = 13.6, 9.9, 6.2 Hz, 1 H), 1.03 (s, 9 H);  
13
C 
NMR (150 MHz, CDCl3) δ 165.8, 148.1, 135.6, 133.4, 133.4, 133.1, 130.9, 129.8, 129.8, 129.6, 128.4, 
127.8, 121.8, 119.7, 117.6, 115.4, 115.4, 80.5, 59.8, 38.7, 34.8, 31.3, 26.9, 24.9, 19.1; HRMS (ESI) m/z 
calcd for C32H36O6F3SSi ([M+H]
+
) 633.19485, found 633.19342. 
 
1-(2-((tert-Butyldiphenylsilyl)oxy)ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-
en-1-yl benzoate (3-177). To a Schlenk flask with a magnetic stir bar was added 3-176 (45.0 mg, 0.0711 
mmol), PPh3 (1.9 mg, 0.0071 mmol), Pd(PPh3)2Cl2 (2.5 mg, 0.0036 mmol), bis(pinacolato)diboron (19.9 
mg, 0.0782 mmol), PhOK (9.2 mg, 0.11 mmol) and toluene (710 µL). The reaction mixture was degassed 
with freeze pump thaw cycles for 3 times. The reaction mixture was stirred at 50 °C for 6 h. The reaction 
was quenched adding H2O (10 mL). The mixture was extracted with EtOAc (3x10 mL) and the combined 
organic layer was washed with brine (10 mL), dried (Na2SO4) and concentrated in vacuo. The resulting 
residue was purified with column chromatography on SiO2 (Et2O:hexanes, 1:40 to EtOAc :hexanes, 1:15) 
to afford 3-177 (22.3 mg, 0.365 mmol, 51%) as light brown oil: IR (neat) 3071, 2961, 2930, 2891, 2857, 
1712, 1637, 1602,  1589, 1472, 1450, 1428, 1388, 1371, 1314, 1285, 1214, 1175, 1144, 1112, 1082, 1026, 
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1012, 999, 964, 937, 910, 857, 823, 736, 703, 688, 660 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.91 (dd, J = 
7.1, 1.3 Hz, 2 H), 7.61 (dt, J = 8.0, 1.6 Hz, 4 H), 7.51 (tt, J = 7.4, 1.2 Hz, 1 H), 7.41-7.33 (m, 4 H), 7.33-
7.26 (m, 4 H), 6.46 (m, 1 H), 3.78 (t, J = 6.6 Hz, 2 H), 2.84 (dd, J = 19.0, 2.2 Hz, 1 H), 2.53 (dd, J = 19.6, 
2.7 Hz, 1 H), 2.48-2.39 (m, 2 H), 2.37-2.27 (m, 1 H), 2.25-2.17 (m, 2 H), 1.85-1.74 (m, 1 H), 1.26 (d, J = 
1.9 Hz, 12 H), 1.00 (s, 9 H); 
13
C NMR (100 MHz, CDCl3) δ 165.7, 139.5, 135.6, 135.6, 133.7, 132.6, 
131.7, 129.7, 128.3, 127.7, 83.3, 82.3, 59.9, 39.0, 37.7, 31.1, 26.9, 25.0, 24.9, 23.8, 19.2; HRMS (ESI) 
m/z calcd for C37H47O5BSi ([M+H]
+
) 611.33586, found 611.33574. 
 
tert-Butyl (4aS,9aS)-3-(4'-(benzoyloxy)-4'-(2-((tert-butyldiphenylsilyl)oxy)ethyl)-4-methoxy-
2',3',4',5'-tetrahydro-[1,1'-biphenyl]-2-yl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-
1H-indeno[2,1-b]pyridine-1-carboxylate (3-178). To a flask was added 3-152 (40.0 mg, 0.0625 mmol), 
3-177 (57.3 mg, 0.0938 mmol) and PdCl2(dppf) (2.3 mg, 0.0031 mmol) and the flask was purged with N2. 
To this flask was added THF (7.2 mL, degassed with freeze pump thaw cycles for three times) and 10% 
NaOH solution in H2O (2.4 mL, degassed with freeze pump thaw cycles for three times). The reaction 
mixture was stirred at room temperature for 36 h. The reaction was quenched by adding H2O (5 mL). The 
resulting mixture was extracted with EtOAc (3x5 mL). The combined organic layers were washed with 
brine (5 mL), dried (MgSO4) and concentrated in vacuo. The resulting residue was purified with column 
chromatography on SiO2 (EtOAc:hexanes, 1:10) to afford 3-178 (40.1 mg, 0.0402 mmol, 64%) as 
colorless oil: IR (neat) 2933, 2857, 2835, 1691, 1601, 1587, 1564, 1480, 1450, 1427, 1417, 1391, 1363, 
1343, 1314, 1287, 1259, 1211, 1164, 1112, 1079, 1043, 1025, 970, 895, 850, 824, 775, 735, 705 cm
-1
; 
1
H 
NMR (600 MHz, CDCl3, mixture of diasteromers) δ 7.99 (d, J = 7.6 Hz, 1 H), 7.96 (d, J = 7.6 Hz, 1 H), 
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7.67 (d, J = 6.5 Hz, 4 H), 7.57-7.52 (m, 1 H), 7.46-7.37 (m, 5 H), 7.37-7.30 (m, 4 H), 7.23-7.09 (m, 2 H), 
7.00-6.91 (m, 2 H), 6.90-6.84 (m, 2 H), 6.84-6.71 (m, 4 H), 6.66 (dd, J = 19.9, 8.2 Hz, 1 H), 6.00 (s, 0.5 
H), 5.90 (s, 0.5 H),  5.40 (s, 0.5 H), 5.37 (s, 0.5 H), 5.12-4.90 (m, 1 H), 4.86 (d, J = 18.3 Hz, 1 H), 3.82 (s, 
3 H), 3.81-3.75 (m, 3 H), 3.74 (s, 3 H), 3.51 (s, 1.5 H), 3.50 (s, 1.5 H), 3.23-2.85 (m, 2 H), 2.73-2.53 (m, 
1 H), 2.53-2.33 (m, 1 H), 2.33-1.95 (m, 5 H), 1.53-1.35 (m, 9 H), 1.18-1.11 (s, 9 H), 1.04 (s, 9 H); 
13
C 
NMR (150 MHz, CDCl3, mixture of diastereomers) δ 165.7, 159.4, 158.5, 158.3, 156.3, 156.3, 154.8, 
154.7, 147.8, 147.8, 142.4, 139.8, 137.3, 135.9, 135.6, 135.1, 135.0, 133.7, 132.7, 132.6, 132.1, 132.0, 
131.7, 130.4, 129.7, 129.6, 129.5, 129.3, 128.8, 128.3, 128.3, 127.7, 126.3, 122.6, 122.4, 119.3, 119.2, 
117.7, 117.5, 114.8, 112.7, 111.1, 109.9, 109.9, 81.7, 81.7, 79.3, 79.5, 63.3, 60.0, 59.9, 55.6, 55.5, 55.4, 
55.3, 55.2, 55.1, 42.1, 39.0, 36.3, 36.2, 33.2, 33.1, 30.8, 30.6, 28.5, 28.1, 28.0, 26.9, 19.2, 14.2; HRMS 
(ESI) m/z calcd for C56H64O6NSi ([M-OBz]
+
) 874.44974, found 874.44934. 
 
tert-Butyl (4aS,9aS)-3-(4'-(2-(benzoyloxy)ethyl)-4'-hydroxy-4-methoxy-2',3',4',5'-tetrahydro-[1,1'-
biphenyl]-2-yl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-1H-indeno[2,1-b]pyridine-1-
carboxylate (3-179).  To a solution of 3-178 (89.3 mg, 0.0896 mmol) in THF (3.7 mL) at 0 °C was added 
TBAF (23.4 mg, 0.448 mmol, 448 µL 1 M solution in THF) and the reaction mixture was stirred warmed 
to room temperature and stirred at room temperature for 12 h. The reaction was quenched by adding sat. 
NaHCO3 (10 mL) and the mixture was extracted with EtOAc (3x5 mL) and the combined organic layers 
were washed with brine (5 mL) and concentrated in vacuo. The resulting residue was purified with 
column chromatography on SiO2 (EtOAc:hexanes, 1:4) to afford 3-179 (52.4 mg, 0.0691 mmol, 77%) as 
colorless oil: IR (neat) 3482, 2934, 2835, 1717, 1688, 1601, 1586, 1563, 1480, 1451, 1420, 1364, 1392, 
157 
1345, 1315, 1268, 1210, 1164, 1114, 1079, 1043, 1026, 967, 894, 809, 776, 734, 713 cm
-1
;
 1
H NMR (500 
MHz, CDCl3, one of mixture of diastereomers) δ 8.06 (d, J = 7.6 Hz, 2 H), 7.57 (t, J = 7.4 Hz, 1 H), 7.45 
(t, J = 7.5 Hz, 2 H), 7.25-7.18 (m, 1 H), 7.16-7.12 (t, J = 7.9 Hz, 1 H), 7.12-7.08 (m, 1 H), 6.86 (t, J = 8.0 
Hz, 1 H),  6.82-6.66 (m, 6 H), 5.98 (s, 0.5 H), 5.92 (s, 0.5 H),  5.69 (s, 0.5 H),5.48 (s, 0.5 H), 5.00 (d, J = 
19.4 Hz, 1 H), 4.98-4.92 (m, 1 H), 4.65-4.50 (m, 2 H), 3.80 (s, 1.5 H), 3.77 (s, 1.5 H), 3.73 (s, 1.5 H), 
3.71 (s, 1.5 H), 3.64 (t, J = 18.5 Hz, 1 H), 3.51 (s, 1.5 H), 3.50 (s, 1.5 H),  3.10 (dd, J = 25.5, 10.2 Hz, 1 
H), 3.01 (dd, J = 15.1, 8.4 Hz, 1 H), 2.57-2.46 (m, 1 H), 2.42-2.21 (m, 2 H), 2.20-2.06 (m, 2 H), 2.06-1.88 
(m, 2 H), 1.76 (d, J = 11.8 Hz, 0.5 H), 1.56 (d, J = 11.8 Hz, 0.5 H), 1.48-1.35 (m, 2 H), 1.15-1.05 (m, 9 
H);
13
C NMR (100 MHz, CDCl3, mixture of diastereomers) δ 166.8, 166.7, 159.5, 158.3, 158.2, 156.3, 
154.9, 154.8, 148.0, 147.9, 142.5, 139.5, 137.7, 137.1, 136.4, 135.3, 134.7, 133.0, 132.9, 132.2, 132.1, 
130.7, 130.6, 129.8, 129.7, 129.6, 129.2, 128.8, 128.7, 128.5, 128.5, 126.8, 126.3 123.7, 123.1, 119.3, 
117.6, 116.5, 115.6, 113.1, 112.8, 112.4, 112.2, 111.2, 110.9, 110.0, 80.0, 68.6, 68.0, 63.4, 61.7, 61.6, 
55.6, 55.5, 55.2, 55.1, 41.8, 41.1, 40.2, 38.6, 38.1, 34.6, 33.7, 33.0, 32.8, 28.0, 28.0, 27.9, 27.0; HRMS 
(ESI) m/z calcd for C47H52O8N ([M+H]
+
) 758.36929, found 758.37133. 
 
tert-Butyl (4aS,9aS)-3-(4'-hydroxy-4'-(2-hydroxyethyl)-4-methoxy-2',3',4',5'-tetrahydro-[1,1'-
biphenyl]-2-yl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-1H-indeno[2,1-b]pyridine-1-
carboxylate (3-181). To a solution of 3-180 (52.4 mg, 0.0691 mmol) in MeOH (2.0 mL) was added 
K2CO3 (95.5 mg, 0.691 mmol) and the reaction mixture was stirred at room temperature for 6 h. The 
reaction was quenched by adding H2O (5 mL) and the mixture was extracted with EtOAc (3x5 mL) and 
the combined organic layers were washed with brine (4 mL), dried (MgSO4), and concentrated in vacuo. 
158 
The resulting residue was purified with column chromatography on SiO2 (EtOAc:hexanes, 1:1) to afford 
3-181 (45.2 mg, 0.0401 mmol, 89%) as colorless oil: IR (neat) 3420, 3002, 2935, 2836, 1676, 1601, 1587, 
1563, 1480, 1466, 1420, 1392, 1365, 1345, 1317, 1288, 1257, 1224, 1210, 1164, 1140, 1114, 1080, 1044, 
1021, 968, 909, 853, 809, 826, 776, 732, 707, 663 cm
-1
; 
1
H NMR (700 MHz, CDCl3, mixture of 
diastereomers) δ 7.26-7.21 (m, 1 H), 7.19-7.15 (m, 1 H),  7.14 (d, J = 8.5 Hz, 0.5 H), 7.05 (d, J = 8.3 Hz, 
0.5 H), 6.89 (t, J = 7.2 Hz, 1 H), 6.82-6.71 (m, 5 H), 6.70 (s, 0.5 H), 6.66 (s, 0.5 H), 5.98 (s, 0.5 H), 5.96 
(s, 0.5 H), 5.71 (s, 0.5 H), 5.56 (s, 0.5 H), 5.03-4.92 (m, 2 H), 3.96-3.83 (m, 3 H), 3.78 (s, 1.5 H), 3.77 (s, 
1.5 H), 3.61 (dd, J = 34.6, 18,5 Hz, 1 H), 3.53 (s, 1.5 H), 3.52 (s, 1.5 H), 3.15-3.07 (m, 1 H), 3.05-2.98 (m, 
1 H), 2.61-2.50 (m, 1 H), 2.40 (t, J = 16.8 Hz, 1 H), 2.31-2.11 (m, 3 H), 1.91-1.53 (m, 5 H), 1.53-1.36 (m, 
2 H), 1.26-1.08 (m, 9 H) ; 
13
C NMR (175 MHz, CDCl3, mixture of diastereomers) δ159.6, 159.5, 158.4, 
158.2, 156.3, 155.1, 154.9, 148.1, 148.0, 142.5, 139.6, 139.3, 138.0, 137.3, 136.9, 136.8, 135.5, 134.7, 
132.3, 132.0. 130.1, 129.7, 129.2, 128.8, 126.6, 126.3, 124.0, 119.4, 119.3, 117.6, 116.8, 116.2, 113.4, 
112.9, 112.2, 112.2, 110.7, 110.0, 80.2, 80.1, 71.0, 70.7, 63.5, 63.4, 59.6, 55.6, 55.5, 55.2, 43.1, 42.1, 41.6, 
41.2, 39.0, 38.4, 34.5, 33.7, 32.9, 32.7, 29.8, 28.0, 28.0, 27.6; HRMS (ESI) m/z calcd for C40H47O7NNa 
([M+Na]
+
) 676.32447, found 676.32232. 
 
tert-Butyl (4aS,9aS)-3-(4'-hydroxy-4-methoxy-4'-(2-((methylsulfonyl)oxy)ethyl)-2',3',4',5'-
tetrahydro-[1,1'-biphenyl]-2-yl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-1H-
indeno[2,1-b]pyridine-1-carboxylate (3-181).  To a solution of 3-180 (40.1 mg, 0.0613 mmol) in 
CH2Cl2 (0.6 mL) was added Et3N (31.0 mg, 0.307 mmol) and MsCl (14.1 mg, 0.123 mmol). The reaction 
mixture was stirred at room temperature for 24 h. The reaction was quenched by adding H2O (5 mL) and 
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the resulting mixture was extracted with EtOAc (3x4 mL). The combined organic layers were washed 
with brine (4 mL), dried (MgSO4) and concentrated in vacuo. The resulting residue was purified with 
column chromatography on SiO2 (EtOAc:hexanes, 2:3) to afford 3-181 (40.4 mg, 0.0552 mmol, 90%) as 
colorless oil: IR (neat) 3472, 2937, 2836, 1677, 1601, 1587, 1564, 1480, 1419, 1392, 1357, 1288, 1257, 
1224, 1210, 1170, 1140, 1114, 1079, 1043, 1020, 971, 950, 909, 852, 826, 808, 776, 729, 707 cm
-1
; 
1
H 
NMR (600 MHz, CDCl3, mixture of diastereomers) δ 7.24 (td, J = 7.8, 3.7 Hz, 1 H), 7.20-7.12 (m, 1.5 H),  
7.04 (d, J = 8.4 Hz, 0.5 H), 6.89 (d, J = 7.2 Hz, 1 H), 6.82-6.66 (m, 6 H), 5.98 (s, 0.5 H), 5.93 (s, 0.5 H), 
5.70 (s, 0.5 H), 5.51 (s, 0.5 H), 5.04-4.93 (m, 2 H), 4.55-4.42 (m, 2 H), 3.79 (s, 1.5 H), 3.77 (s, 1.5 H), 
3.74 (s, 3 H), 3.68-3.56 (m, 1 H), 3.53 (s, 1.5 H), 3.51 (s, 1.5 H), 3.13-3.04 (m, 1 H), 3.02 (s, 3 H), 2.58-
2.44 (m, 1 H), 2.44-2.33 (m, 1 H), 2.32-2.06 (m, 2 H), 2.06-1.82 (m, 2 H), 1.78-1.21 (m, 4 H), 1.19-1.02 
(m, 9 H); 
13
C NMR (150 MHz, CDCl3) δ 159.5, 159.5, 158.4, 158.2, 156.3, 155.0, 154.8, 148.0, 148.0, 
142.5, 139.5, 139.3, 137.9, 137.2, 136.9, 136.5, 135.2, 134.4, 132.2, 132.0, 129.9, 119.7, 129.2, 128.8, 
126.8, 126.3, 123.5, 122.9, 119.3, 117.6, 116.8, 115.9, 113.3, 112.9, 112.3, 112.1, 111.1, 110.7, 110.0, 
110.0, 80.0, 79.9, 68.2, 67.6, 67.3, 67.1, 63.4, 63.4, 55.6, 55.5, 55.2, 55.2, 41.7, 41.6, 41.1, 40.6, 38.8, 
38.1, 37.4, 34.6, 33.7, 32.9, 32.7, 28.0, 27.9, 27.5, 26.7; HRMS (ESI) m/z calcd for C41H50O9NS ([M+H]
+
) 
732.32063, found 732.31990. 
 
tert-Butyl (4aS,9aS)-3-(4'-hydroxy-4'-(2-iodoethyl)-4-methoxy-2',3',4',5'-tetrahydro-[1,1'-biphenyl]-
2-yl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-1H-indeno[2,1-b]pyridine-1-
carboxylate (3-182). To a solution of 3-181 (6.9 mg, 0.0094 mmol) in THF (0.5 mL) was added LiI (2.5 
mg, 0.019 mmol) and the reaction mixture was heated at 60 °C for 8 h. The reaction was cooled to room 
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temperature and was quenched by adding 10% aqueous Na2S2O3 solution (5 mL). The reaction mixture 
was extracted with EtOAc (3x5 mL) and the combined organic layers were washed with brine (5 mL), 
dried (MgSO4) and concentrated in vacuo. The resulting residue was purified with column 
chromatography on SiO2 (EtOAc:hexanes, 1:5) to afford 3-182 (6.4 mg, 0.0084 mmol, 89%) as colorless 
oil: IR (neat) 3469, 3004, 2934, 2835, 1736, 1674, 1601, 1586, 1563, 1479, 1465, 1438, 1420, 1392, 1363, 
1345, 1317, 1287, 1253, 1224, 1210, 1162, 1140, 1115, 1-78, 1043, 969, 907, 855, 825, 808, 774, 728, 
706, 664 cm
-1
; 
1
H NMR (600 MHz, CDCl3, mixture of diastereomers) δ 7.24 (td, J = 7.7, 3.4 Hz, 1 H), 
7.19-7.11 (m, 1.5 H), 7.04 (d, J = 8.3 Hz, 0.5 H), 6.89 (dd, J = 7.2, 3.5 Hz, 1 H), 6.82-6.66 (m, 6 H), 5.98 
(s, 0.5 H), 5.92 (s, 0.5 H), 5.70 (s, 0.5 H), 5.49 (s, 0.5 H), 5.02-4.92 (m, 2 H), 3.79 (s, 1.5 H), 3.77 (s, 1.5 
H), 3.74 (s, 1.5 H), 3.73 (s, 1.5 H), 3.69-3.56 (m, 1 H), 3.53 (s, 1.5 H), 3.52 (s, 1.5 H), 3.43-3.35 (m, 1 H), 
3.35-3.28 (m, 2 H), 3.15-3.06 (m, 1 H), 3.05-2.98 (m, 1 H), 2.55-2.45 (m, 1 H), 2.38 (d, J = 16.9 Hz, 1 H), 
2.25-2.02 (m, 6 H), 1.86-1.61 (m, 1 H), 1.57-1.33 (m, 4 H), 1.20-1.05 (m, 9 H); 
13
C NMR (150 MHz, 
CDCl3, mixture of diastereomers) δ159.5, 159.5, 158.3, 158.2, 156.3, 156.3, 154.9, 154.8, 148.1, 142.5, 
139.5, 137.8, 137.3, 137.1, 135.3, 134.5, 132.1, 129.9, 129.6, 129.2, 128.8, 128.8, 126.8, 126.3, 123.4, 
122.9, 119.3, 117.6, 117.5, 116.8, 115.8, 113.3, 112.8, 112.3, 112.1, 111.1, 110.7, 110.0, 80.0, 79.9, 63.4, 
55.6, 55.5, 55.5, 55.2, 55.2, 48.3, 47.2, 41.7, 41.1, 38.0, 37.5, 34.0, 33.0, 32.9, 32.7, 31.7, 28.0, 28.0, 27.5, 
26.8, 14.2, 0.0, -0.3; HRMS (ESI) m/z calcd for C40H47O6NI ([M+H]
+
) 764.24426, found 764.24557. 
 
2-(8-Hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)ethyl benzoate (3-185). To a solution of 3-172 (35 mg, 
0.173 mmol) and DMAP (2.1 mg, 0.017 mmol) in CH2Cl2 (2.0 mL) at 0 °C was added BzCl (122 mg, 865 
mmol) and Et3N (175 mg, 1.73 mmol). The reaction mixture was allowed to warm to room temperature 
and stirred for 12 h. Upon completion, saturated NaHCO3 solution (5 mL) was added to the reaction 
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mixture and extracted with EtOAc (3 x 5 mL). The combined organic layers were washed with brine (5 
mL), dried (MgSO4), concentrated in vacuo and purified by flash column chromatography on SiO2 
(EtOAc:hexanes, 1:3) to afford 3-185 (34.2 mg, 0.112 mmol, 65%) as pale yellow oil: IR (neat) 3488, 
2929, 2884, 1715, 1602, 1584, 1451, 1370, 1315, 1273, 1170, 1109, 1095, 1035, 1026, 1002, 947, 934, 
887, 808, 771, 709, 687, 767 cm
-1
;  
1
H NMR (500 MHz, CDCl3) δ 8.01 (dd, J = 8.5, 1.4 Hz, 2 H), 7.55 (tt, 
J = 7.5, 1.5 Hz, 1 H), 7.43 (t, J = 7.6 Hz, 2 H), 4.52 (t, J = 6.6 Hz, 2 H), 3.98-3.90 (m, 4 H), 1.98 (t, J = 
6.6 Hz, 2 H), 1.95-1.85 (m, 2 H), 1.79-1.70 (m, 4 H), 1.65-1.57 (m, 2 H);  
13
C NMR (125 MHz, CDCl3) δ 
166.7, 133.1, 130.3, 129.6, 128.5, 108.7, 70.0, 64.4, 64.3, 61.5, 40.7, 35.2, 30.6; HRMS (ESI) m/z calcd 
for C17H23O5 ([M+H]
+
) 307.15400, found 307.15530. 
 
2-(8-(Benzoyloxy)-1,4-dioxaspiro[4.5]decan-8-yl)ethyl benzoate (3-186). To a solution of 3-185 (34.2 
mg, 0.112 mmol) in THF (2 mL) under N2 at -78 °C was added nBuLi (14.3 mg, 0.223 mmol, 140 µL 1.6 
M solution in THF) via syringe. The resulting reaction mixture was stirred at -78 °C for 1 h and was 
added benzoyl chloride (78.5 mg, 0.558 mmol, 65 µL) via syringe and was stirred for 1 h at -78 °C. The 
reaction mixture was slowly warmed to room temperature was stirred for 12 h. The reaction was 
quenched by adding H2O (5 mL) and the mixture was extracted with EtOAc (3x4 mL). The combined 
organic layers were washed with brine (4 mL), dried (MgSO4) and concentrated in vacuo. The resulting 
residue was purified with column chromatography on SiO2 (EtOAc:hexanes, 1:6) to afford 3-186 (41.2 
mg, 0.100 mmol, 90%) as colorless oil: IR (neat) 3062, 2958, 2935, 2883, 1710, 1601, 1584, 1491, 1450, 
1380, 1361, 1316, 1272, 1246, 1176, 1163, 1108, 1094, 1070, 1036, 1026, 1001, 967, 946, 922, 873, 847, 
829, 806, 772, 708, 687, 671 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.97 (d, J = 7.3 Hz, 2 H), 7.91 (d, J = 
7.2 Hz, 2 H), 7.51 (t, J = 7.4 Hz, 1 H), 7.48 (t, J = 7.4 Hz, 1 H), 7.38 (t, J = 7.7 Hz, 2 H), 7.32 (t, J = 7.7 
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Hz, 2 H), 4.44 (t, J = 6.5 Hz, 2 H), 3.95 (s, 3 H), 2.66-2.61 (m, 2 H), 2.60 (t, J = 6.5 Hz, 2 H), 1.91-1.80 
(m, 4 H), 1.69 (d, J = 11.0 Hz, 2 H); 
13
C NMR (150 MHz, CDCl3) δ 166.6, 165.7, 132.9, 132.9, 131.1, 
130.8, 129.6, 129.6, 128.4, 128.3, 108.1 81.9, 64.5, 64.4, 60.9, 36.0, 32.6, 30.6; HRMS (ESI) m/z calcd 
for C24H26O6Na ([M+Na]
+
) 433.12616, found 433.16283. 
 
2-(1-(Benzoyloxy)-4-oxocyclohexyl)ethyl benzoate (3-187). To a solution of 3-186 (41.2 mg, 0.100 
mmol) in THF (3 mL) at room temperature was added aqueous HCl (3.7 mg, 3.0 mmol, 1 mL 3 M 
solution in H2O). The reaction mixture was stirred at room temperature for 24 h. The reaction was 
quenched by adding sat. NaHCO3 (5 mL) and the mixture was extracted with EtOAc (3x5 mL). The 
combined organic layers were washed with brine (4 mL), dried (MgSO4) and concentrated in vacuo. The 
resulting residue was purified with column chromatography on SiO2 (EtOAc:hexanes, 1:5) to afford 3-
187 (31.6 mg, 0.00862 mmol, 86%) as colorless oil: IR (neat) 3602, 2963, 2931, 1708, 1601, 1584, 1491, 
1451, 1393, 1328, 1314, 1268, 1221, 1176, 1144, 1107, 1096, 1070, 1025, 1000, 957, 937, 892, 850, 832, 
807, 707, 687, 676 cm
-1
; 
1
H NMR (600 MHz, CDCl3) δ 7.99 (d, J = 7.2 Hz, 2 H), 7.90 (d, J = 7.2 Hz, 2 
H), 7.54 (t, J = 7.4 Hz, 1 H), 7.49 (t, J = 7.4 Hz, 1 H), 7.40 (t, J = 7.7 Hz, 2 H), 7.32 (t, J = 7.7 Hz, 2 H), 
4.49 (t, J = 6.4 Hz, 2 H), 2.99-2.92 (m, 2 H), 2.67 (t, J = 6.4 Hz, 2 H), 2.61 (td, J = 14.5, 5.9 Hz, 2 H), 
2.39 (dt, J = 15.5, 2.3 Hz, 2 H), 1.98 (td, J = 13.7, 4.8 Hz, 2 H); 
13
C NMR (150 MHz, CDCl3) δ 209.8, 
166.5, 165.6, 133.3, 133.0, 130.6, 129.9, 129.6, 129.5, 128.6, 128.4, 81.0, 60.7, 36.8, 35.7, 34.7; HRMS 
(ESI) m/z calcd for C22H23O5 ([M+H]
+
) 367.15400, found 367.15585. 
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2-(1-(Benzoyloxy)-4-(((trifluoromethyl)sulfonyl)oxy)cyclohex-3-en-1-yl)ethyl benzoate (3-188). To a 
solution of 3-187 (31.6 mg, 0.0862 mmol) in THF (1 mL) at -78 °C was added LiHMDS (28.9 mg, 0.172 
mmol) in THF (0.2 mL). The reaction mixture was stirred at -78 °C for 30 min and PhNTf2 (46.2 mg, 
0.129 mmol) in THF (5.0 mL) was added into the reaction mixture via syringe. The reaction mixture was 
stirred at -78 °C for 1 h allowed to warm to room temperature and stirred at room temperature for 12 h. 
The reaction was quenched with sat. NH4Cl solution (10 mL) and extracted with EtOAc (3x5 mL). The 
combined organic layers were washed with brine (5 mL), dried (MgSO4) and concentrated in vacuo. The 
residue was purified by chromatography on SiO2 (Et2O:hexanes, 1:20) to yield 3-188 (35.7 mg, 0.0716 
mmol, 83%) as colorless oil: IR (neat) 3185, 3065, 2960, 2924, 2850, 1714, 1695, 1601, 1585, 1495, 
1452, 1416, 1379, 1316, 1275, 1245, 1203, 1139, 1112, 1096, 1065, 1026, 978, 945, 866, 819, 752, 709, 
693 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.84 (t, J = 7.2 Hz, 4 H), 7.48-7.39 (m, 2 H), 7.31 (t, J = 7.8 Hz, 
3 H), 7.26 (t, J = 7.5 Hz, 3 H), 7.23-1.17 (m, 2 H), 5.67-5.62 (m, 1 H), 4.41 (t, J = 6.3 Hz, 2 H), 2.97 (dq, 
J = 17.2, 2.2 Hz, 1 H), 2.81-2.63 (m, 2 H), 2.55-2.39 (m, 3 H), 2.39-2.28 (m, 1 H), 1.91 (ddd, J =  15.9, 
10.0, 6.2 Hz, 1 H);
 13
C NMR (100 MHz, CDCl3) δ 166.7, 166.0, 148.1, 133.9, 133.3, 133.2, 130.5, 129.8, 
129.8, 129.6, 129.6, 128.5, 128.4, 127.6, 123.7, 121.5, 120.2, 118.3, 117.0, 115.0, 79.6, 60.6, 35.1, 34.5, 
31.2, 24.8; HRMS (ESI) m/z calcd for C23H21O7F3NaS ([M+Na]
+
) 521.08523, found 521.08538. 
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2-(1-(Benzoyloxy)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)ethyl benzoate 
(3-189). To a Schlenk flask with a magnetic stir bar was added 3-188 (60.0 mg, 0.120 mmol), PPh3 (3.2 
mg, 0.012 mmol), Pd(PPh3)2Cl2 (4.2 mg, 0.0060 mmol), bis(pinacolato)diboron (42.8 mg, 0.169 mmol), 
PhOK (47.7 mg, 0.361 mmol) and toluene (1.3 mL). The reaction mixture was degassed with freeze pump 
thaw cycles for 3 times. The reaction mixture was stirred at 50 °C for 5 h. The reaction was quenched 
adding H2O (10 mL). The mixture was extracted with EtOAc (3x10 mL) and the combined organic layer 
was washed with brine (10 mL), dried (Na2SO4) and concentrated in vacuo. The resulting residue was 
purified with column chromatography on SiO2 (Et2O:hexanes, 1:40 to EtOAc :hexanes, 1:15) to afford 3-
189 (44.3 mg, 0.0930 mmol, 77%) as light brown oil: IR (neat) 3003, 2977, 2923, 2849, 1712, 1638, 1602, 
1584, 1451, 1417, 1388, 1372, 1314, 1272, 1214, 1176, 1143, 1111, 1070, 1026, 1013, 910, 856, 831, 805, 
732, 707, 687, 677, 658 cm
-1
;  
1
H NMR (400 MHz, CDCl3) δ 7.92 (td, J = 9.8, 1.2 Hz, 4 H), 7.57-7.45 (m, 
2 H), 7.39-7.29 (m, 4 H), 6.51-6.46 (m, 1 H), 4.47 (t, J = 6.6 Hz, 2 H), 2.89 (d, J = 18.9, 2.0 Hz, 1 H), 
2.68-2.55 (m, 3H), 2.55-2.43 (m, 1 H), 2.33-2.45 (m, 2 H), 1.96-1.86 (m, 1 H), 1.25 (s, 12 H);
 13
C NMR 
(100 MHz, CDCl3) δ 166.7, 165.9, 139.0, 132.9, 132.8, 131.4, 130.1, 129.7, 129.7, 129.6, 128.3, 83.4, 
81.5, 61.0, 37.4, 34.9, 31.0, 24.9, 23.8; HRMS (ESI) m/z calcd for C28H33O6BNa ([M+Na]
+
) 499.22624, 
found 499.22644. 
 
tert-Butyl (4aS,9aS)-3-(4'-(benzoyloxy)-4'-(2-(benzoyloxy)ethyl)-4-methoxy-2',3',4',5'-tetrahydro-
[1,1'-biphenyl]-2-yl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-1H-indeno[2,1-
b]pyridine-1-carboxylate (3-190). To a flask was added 3-152 (25.0 mg, 0.0391 mmol), 3-189 (37.2 mg, 
0.0782 mmol) and PdCl2(dppf) (2.9 mg, 0.0039 mmol) and the flask was purged with N2. To this flask 
165 
was added THF (3.0 mL, degassed with freeze pump thaw cycles for three times) and 10% NaOH 
solution in H2O (1.0 mL, degassed with freeze pump thaw cycles for three times). The reaction mixture 
was stirred at room temperature for 36 h. The reaction was quenched by adding H2O (5 mL). The 
resulting mixture was extracted with EtOAc (3x5 mL). The combined organic layers were washed with 
brine (5 mL), dried (MgSO4) and concentrated in vacuo. The resulting residue was purified with column 
chromatography on SiO2 (EtOAc:hexanes, 1:10) to afford 3-190 (21.3 mg, 0.0247 mmol, 63%) as 
colorless oil: IR (neat) 3062, 3003, 2961, 2931, 2836, 1712, 1689, 1601, 1585, 1564, 1480, 1455, 1450, 
1417, 1391, 1364, 1343, 1315, 1266, 1224, 1212, 1165, 1112, 1079, 1070, 1043, 1025, 1001, 968, 909, 
875, 852, 825, 808, 785, 777, 731, 710, 688, 676 cm
-1
;  
1
H NMR (600 MHz, CDCl3) δ 8.01-7.89 (m, 4 H), 
7.57-7.48 (m, 2 H), 7.43-7.31 (m, 5 H), 7.22-7.12 (m, 2 H), 6.96-6.83 (m, 3 H), 6.80-6.64 (m, 5 H), 5.99 
(s, 0.5 H), 5.88 (s, 0.5 H), 5.41 (s, 1 H), 5.06-4.82 (m, 2 H), 4.55-4.40 (m, 2 H), 3.81 (s, 1.5 H), 3.80 (s, 
1.5 H), 3.73 (s, 1.5 H), 3.72 (s, 1.5 H), 3.50 (s, 1.5 H), 3.49 (s, 1.5 H), 3.16-2.90 (m, 2 H), 2.75-2.55 (m, 3 
H), 2.50-2.40 (m, 1 H), 2.39-2.05 (m, 5 H), 1.94 (td, J = 13.8, 4.7 Hz, 0.5 H), 1.45-1.20 (m, 9 H);
 13
C 
NMR (150 MHz, CDCl3) δ 166.7, 166.6, 165.9, 165.9, 165.7, 159.5, 158.6, 158.3, 156.4, 156.4, 154.9, 
154.7, 147.8, 142.5, 139.8, 139.2, 138.3, 137.4, 135.9, 135.0, 134.9, 133.4, 133.1, 132.9, 132.9, 132.8, 
132.2, 132.1, 131.5, 131.4, 130.6, 130.4, 130.2, 129.9, 129.6, 129.6, 129.5, 129.5, 129.4, 129.3, 128.8, 
128.6, 128.4, 128.4, 128.4, 127.2, 126.4, 122.3, 122.0, 119.3, 119.2, 117.8, 117.5, 115.0, 114.6, 112.9, 
112.8, 111.1, 110.0, 110.0, 81.1, 81.1, 81.1, 79.7, 79.6, 63.3, 61.0, 60.7, 55.6, 55.4, 55.4, 55.2, 55.2, 42.1, 
41.7, 36.8, 35.9, 35.8, 35.2, 34.8, 33.2, 33.1, 30.6, 30.4, 29.8, 28.5, 28.1, 28.0; HRMS (ESI) m/z calcd for 
C54H56O9N ([M+H]
+
) 862.39496, found 862.39611. 
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tert-Butyl (4aS,9aS)-3-(4'-hydroxy-4'-(2-hydroxyethyl)-4-methoxy-2',3',4',5'-tetrahydro-[1,1'-
biphenyl]-2-yl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-1H-indeno[2,1-b]pyridine-1-
carboxylate (3-180). To a solution of 3-190 (126 mg, 0.146 mmol) in MeOH (2.4 mL) was added K2CO3 
(202 mg, 1.46 mmol) and the reaction mixture was stirred at room temperature for 6 h. The reaction was 
quenched by adding sat. aqueous NaHCO3 (10 mL) and the mixture was extracted with EtOAc (3x5 mL). 
The combined organic layers were washed with brine (3 mL), dried (MgSO4) and concentrated in vacuo. 
The resulting residue was purified with column chromatography on SiO2 (EtOAc:hexanes, 2:1) to afford 
3-180 (90.5 mg, 0.138 mmol, 95%) as colorless oil. 
 
tert-Butyl (4aS,9aS)-3-(4'-(benzoyloxy)-4'-(2-hydroxyethyl)-4-methoxy-2',3',4',5'-tetrahydro-[1,1'-
biphenyl]-2-yl)-5-methoxy-4a-(3-methoxyphenyl)-2,4a,9,9a-tetrahydro-1H-indeno[2,1-b]pyridine-1-
carboxylate (3-184). To a solution of 3-178 (90.0 mg, 0.0903 mmol) in THF (5.0 mL) at 0 °C was added 
HF-pyridine (1.09 g, 7.77 mmol, 1.0 mL) via syringe and the reaction mixture was warmed to room 
temperature and stirred at room temperature for 3 h. The reaction mixture was quenched by adding 10% 
aqueous NaOH solution (3 mL) and the resulting mixture was extracted with EtOAc (3x2 mL). The 
combined organic layers were washed with brine (3 mL), dried (MgSO4) and concentrated in vacuo. The 
167 
resulting residue was purified with column chromatography on SiO2 (EtOAc:hexanes, 1:6) to afford 3-184 
(49.6 mg, 0.0654 mmol, 72%) as colorless oil: IR (neat) 3472, 2933, 2836, 1736, 1690, 1601, 1586, 1480, 
1450, 1418, 1391, 1367, 1344, 1315, 1286, 1247, 1164, 1115, 1078, 1045, 1025, 968, 936, 895, 851, 825, 
809, 775, 738, 711 cm
-1
;  
1
H NMR (400 MHz, CDCl3) δ 8.01 (d, J = 7.5 Hz, 1 H), 7.96 (d, J = 7.2 Hz, 1 
H), 7.58-7.51 (m, 1 H), 7.46-7.39 (m, 2 H), 7.25-7.13 (m, 2 H), 6.98-6.93 (m, 1 H), 6.90 (d, J = 7.4 Hz, 1 
H), 6.85 (d, J = 2.6 Hz, 1 H), 6.81-6.66 (m, 5 H), 5.98 (s, 0.5 H), 5.88 (s, 0.5 H), 5.48 (s, 0.5 H), 5.44 (s, 
0.5 H), 5.07-4.77 (m, 2 H), 3.80 (s, 3 H), 3.78 (s, 3 H), 3.74 (s, 1.5 H), 3.73 (s, 1.5 H), 3.71-3.64 (m, 1 H), 
3.52 (s, 3 H), 3.12-2.90 (m, 2 H), 2.77-2.57 (m, 1 H), 2.57-2.32 (m, 2 H), 2.32-2.06 (m, 4 H), 1.30-1.05 
(m, 9 H); 
13
C NMR (100 MHz, CDCl3) δ 166.1, 166.0, 159.5, 158.5, 158.2, 156.4, 156.3, 154.9, 154.8, 
147.8, 147.6, 142.4, 139.8, 139.2, 138.1, 136.9, 136.2, 135.3, 135.0, 134.9, 132.9, 132.2, 131.9, 131.6, 
130.4, 129.5, 129.5, 129.3, 128.8, 128.5, 128.4, 127.0, 126.2, 123.0, 122.6, 119.3, 117.8, 117.5, 115.6, 
115.0, 113.0, 112.8, 112.4, 110.9, 110.0, 82.1, 81.8, 79.8, 63.4, 58.7, 55.5, 55.2, 55.2, 55.1, 42.0, 41.7, 
39.5, 39.3, 36.1, 33.1, 33.0, 32.0, 30.9, 30.6, 29.8, 28.4, 28.0; HRMS (ESI) m/z calcd for C47H52O8N 
([M+H]
+
) 758.36874, found 758.37344. 
 
 
(11aS,16bS)-2,16-Dimethoxy-16b-(3-methoxyphenyl)-7,9,10,11a,12,16b-hexahydro-8H-5,8-ethano-
11,18-methanobenzo[f]indeno[2,1-b][1]azacyclotridecin-8-ol (3-183). To a solution of 3-182 (40.1 mg, 
0.0525 mmol) in CH2Cl2 (6.5 mL) at 0 °C under N2 was added TFA (838 mg, 7.35 mmol) and the 
reaction mixture was stirred at 5 °C for 24 h. The reaction mixture was diluted with toluene and the 
mixture was concentrated in vacuo. The resulting residue was added toluene and concentrated in vacuo 
for two more times.  
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The resulting oil was dissolved in CH3CN (32 mL) and the mixture was added DIPEA (67.8 mg, 
0.525 mmol). The reaction mixture was degassed with freeze-pump-thaw cycles for three times, and was 
heated at 80 °C for 36 h. The reaction mixture was cooled to room temperature and was concentrated in 
vacuo. The resulting residue was added sat. NaHCO3 (10 mL) and the mixture was extracted with EtOAc 
(3x5 mL). The combined organic layers were washed with brine (5 mL), dried and concentrated in vacuo. 
The resulting residue was purified with column chromatography on SiO2 (EtOAc:hexanes, 1:1 with 0.5% 
Et3N) to afford 3-183 (19.8 mg, 0.0370 mmol, 70%) as pale yellow oil: IR (neat) 3364, 3000, 2934, 2835, 
1599, 1562, 1478, 1463, 1437, 1367, 1338, 1288, 1261, 1205, 1172, 1137, 1079, 1040, 1001, 959, 909, 
872, 853, 818, 773, 731, 699 cm
-1
; 
1
H NMR (600 MHz, CDCl3, mixture of diastereomers) δ 7.23 (t, J = 
7.7 Hz, 1 H), 7.21-7.15 (m, 2 H), 7.13 (d, J = 8.2 Hz, 2 H), 7.00 (d, J = 2.6 Hz, 1 H), 6.90-6.85 (m, 2 H), 
6.80 (ddd, J = 14.0, 8.4, 2.7 Hz, 2 H), 6.75-6.69 (m, 3 H), 6.64-6.63 (m, 5 H), 6.56 (d, J = 1.8 Hz, 1 H), 
5.79 (d, J = 6.6 Hz, 1 H), .37 (d, J = 6.6 Hz, 1 H), 3.98 (t, J = 8.6 Hz, 1 H), 3.85 (s, 2 H), 3.76 (s, 3 )H, 
3.74 (s, 2 H), 3.73 (s, 3 H), 3.62 (s, 2 H), 3.48 (s, 3 H), 3.26-3.21 (m, 3 H), 3.17-3.11 (m, 1 H), 3.01-2.87 
(m, 3 H), 2.87-2.76 (m, 2 H), 2.70-2.63 (m, 1 H), 2.57-2.43 (m, 2 H), 2.43-2.35 (m, 1 H), 2.35-2.26 (m, 2 
H), 2.26-2.12 (m, 2 H), 2.05-1.81 (m, 6 H), 1.81-1.67 (m, 3 H); 
13
C NMR (100 MHz, CDCl3, mixture of 
diastereomers) δ 159.7, 159.4, 158.4, 158.4, 158.4, 156.8, 156.4, 152.9, 148.8, 144.3, 143.7, 143.1, 139.1, 
135.9, 134.9, 133.9, 133.8, 133.1, 132.1, 129.9, 129.7, 129.3, 129.2, 128.8, 128.6, 128.5, 128.4, 128.3, 
119.4, 119.3, 117.1, 116.8, 115.2, 115.2, 113.3, 112.9, 112.1, 111.9, 110.7, 110.4, 109.9, 109.5, 75.1, 74.4, 
72.1, 72.0, 58.9, 55.5, 55.4, 55.1, 53.4, 50.1, 50.0, 54.1, 43.3, 39.2, 38.9, 37.9, 37.5, 36.9, 36.2, 35.4, 34.8, 
30.9, 30.7; HRMS (ESI) m/z calcd for C35H38O4N ([M+H]
+
) 536.27954, found 536.27879. 
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(6aS,11bS)-2,11-dimethoxy-13-(4-methoxy-4'-methyl-[1,1'-biphenyl]-2-yl)-6a,7-dihydro-5H-11b,6-
prop[1]enoindeno[2,1-c]isoquinoline (3-191). To a solution of 3-183 (32.0 mg, 0.0597 mmol) in toluene 
(18 mL) was added p-toluenesulfonic acid monohydrate (160 mg, 0.841 mmol) and H2O (20.0 mg, 1.11 
mmol). The mixture was stirred at reflux for 6 h and was cooled to room temperature. The reaction 
mixture was diluted with EtOAc (30 mL), washed with 1 M NaOH aqueous solution (10 mL), H2O (10 
mL), brine (5 mL), and concentrated in vacuo. The resulting residue was purified with column 
chromatography on SiO2 (EtOAc: hexanes, 1:2) to afford 3-191 (22.8 mg, 0.0442 mmol, 74%) as pale 
yellow oil: IR (neat) 2998, 2926, 2835, 1726, 1676, 1602, 1578, 1478, 1456, 1452, 1352, 1304, 1282, 
1262, 1245, 1229, 1206, 1174, 1150, 1129, 1111, 1077, 1046, 1026, 1003, 971, 909, 883, 810, 777, 731, 
705 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 2.5 Hz, 1 H), 7.25 (t, J = 7.8 Hz, 1 H), 7.14 (d, J = 
8.4 Hz, 1 H), 6.98 (d, J = 7.9 Hz, 2 H), 6.94-6.87 (m, 4 H), 6.85 (d, J = 8.2 Hz, 1 H), 6.79 (dd, J = 8.4, 2.6 
Hz, 1 H), 6.72 (dd, J = 8.3, 2.6 Hz, 1 H), 6.60 (d, J = 2.6 Hz, 1 H), 6.00 (s, 1 H), 4.51 (d, J = 17.6 Hz, 1 
H), 3.95 (s, 3 H), 3.82 (s, 3 H), 3.78 (s, 3 H), 3.75-3.66 (m, 1 H), 3.59 (d, J = 17.5 Hz, 1 H), 3.57 (dd, J = 
18.2, 1.4 Hz, 1 H), 2.94 (d, J = 18.3 Hz, 1 H), 2.91-2.76 (m, 2 H), 2.35 (s, 3 H); 
13
C NMR (100 MHz, 
CDCl3) δ 158.6, 157.3, 157.2, 146.1, 144.9, 141.1, 138.3, 136.1, 135.4, 133.1, 131.1, 130.6, 130.3, 129.0, 
128.9, 128.7, 126.9, 118.3, 115.1, 112.2, 111.9, 111.2, 109.7, 65.3, 59.3, 55.6, 55.2, 55.0, 53.7, 47.8, 31.8, 
29.8, 21.3; HRMS (ESI) m/z calcd for C35H34O3N ([M+H]
+
) 516.25332, found 516.25302. 
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(6aS,11bS)-13-(4-hydroxy-4'-methyl-[1,1'-biphenyl]-2-yl)-11-methoxy-6a,7-dihydro-5H-11b,6-
prop[1]enoindeno[2,1-c]isoquinolin-2-ol (3-203). To a solution of 3-191 (21.2 mg, 0.0411 mmol) in 
CH2Cl2 (1.4 mL) at -78 °C was added BBr3 (154 mg, 0.617 mmol, 617 μL 1 M solution in CH2Cl2). The 
flask of the reaction mixture was moved to a 0 °C cold bath and the reaction mixture was stirred at 0 °C 
for 20 h. The reaction mixture at 0 °C was quenched by adding KH2PO4/Na2HPO4(pH=7) buffer solution 
(0.5 mL) followed by EtOAc (2 mL) and MeOH (0.5 mL). The mixture was stirred at 0 °C for 20 min and 
was warmed to room temperature. The resulting mixture was partitioned in sep funnel and the aqueous 
layer was extracted with a solvent mixture (EtOAc: MeOH, 10:1) (4x2 mL). The combined organic layers 
were dried (MgSO4) and concentrated in vacuo. The resulting residue was purified with column 
chromatography on SiO2 (MeOH: CH2Cl2, 3:100 to 3.5:100) to afford 3-203 (10.3 mg, 0.0211 mmol, 51%) 
as white semi-solid: IR (neat) 3250, 2922, 2853, 1671, 1582, 1464, 1264, 1199, 1067, 874, 813, 777, 734 
cm
-1
;  
1
H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 2.2 Hz, 1 H), 7.23 (t, J = 7.8 Hz, 1 H), 7.08 (d, J = 8.3 
Hz, 1 H), 6.96 (d, J = 8.0 Hz, 2 H), 6.89 (d, J = 8.0 Hz, 2 H), 6.87-6.79 (m, 3 H), 6.71 (dd, J = 7.5, 2.6 
Hz, 1 H), 6.61 (dd, J = 8.0, 2.2 Hz, 1 H), 6.52 (d, J = 2.4 Hz, 1 H), 5.96 (s, 1 H), 4.48 (d, J = 16.1 Hz, 1 
H), 3.91 (s, 3 H), 3.67 (t, J = 9.6 Hz, 1 H), 3.55 (d, J = 17.6 Hz, 2 H), 2.93 (d, J = 18.4 Hz, 1 H), 2.88-
2.70 (m, 2 H), 2.33 (s, 3 H); 13C NMR (150 MHz, CDCl3) δ 167.9, 157.2, 132.8, 132.6, 131.4, 131.0, 
128.9, 128.7, 127.1, 118.2, 116.0, 113.9, 109.9, 68.3, 55.1, 53.6, 38.9, 32.1, 30.5, 29.8, 29.8, 29.5, 29.1, 
23.9, 23.1, 22.8; HRMS (ESI) m/z calcd for C33H29O3N ([M+H]
+
) 488.22202, found 488.22148. 
171 
APPENDIX A 
X-RAY DATA 
 
Figure 12 X-ray structure of 1-55 
 
Figure 13 X-ray structure of 1-78 
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Figure 14 X-ray structure of 1-82 
 
Figure 15 X-ray structure of 2-36 
 
Figure 16 X-ray structure of 2-40 
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Figure 17 X-ray structure of 2-41 
 
Figure 18 X-ray structure of 3-191 
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